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Abstract 
 
Introduction 
 
Depression is important to identify in patients with a diagnosis of acute 
coronary syndrome (ACS) because it is a prevalent comorbid diagnosis that confers 
an increased risk of mortality, disability and a reduced health related quality of life. 
Identifying patients at risk of developing depression following a diagnosis of ACS is a 
new strategy that creates an important opportunity for the provision of early 
psychological support at a critical phase in a patient’s recovery. The aim of this 
research programme was to develop a brief depression risk assessment instrument for 
use by nurses in the clinical setting and test its psychometric properties using a mixed 
method approach. 
 
Methods 
 
The Depression Risk Assessment Questionnaire (DRAQ) was developed using 
a four step approach starting from a literature review, drafting of key points for 
review by an expert panel, preliminary tool development and contextual survey, and 
lastly preliminary psychometric testing. Initially a systematic review and critique of 
the literature to identify risk factors for depression in cardiac populations was 
conducted. Databases were searched for studies conducted during the period of 
January 1990 to January 2010. To be included in the review articles had to be 
published in English, refer to research conducted with adult participants (> 18 years) 
of either sex, describe a primary research study using a quantitative methodology and 
report results of risk factors for depression obtained from prospective data or 
correlations between factors obtained from cross-sectional data. These studies were 
further graded for the quality of the evidence using the Oxford Centre for Evidence-
based Medicine Levels of Evidence (2009). The results of the review were then 
developed into the first draft DRAQ. 
 
The comprehensiveness and content validity of the DRAQ was then assessed by 
a panel of eight experts and items retained or removed based on the Content Validity 
Index score. The DRAQ was then tested for internal consistency, reliability and 
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temporal stability in a sample of 220 patients admitted to a coronary care unit with a 
diagnosis of ACS. Patient acceptability of the DRAQ as part of a routine clinical 
assessment was established in a sample of 11 study participants. Contextual data 
regarding barriers and facilitators to a screening intervention were generated from 
semi-structured qualitative interviews conducted with 10 members of the cardiology 
clinical team. 
 
Results 
 
In total 1,887 full-text papers were assessed and 1,860 papers were excluded 
from the systematic review on eligibility and methodological grounds. Twenty-seven 
articles, reporting 24 studies, met the selection criteria and were included in the 
review. Based on evidence from these studies, and supporting evidence from the 
psychosocial literature, 13 risk factors were identified as highly relevant to the risk of 
developing depression. 
 
Items were generated from the risk factors and two draft questionnaires were 
developed, one designed for patients containing 15 questions and the other for staff 
members containing 7 questions. The structure, layout and choice of question type 
were influenced by the need to consider a high level of clinical utility. Following 
assessment of the comprehensiveness and content validity, the patient questionnaire 
(DRAQ) retained nine questions and the staff questionnaire retained five questions. 
Only the DRAQ was further developed and underwent psychometric testing in a 
sample of ACS patients. 
 
The internal consistency of the DRAQ was determined by calculating the 
Cronbach’s coefficient alpha based on raw (0.71) and standardized (0.68) variables. 
Temporal stability was assessed by calculating the kappa statistic based on data 
collected at two time points. The kappa result for question 5 was a negative value 
indicating no agreement. The remaining results ranged from 0.47 indicating ‘fair 
agreement’ to 1.00 indicating ‘excellent agreement’. The 11 patient participants 
reviewing the acceptability of the DRAQ reported that the questions were clear, 
relevant and appropriate to the clinical situation. 
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Interpretation of the qualitative data from the staff contextual survey revealed 
12 major interrelated issues. Staff reported a lack of a systematic approach to the 
identification of depression and a lack of access to specialised psychiatric support 
services. Key barriers to the introduction of a screening intervention were perceived 
time constraints, stigma, lack of mental health related skills and knowledge related to 
depression in cardiac patients, however, there was overall support for a depression 
screening intervention. 
 
Conclusion 
 
The results of the preliminary psychometric testing of the DRAQ have 
demonstrated acceptable levels of internal consistency reliability and temporal 
stability. Further research is needed to establish a systematic approach to depression 
screening in cardiac patients and the identification of high risk patient groups. 
Detecting such groups creates opportunities to explore preventive therapies rather 
than observing the onset of depression and then treating the disease. The DRAQ has 
been developed in response to the increasing recognition of psychological factors 
mediating health outcomes in ACS and the need to move beyond depression 
screening as a single strategy towards an integrated screening and collaborative care 
model.  
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Glossary of Terms 
 
Acute coronary syndrome: A sequela of coronary artery plaque disruption leading 
to varying signs and symptoms associated with myocardial ischaemia  
Bias: Any tendency to influence the results of a trial (or their interpretation) other 
than the experimental intervention.  
Case-control study: The observational epidemiologic study of persons with the 
disease (or other outcome variable) of interest and a suitable control (comparison, 
reference) group of persons without the disease. The relationship of an attribute to 
the disease is examined by comparing the diseased and non-diseased with regard to 
how frequently the attribute is present or, if quantitative, the levels of the attribute, in 
each of the groups. 
Clinical practice guideline: A systematically developed statement designed to assist 
health care professionals and patients make decisions about appropriate health care 
for specific clinical circumstances.  
Cohort study: The analytic method of epidemiologic study in which subsets of a 
defined population can be identified who are, have been, or in the future may be 
exposed or not exposed, or exposed in different degrees, to a factor or factors 
hypothesized to influence the probability of occurrence of a given disease or other 
outcome. The main feature of cohort study is observation of large numbers over a 
long period (commonly years) with comparison of incidence rates in groups that 
differ in exposure levels. 
Confounding variable: A variable which is not the one you are interested in but 
which may affect the results of trial.  
Heterogeneity: In systematic reviews, the amount of incompatibility between trials 
included in the review, whether clinical (ie the studies are clinically different) or 
statistical (ie the results are different from one another).  
Observational study: A family of studies in which investigators compare people 
who take an intervention with those who do not. The investigators neither allocate 
patients to receive the intervention not administer the intervention. Instead, they 
compare records of patients who had taken an intervention and been treated in 
routine practice with similar patients who had not taken the intervention. The most 
common observational designs are case-studies, case-series, case-control studies, 
cohort studies, and historically controlled studies.  
Odds: A ratio of events to non-events. If the event rate for a disease is 0.2 (20%), its 
non-event rate is 0.8 and therefore its odds are 2/8.  
Prevalence: The baseline risk of a disorder in the population of interest.  
Secondary prevention: refers to strategies used in those with an existing disease 
which prevent recurrence, or significant morbidity. For example, in someone who 
 xiv 
has a heart attack cholesterol lowering drugs are used to lower the risk of subsequent 
heart attack and death. 
Publication bias: A bias in a systematic review caused by incompleteness of the 
search, such as omitting non-English language sources, or unpublished trials 
(inconclusive trials are less likely to be published than conclusive ones, but are not 
necessarily less valid).  
Randomized trial: An epidemiological experiment in which subjects in a population 
are randomly allocated into groups, usually called study and control groups, to 
receive or not receive an experimental preventive or therapeutic procedure, 
maneuver, or intervention. The results are assessed by rigorous comparison of rates 
of disease, death, recovery, or other appropriate outcome in the study and control 
groups. 
Sensitivity: The proportion of people with disease who have a positive test.  
Specificity: The proportion of people free of a disease who have a negative test. 
Systematic review: The application of strategies that limit bias in the assembly, 
critical appraisal, and synthesis of all relevant studies on a specific topic. Systematic 
reviews focus on peer-reviewed publications about a specific health problem and use 
rigorous, standardized methods for selecting and assessing articles. A systematic 
review differs from a meta-analysis in not including a quantitative summary of the 
results. 
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Chapter 1 – Introduction 
 
Depression following an acute cardiac event is associated with higher rates of 
mortality and poorer health outcomes (Beck, Joseph, Belisle, & Pilote, 2001; Meijer 
et al., 2011). This thesis describes the development of an instrument to detect patients 
‘at risk’ of becoming depressed in the period following an acute coronary syndrome 
(ACS) event. Acute coronary syndrome is the umbrella term for the clinical signs and 
symptoms of myocardial ischaemia as seen in unstable angina (UA), non-ST segment 
elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial 
infarction (STEMI) (Overbaugh, 2009). To date initiatives have focussed on 
screening for depressive symptoms, rather than identifying future risk. Identifying 
patients who may be considered most ‘at risk’ of depression is a novel approach that 
provides an opportunity for early intervention. 
 
This chapter provides a background to the problem of depression in patients 
with a diagnosis of ACS. It briefly discusses the prevalence and clinical significance 
of depression in patients with heart disease and argues the need for identifying 
patients who have depression on admission and those who are at risk of becoming 
depressed in the weeks following discharge. It also highlights the slow uptake of 
screening strategies in the acute setting and the barriers to effective screening. The 
aims and scope of the research are identified and finally the chapter concludes with an 
overview of the structure of the thesis. 
 
Background 
 
Coronary artery disease (CAD) prevalence rates of depression in patients with 
heart disease are influenced by a number of factors including the definition of 
depression and the type of measure used to detect depression or depressive symptoms. 
Clinically significant depressive symptoms have been found in between 31% to 45% 
of patients with ACS. In addition, 20% patients with CAD may have depression that 
fulfils the criteria for major depressive disorder (MDD) as defined within the 
American Psychiatric Association Diagnostic and Statistical Manual, 4th edition (APA 
DSM IV) (Carney & Freedland, 2008; Lesperance, Frasure-Smith, Juneau, & 
Theroux, 2000; Schrader, Cheok, Hordacre, & Guiver, 2004; Thombs et al., 2006). 
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Similar rates of depression have been identified with other chronic or life threatening 
disease such as cancer (Snyderman & Wynn, 2009). In comparison a total prevalence 
rate of 3.2% was found for MDD in a national community survey conducted in 
Australia (Wilhelm, Mitchell, Slade, Brownhill, & Andrews, 2003). 
 
Depression is important to identify in patients with heart disease because it is a 
prevalent comorbid diagnosis that confers an increased risk of death and disability 
and affects a patient’s quality of life (Beck et al., 2001). An independent causal 
relationship between depression and post acute myocardial infarction (AMI) mortality 
and morbidity has yet to be established. Recent meta-analyses have produced 
conflicting results, suggesting the issue of causality remains uncertain (Nicholson, 
Kuper, & Hemingway, 2006; van Melle et al., 2004). Although there is insufficient 
evidence for a causal link between the two diseases, a long standing, robust 
association exists between depression and poor prognosis following post-myocardial 
infarction (Meijer et al., 2011). 
 
There is growing evidence that depression is not only associated with clinical 
CAD but also sub-clinical disease. Depression has been associated with the 
prospective development of carotid atherosclerosis, a marker of coronary 
atherosclerosis (Faramawi et al., 2007; Haas et al., 2005; Stewart, Janicki, Muldoon, 
Sutton-Tyrell, & Kamarck, 2007) and other markers of atherosclerosis (Seldenrijk et 
al., 2010). 
 
Recent studies suggest that the relationship between depression and adverse 
events in patients with established ACS may depend upon whether the episode of 
depression is recurrent or an initial episode. Whilst one study found a prospective 
association between recurrent depression and increased risk of cardiac events 
(Lesperance, Frasure-Smith, & Talajic, 1996) other studies have reported that 
depression occurring for the first time is most strongly associated with future 
prognosis (de Jonge et al., 2006a; de Jonge, van den Brink, Spijkerman, & Ormel, 
2006b; Dickens et al., 2008a; Grace et al., 2005). There is also convincing evidence to 
suggest that it is the timing of the depressive episode, directly after an acute cardiac 
event, that is the most significant factor determining prognosis (Parashar et al., 2006; 
Parker et al., 2008). Results from a meta-analyses have demonstrated that patients 
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developing depression in this period of unstable CAD have an increased risk of all-
cause mortality (Odds Ratio, 1.76) even after adjusting for other cardiac risk factors 
related to poor prognosis (Barth, Schumacher, & Herrmann-Lingen, 2004).  
 
Both biological and behavioural mechanisms may mediate the relationship 
between depression and prognosis following an ACS event. Research conducted on 
patients with heart disease and depression reveals a number of detrimental 
physiological changes, including increased platelet adhesion, increased inflammatory 
response and decreased heart rate variability. These physiological abnormalities are 
surrogate markers of increased cardiac risk (Carney et al., 2007; Kuijpers, Hamulyak, 
Strik, Wellens, & Honig, 2002; Lesperance, Frasure-Smith, Theroux, & Irwin, 2004). 
Furthermore, some studies suggest that depression in those already vulnerable to 
cardiac arrhythmia heightens the risk of resuscitated cardiac arrest or sudden cardiac 
death (Ahern et al., 1990; Frasure-Smith, Lesperance, & Talajic, 1995). Further 
research is required to clarify the relationship between, depression, ventricular 
arrhythmia, left ventricular function and mortality (Jiang, Glassman, Krishnan, 
O'Connor, & Califf, 2005). 
 
In addition to their physiological vulnerability, patients who are depressed find 
it more difficult than non-depressed patients to modify their risk factors through 
lifestyle change (Meyers, Gerber, Benyamini, Goldbourt, & Drory, 2012). Of 
particular concern are the low smoking cessation and exercise rates (Glassman & 
Shapiro, 1998) and reduced adherence to low fat diets (Zieglestein et al., 2000). 
Depressed patients are more than twice as likely not to adhere to prescribed therapies 
(DiMatteo, Lepper, & Croghan, 2000). Depression is associated with poorer 
attendance at cardiac rehabilitation programmes (Glazer, Emery, Frid, & Banyasz, 
2002) and lower adherence to medical treatment (Bane, Hughes, & McElnay, 2006). 
Recent studies have found behavioural mechanisms explained a substantial proportion 
of the excess risk of MI or cardiac death associated with depressive symptoms (Win 
et al., 2011; Ye et al., 2013). 
 
Patients who develop depression following an acute admission for ACS are a 
disadvantaged group. They are likely to experience a lower quality of life (Beck et al., 
2001) and poorer health outcomes (Meijer et al., 2011) and they are further 
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disadvantaged because they will feel less able to make lifestyle changes in order to 
actively promote health and manage their heart disease (Meyers et al., 2012). 
 
Research has provided greater insight into the development of depression in 
cardiac patients. Dickens and colleagues (2004) found that 21% of the participants in 
their study were already depressed prior to admission for a first AMI. However, this 
may be an underestimation of the true figure in clinical practice. Prospective studies 
following the natural history of depression report an additional 10 to 20% of patients 
develop depression following discharge from hospital (Dickens et al., 2004; 
Lesperance et al., 1996; Travella, Forrester, Schultz, & Robinson, 1994). This 
evidence suggests a need to identify those patients who may already be depressed on 
admission and those patients at risk of becoming depressed following discharge from 
hospital. 
 
Importance of Screening and Identifying Individuals at Risk 
 
Identifying patients who are depressed is important so that they may receive 
appropriate treatment for their condition, however, depression is under diagnosed in a 
cardiac setting, with as little as 10% of depressed patients actually diagnosed and 
treated (Amin, Jones, Nugent, Rumsfeld, & Spertus, 2006; O'Connor, Gurbel, & 
Serebruany, 2000; Reddy et al., 2007; Ziegelstein et al., 2005). Research indicates a 
need for formalised screening for depression to be integrated into clinical practice. In 
Australia, ACS practice guidelines (Aroney, Aylward, Kelly, Chew, & Clune, 2006) 
and a consensus statement from the National Heart Foundation (Colquhoun et al., 
2013) recommend evaluation of psychosocial risk factors, in particular the assessment 
of depression.  
 
Several instruments have been found to have acceptable psychometric 
properties to detect depression in patients with heart disease: Hospital Anxiety and 
Depression Scale; (Bambauer, Locke, Aupont, Mullan, & McLaughlin, 2005) Patient 
Health Questionnaire – 9 (Stafford, Berk, & Jackson, 2007); 90-item Symptom 
Check List (SCL-90); Beck Depression Inventory (BDI); 17 – item Hamilton 
Depression Rating Scale (HAM-D) (Strik, Honig, Lousberg, & Denollet, 2001a). In 
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addition, the Cardiac Depression Scale (Hare & Davis, 1996) has been developed 
and validated specifically for cardiac patients.  
 
Although validated screening instruments exist, in clinical practice patients are 
not routinely screened for depression (Herridge, Stimler, Southard, & King, 2005; 
Huffman et al., 2006a). This is particularly true of patients admitted to busy cardiac 
units with high medical acuity (Huffman et al., 2006b). Both internationally and in 
Australia, advances in medical care have decreased the length of hospital stay for 
patients following an acute myocardial infarction (Berger et al., 2008). Significantly, 
treatment options such as primary angioplasty increase the proportion of time patients 
are engaged in medical procedures and decrease time available for assessment of 
psychosocial needs.  
 
Studies have identified barriers to screening and diagnosis of depression in 
acute cardiac settings. These include a lack of knowledge among medical and nursing 
staff regarding screening, diagnosis, and identification of risk factors for post ACS 
depression (Dobbels et al., 2002; Ziegelstein et al., 2005). Importantly, there is a 
reported lack of clinical psychology support in many cardiology units in Australia 
(Goldston & Baillie, 2008). Furthermore, whether a patient discloses symptoms can 
also be influenced by the health provider’s communication skills, the patient’s own 
understanding of the nature of their symptoms and the amount of time that is available 
for assessment (Hickie, Davenport, & Ricci, 2002; Savard, 2004). 
 
The clinical importance of depression in patients with heart disease is well 
recognised. Clinical guidelines recommend screening for depression, however, there 
has been limited transfer of current evidence into practice (Lichtman et al., 2008). 
Strategies for facilitating the adoption of depression screening are not well described 
in the literature. As a consequence, screening for depression is not routinely 
undertaken and depression remains under diagnosed in patients with heart disease 
(Amin et al., 2006; O'Connor et al., 2000; Reddy et al., 2007; Ziegelstein et al., 2005). 
 
Both structured clinical interviews and self-report questionnaires may be used to 
identify depression in cardiac patients (Thombs et al., 2006). These methods are 
designed to detect current depression or depressive symptoms but do not predict the 
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risk of future depression. Patients who may become depressed following discharge 
will not be identified using currently available tools. 
 
It is not feasible to perform repeated screening of every ACS patient following 
discharge into the community as this may be a considerable drain upon the resources 
of cardiac rehabilitation services. Depressed patients are less likely to attend cardiac 
rehabilitation programmes and as a consequence there may be limited opportunities to 
screen for depression out of hospital (Glazer et al., 2002). Opportunities to screen for 
depression following discharge are further limited by the geographical location of 
patients. A significant proportion of patients treated for ACS at tertiary hospitals in 
Australia live in rural or remote locations with reduced access to medical services.  
 
An alternative strategy would be the identification of the sub-group of patients 
at risk of developing depression, enabling resources to be focused more effectively 
and prompt intervention initiated for those with the greatest need. There is a relatively 
small and diverse body of research exploring risk factors for depression in cardiac 
patients. Reported risk factors include female sex; younger age (<55 years); previous 
history of depression, anxiety or stress; depressive symptoms in hospital; severe left 
ventricular dysfunction; pre-existing medical condition; and smoking (Dickens et al., 
2004; Schrader et al., 2004; Spijkerman, van den Brink, Jansen, Crijns, & Ormel, 
2005a; Strik, Lousberg, Cheriex, & Honig, 2004) Whilst a number of risk factors for 
developing depression have been identified, no definitive predictive model exists to 
inform screening protocols. 
 
Defining the Population 
 
ACS is the umbrella term used to describe any condition characterized by signs 
and symptoms of sudden myocardial ischaemia (Overbaugh, 2009). The term ACS 
has been adopted to reflect the evolving diagnostic definitions associated with this 
patient population and more clearly reflects common underlying biological processes 
of AMI and UA. The signs and symptoms of ACS constitute a continuum of intensity 
from UA to NSTEMI to STEMI. Partially or intermittently occluded coronary arteries 
normally result in UA or NSTEMI, whereas STEMI results from a fully occluded 
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coronary artery (Overbaugh, 2009). Depression is significantly associated with UA, 
NSTEMI and STEMI. 
 
Problem Statement 
 
Although there is strong evidence regarding the adverse impact of a diagnosis of 
depression in post ACS patients depression remains under diagnosed with screening 
programmes yet to be fully integrated into routine clinical practice. Patients may 
already be depressed prior to an admission for ACS and this could be detected by 
screening for current depressive symptoms using existing tools, such as the PHQ-9. 
These instruments identify current depressive symptoms, however, no screening tools 
exist to identify the significant proportion of patients who may be ‘at risk’ of 
developing depression following discharge from hospital. 
 
A strategy of screening for depression symptoms following discharge misses 
an opportunity for early psychological support of patients at a critical phase in their 
recovery. Whilst there has been some research in the field, no theoretical framework 
describing the risk factors for depression in ACS patients exists to inform screening 
practice. 
 
Research Aim 
 
To develop a brief screening instrument designed to assess the risk of 
developing depression following a diagnosis of ACS that can be used by nursing 
staff in the acute clinical setting. 
 
Objectives 
 
1. To identify the risk factors for depression from the literature and critically 
evaluate the evidence base. 
 
2. To define the concept of depression in patients with a diagnosis of ACS, 
and develop a theoretical framework illustrating potential risk factors for 
post ACS depression. 
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3. To determine the barriers and facilitators to the introduction of a screening 
intervention as perceived by the key members of a clinical team and to use 
this contextual data to aid the development of the questionnaire. 
 
4. To develop a risk assessment instrument for post ACS depression with 
high clinical utility that can be used by nurses in hospital. 
 
5. To perform preliminary assessment of the psychometric properties of the 
instrument following application in a sample of ACS patients. 
 
6. To establish the extent to which patients find the questionnaire acceptable 
as part of clinical care. 
 
A schematic diagram of the research design is included as figure 1.1. 
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Figure 1.1 
Schematic diagram of the research design 
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Note. PHQ-9 = Patient Health Questionnaire-9; ACS = acute coronary syndrome. 
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Limitation of the Scope of Research 
 
There are a number of existing questionnaires that have high clinical utility and 
validity that can detect current levels of depressive symptoms. The scope of this 
research is confined to understanding the epidemiological concept of increased risk 
of developing a disease in relation to the development of depression in ACS patients.  
 
The focus of this project has been limited to identifying those risk factors for 
post ACS depression that can be readily confirmed in hospital by patients completing 
a self-report questionnaire. There are a number of risk factors for depression that 
may be difficult, costly, or inappropriate to assess in an acute clinical environment 
and this has guided the development of the risk assessment questionnaire. 
 
Significance 
 
This research adds to the body of knowledge about the nature of depression in 
ACS and specifically addresses the underlying knowledge deficit regarding 
identification of risk factors for the disease. The risk assessment instrument is unique 
to the field of cardiovascular nursing practice. The instrument is intended to form 
part of a novel systematic approach to screening that will combine both screening for 
current depression with risk assessment for future depression. 
 
This study represents an initial step towards the identification of those patients 
with depression and those most at risk of developing depression once discharged 
back to the community. Recognition of patients who may require additional 
psychosocial support, or assistance with modifying cardiac risk factors, will enable 
existing cardiac rehabilitation services to direct appropriate interventions to 
individuals most in need. Screening for patients with an increased risk of depression 
can facilitate efficient utilization of available resources.  
 
Overview of the Layout of the Thesis 
 
Following the introduction, problem statement and research questions 
identified in Chapter 1, Chapter 2 explores the literature surrounding the 
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identification of depression in clinical populations and provides a detailed review of 
research studies examining risk factors for depression in ACS populations.  
 
Chapter 3 describes the conceptual framework providing the theoretical 
underpinning of the risk factor questionnaire. Chapter 4 describes the research 
methods adopted for the study including the methods for the qualitative research 
component, questionnaire development and psychometric testing. The results of the 
qualitative analysis and a discussion on the psychometric qualities of the risk factor 
questionnaire are presented in Chapter 5. In Chapter 6 the principal findings are 
reviewed, implications for practice discussed, and recommendations offered. 
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Chapter 2 – Literature Review 
 
Introduction 
 
This chapter has been divided into two sections. Section One provides an 
introduction to the concept of risk, and the diagnosis and aetiology of depression. 
Section Two commences by describing the process undertaken to perform the 
systematic review of the literature, including a detailed account of the evidence 
evaluation process. The section continues with the review of the research related to 
significant individual risk factors for depression that have been identified in 
primarily ACS patients and discusses the supporting evidence found in the wider 
psychosocial literature.  
 
Section 1 
 
Concept of Risk, and the Diagnosis and Aetiology of Depression 
 
Undertaking a review and critique of research studies addressing the ‘risk’ of 
developing depression raises a number of issues that relate to the epidemiological 
concepts of causation and risk. The term ‘risk factor’ is commonly used to describe 
factors that are positively associated with the risk of developing a disease but are not 
proven or are insufficient to cause the disease (Lawrence & Farmer, 2004). 
 
Chance, bias and confounding need to be excluded before an association can be 
confirmed as causal (Lawrence & Farmer, 2004). Causal inference is further 
determined by the presence of the correct temporal relationship. Regarding the study 
of risk factors for depression, this refers to the presence of the risk factor prior to the 
development of depression. Significantly, this is difficult to determine in cross-
sectional studies as they cannot provide evidence of the time sequence of events 
(Hulley et al., 2001). Studies that have a prospective, cohort design enable the 
predictive nature of risk factors to be analysed. The evidence for a causal relationship 
is further strengthened by plausibility, consistency and presence of a dose-
relationship between the risk factor and the disease.  
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Previous research studies exploring the possible causes of depression in 
psychiatric and community populations have found multiple and diverse risk factors 
responsible for the development of the disease. At present, there is little evidence to 
suggest that the risk factors for post ACS depression are restricted to a single 
proximal cause (Davidson, Rieckmann, & Lesperance, 2004). With this in mind, a 
wide-ranging search of the nursing, medical and psychosocial literature was 
undertaken. Only a small number of prospective, cohort studies have been conducted 
in cardiac populations. To fully explore all the potential risk factors for depression in 
this population, cross-sectional studies have been included in the review. The 
evidence in support of these risk factors has been considered in light of the additional 
findings from prospective, cohort studies conducted in ACS samples and the wider 
literature. 
 
Clarification of the Term ‘Depression’ 
 
There are a number of psychiatric disorders, of which depression is one, in 
which pathological mood and related disturbances are major features of the clinical 
profile and are collectively referred to as ‘mood disorders’ (Sadock & Sadock, 2003). 
Mood Disorders are sustained emotional states considered as syndromes consisting 
of a cluster of signs and symptoms that occur over a period of time and which mark a 
distinct change in the person’s normal functioning (Sadock & Sadock, 2003). The 
presence of depressive symptoms in ACS patients may be a transient response but it 
may also be a manifestation of a previous history of major depressive disorder, 
continuation of a first episode of depression with onset before the acute event, or 
onset of depression after the event (Shapiro, Fedoronko, Epstein, Mirasol, & Desai, 
2008). 
 
Within the reported cardiovascular literature, the term depression is often used 
to describe a number of differing psychiatric conditions making direct comparison 
between research studies complicated and sometimes impossible (Davidson, 
Rieckmann, & Rapp, 2005). Psychiatric clinical definitions were described within the 
American Psychiatric Association Diagnostic and Statistical Manual, 4th edition 
(APA DSM-IV). In the interests of clarity, a brief overview of the clinical definitions 
of depression and related disorders most relevant to ACS are provided. 
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Major Depressive Disorder (MDD). 
 
An essential diagnostic feature of major depression is a period of two weeks 
duration in which there is either depressed mood or loss of pleasure in nearly all 
activities. In addition, the individual must experience at least four symptoms from a 
range including changes to appetite or weight, sleep, and psychomotor activity; 
decreased energy; feelings of guilt or worthlessness; poor concentration or difficulty 
making decisions; recurrent thoughts of death or suicidal ideation. Symptoms must 
be new or worse than previously experienced and the episode must be accompanied 
by significant impairment or distress leading to diminished functioning. MDD is 
defined by the occurrence of a major depressive episode that cannot be ascribed to 
another mental disorder or medical condition, and is not substance-induced (Shapiro 
et al., 2008). 
 
Mood disorder due to a general medical condition. 
 
This diagnosis is reserved for a significant mood disturbance considered to be a 
direct physiological consequence of a medical condition known to cause depression. 
Examples given in the DSM IV manual are hypothyroidism, stroke and multiple 
sclerosis. To date, the biological pathways between depression and acute coronary 
syndrome have yet to be identified and a direct physiological causal link has not been 
established (Belmaker & Agam, 2008). 
 
Adjustment disorder with depressed mood. 
 
This mood disturbance occurs in response to an identifiable psychological 
stressor, however, although clinically significant, the full criteria are not met for 
MDD. Mood and/or behavioural symptoms must develop within three months after 
the onset of the stressor and resolve with six months following resolution of the 
stressful event. An episode of ACS could be deemed such a stressor and therefore 
may trigger adjustment disorder with depressed mood in that population (Davidson et 
al., 2005). 
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Depression not otherwise specified (NOS). 
 
This classification describes milder forms of depression not meeting the full 
diagnostic criteria for MDD. Symptoms may have been present for less time or they 
are fewer in number but still associated with significant impairment of function. 
‘Depressive symptomatology’ is one such term frequently used to describe the 
presence of symptoms in the absence of core criteria (Dobbels et al., 2002).  
 
There are a number of other terms associated with varying degrees of milder 
depression that do not meet the criteria recognized by the DSM-IV. These terms are 
minor depression, sub-syndromal depression, sub-threshold depression, and sub-
clinical depression.  
 
Diagnostic Issues 
 
In recent years there has been a debate in the psychological literature regarding 
the issue of whether depression should be regarded as a categorical diagnostic entity 
(a ‘case’ of depression) or a continuous dimensional variable. Currently, there exists 
a general consensus that depression may be regarded as graduating from mild to 
severe disease along a graded path (Steptoe, 2007a). Historically, a categorical 
perspective developed in recognition of a critical threshold of intensity of disease 
that required treatment because of an increased risk of impaired daily function or 
self-harm (Creed & Dickens, 2007). However, diagnostic thresholds have been 
determined over a number of years in psychiatric populations and there is evidence to 
suggest that the significance of thresholds, as related to health outcomes, may differ 
in cardiac patients (Frasure-Smith et al., 1995; Ketterer et al., 2006). In particular, an 
association has been determined between mild symptoms of depression, not regarded 
as clinically significant, and mortality risk at four months post AMI (Bush et al., 
2001).  
 
The term sub-clinical depression has been used in the psychological literature 
to describe the presence of mild depressive symptoms not meeting the full diagnostic 
criteria for MDD (APA, 1994). Sub-clinical depression is important to identify in 
cardiac patients not only in relation to medical prognosis but also because it has been 
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established as a significant risk factor for the development of MDD in prospective 
studies conducted in community samples of women, adolescents and elderly adults 
(Angst & Merikangas, 1997; Brown, Bifulco, Harris, & Bridge, 1986a; Horwath, 
Johnson, Klerman, & Weissman, 1992; Kessler, Zhao, Blazer, & Swartz, 1997a; 
Lewinsohn, Solomon, Seeley, & Zeiss, 2000). Furthermore, whilst the studies are 
fewer in number, there is evidence that the presence of depressive symptoms in 
hospitalised cardiac patients has been found to predict future depressive episodes 
(Lesperance et al., 1996; Mayou et al., 2000; Schrader et al., 2004; van Melle et al., 
2006). 
 
Identifying ‘Depression’ in Cardiac Populations 
 
In clinical practice, the two differing conceptual definitions of depression co-
exist. Depression regarded as a continuous variable has led to the development of 
questionnaires to measure the number of significant symptoms of the disease as an 
indication of the severity of depression. However, as previously discussed, 
depression can also be regarded as a ‘case’ of depression where distinct criteria must 
be present before a diagnosis can be made (figure 2.1). The latter has given rise to 
the development of lengthy structured clinical interviews in which a clinician decides 
whether specific criteria for a depressive disorder have been met and determines the 
severity of the case. It is essential to have a clear understanding of how depression 
has been defined and measured. For example, prevalence rates of depression in 
patients with CAD have a reported range between 20% and 45%, primarily 
influenced by the definition of ‘depression’ applied and the type of measure used to 
detect depression. (Carney & Freedland, 2008; Lesperance et al., 2000; Schrader et 
al., 2004; Thombs et al., 2006). Higher rates of clinically significant depressive 
symptoms have been found in patients with CAD (31% to 45%) compared to rates 
for diagnosed cases of MDD (20%). Clear definitions enable more accurate 
understanding of the relationship between depressive illness and cardiac disease and 
this is particularly important when undertaking a critique of the research literature in 
this field. 
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Self-Report Questionnaires 
 
Self-report questionnaires play an important role in screening patients for a 
level of depressive symptoms that might indicate a diagnosable depressive illness 
requiring treatment. Clinical guidelines and the latest National Heart Foundation 
consensus statement (Colquhoun et al., 2013) recommend their use as part of a 
screening strategy for identifying depression in cardiac patients (Lichtman et al., 
2008). The accuracy of a questionnaire to detect cases of depression, when compared 
to a full diagnostic interview, is reflected in the questionnaires sensitivity and 
specificity. Psychometric testing of the questionnaire enables the identification a 
‘cut-off’ score above which MDD, or other depressive illness, might be diagnosed. 
However, patients may still be misclassified as having depressive illness that is not 
later confirmed by clinical interview (false positives) or not identified as having 
depressive illness when in fact their illness may meet diagnostic criteria (false 
negatives) (Creed & Dickens, 2007). Many self-report questionnaires have been 
developed and tested in community, psychiatric or non-cardiac medical samples and 
therefore further testing is required with cardiac patients in order to validate 
appropriate cut-off scores specifically for that population. This additional testing has 
been undertaken and several questionnaires have been found to have acceptable 
psychometric properties and valid cut-of points for use in a cardiac setting: Hospital 
Anxiety and Depression Scale; (Bambauer et al., 2005) Patient Health Questionnaire 
– 9 (Stafford et al., 2007); 90-item Symptom Check List (SCL-90); Beck Depression 
Inventory (BDI); 17 – item Hamilton Depression Rating Scale (HAM-D) (Strik et al., 
2001a). In addition, the Cardiac Depression Scale (CDS) (Hare & Davis, 1996) has 
been developed and validated specifically for cardiac patients. The current consensus 
statement from the National Heart Foundation of Australia (Colquhoun et al., 2013) 
recommends routine screening of patients with CHD with a simple tool such as the 
Patient Health Questionnaire –2 (Kroenke, Spitzer, & Williams, 2003). 
 
 
 
  
Figure 2.1 
A diagram illustrating two conceptual definitions of depression 
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Depressive illness is characterised by a number of symptoms that may be 
described as either cognitive or somatic (physical). For example, low mood is a 
cognitive symptom, however, decreased appetite would be regarded as somatic. 
Identifying depression in cardiac patients using self-report measures can be further 
complicated by what has been termed ‘criterion contamination’ (Creed & Dickens, 
2007) where symptoms of depression can overlap with the symptoms of cardiac 
disease itself as would be the case with ‘fatigue’. Attempts to overcome this issue 
have resulted in the development of questionnaires that exclude many of the somatic 
symptoms e.g. the Hospital Anxiety and Depression Scale (HADS) (Zigmond & 
Snaith, 1983). However, it may be important to identify both cognitive and somatic 
symptoms of depression not just in relation to identifying depressive illness but also 
because recent research suggests specific symptoms may be important indicators of 
poor prognosis in both ACS and stable CAD patients (Davidson et al., 2010; Doyle, 
Conroy, McGee, & Delaney, 2010; Hoen, Whooley, Martens, Van Melle, & de 
Jonge, 2010; Leroy, Loas, & Perez-Dias, 2010; Roest et al., 2011). 
 
Who is ‘at Risk’ of Developing Depression Following a Diagnosis of ACS? 
 
Depressive symptoms can be identified in patients with heart disease using 
validated, self-report questionnaires as part of a screening strategy. Individuals 
experiencing depressive symptoms should have a diagnosis of depression confirmed 
by further clinical interview so that appropriate treatment or support may be 
provided. Whilst it is possible to identify patients who are experiencing current 
depressive illness, a ‘snapshot’ of their current mental health status, it is not possible 
to identify patients who may be at risk of developing depression in subsequent weeks 
or months. No known self-report questionnaire or screening protocol is available for 
this purpose. This raises important questions related to clinical practice. If it is only 
possible to identify patients with current disease, when should cardiac patients be 
screened for depression, during a hospital admission, 2 weeks following an acute 
event, or six months following admission?  
 
To date, there exists a significant gap in the research literature to inform 
screening protocols. In addition to the timing of screening, other unanswered 
questions include: What is the most appropriate cardiac setting for screening? Who 
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should be responsible for identifying depression in cardiac patients? How can we 
ensure that screening for depression leads to improved health outcomes for cardiac 
patients? 
 
The concept of ‘risk’ associated with the development of cardiac disease is 
well established. In clinical practice, health professionals routinely identify known 
risk factors for the development of cardiac disease. In comparison, the concept of 
‘risk’ associated with the development of depression in patients with heart disease is 
not well described in the cardiac literature. In the wider psychosocial literature, 
multiple risk factors for depression have been identified and there exists a 
comprehensive body of knowledge describing these risk factors and their often 
complicated relationships with one another (Kendler, Gardner, & Prescott, 2002, 
2006a). 
 
Screening for Depression in the Cardiac Setting 
 
At present, depression is under diagnosed in cardiac patients (Amin et al., 
2006; O'Connor et al., 2000; Reddy et al., 2007; Ziegelstein et al., 2005). However, 
recent American Heart Association recommendations (Lichtman et al., 2008) have 
been criticised for ‘premature’ advice regarding the routine screening of depression 
in clinical practice. Detractors point to a paucity of evidence demonstrating that 
screening for depression improves outcomes in cardiovascular populations (Hasnain, 
Vieweg, Lesnefsky, & Pandurangi, 2011). Others concede that, whilst there is a lack 
of evidence regarding improved outcomes, cardiovascular patients should be at least 
as likely as primary care patients to benefit from depression screening in the context 
of similar collaborative care treatment programmes for depression established in the 
community (Whooley, 2009). 
 
Collaborative care models often incorporate non-medical care managers to 
coordinate care between the patient, primary health care provider and psychiatrist. A 
meta-analysis of community-based collaborative care programmes found evidence of 
improved mental health outcomes at 6 months with further evidence of longer- term 
benefits up to five years (Gilbody, Bower, Fletcher, Richards, & Sutton, 2006). More 
recently, studies of collaborative care programmes adapted for cardiac patients have 
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been able to demonstrate significant improvements in mental health outcomes, 
adherence to medical treatments, reduced number and intensity of cardiac symptoms 
and improved health-related quality of life (Huffman et al., 2011; Rollman et al., 
2009). This model of collaborative care has been shown to be particularly effective 
when a nurse care manager works with the primary care provider to improve 
treatment of both depression and cardiovascular risk factors (Katon et al., 2010). 
 
A strategy of depression screening, in the absence of significant changes to 
current models of care, has been criticised as unlikely to provide the necessary 
benefits to patients (Thombs et al., 2008). The present practice of identifying 
depression in cardiac patients is based on a medical model of diagnosis and treatment 
of recognised disease. Self-report questionnaires used for screening purposes are 
designed to detect current depressive disease. This thesis argues the case for the 
adoption of a broader, integrated model that encompasses not only detection of 
depression requiring treatment but also addresses a primary aim of screening as 
practised in public health, to identify individuals ‘at risk’. This broader model would 
incorporate the detection of current disease, using recognised screening methods, and 
the identification of individual patients at risk of developing depression using a risk 
assessment questionnaire designed for use in the acute setting. Crucially, this model 
should be set in a context of collaborative care partnerships between patients, 
primary health care providers and tertiary or community based cardiac rehabilitation 
and mental health services. 
 
Aetiological Perspectives 
 
Major depressive disorder may be regarded as a chronic illness with a clinical 
presentation that may alter in severity in any individual over time and may be 
characterised by periods of remission. In the field of psychiatric epidemiology, a 
substantial number of putative risk factors for MDD have been identified although it 
has not always been possible to discriminate association from causation (Fava & 
Kendler, 2000). The onset of MDD occurs at different times across a lifespan. MDD 
is found in young children and adolescents (Birmaher, Ryan, & Williamson, 1996; 
Lewinsohn, Clarke, Seeley, & Rohde, 1994a) as well as young, middle aged and 
elderly adults (Andrade et al., 2003; Beekman, Copeland, & Prince, 1999; Forsell & 
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Winblad, 1999). Factors associated with onset may differ in significance at various 
stages of life. Risk factors may be referred to as either being distal or proximal to the 
depressive episode, for example events occurring in childhood compared to recent 
severe life events. 
 
Clinically, a familial risk for MDD has been well recognised as a feature of the 
disease (Farmer, 2001). Whether this is related to family experiences or genetic risk 
factors has been a focus of much past research. The majority of studies conducted on 
twins in community samples have found a modest degree of heritability. In a meta-
analysis of family and twin studies the investigators concluded that genes contributed 
to approximately one third of the variance in liability to develop MDD (Sullivan, 
Neale, & Kendler, 2000). The remaining variance was accounted for by primarily 
environmental influences specific to individuals rather than shared family 
experience.  
 
These results were confirmed in a more recent study of over fifteen thousand 
twin pairs from the National Swedish Twin Registry (Kendler, Gatz, Gardner, & 
Pedersen, 2006b). The investigators estimated the risk of inheriting lifetime major 
depression to be 38% in the overall sample. The familial risk of MDD has also been 
demonstrated in a number of family studies (Klein, Lewinsohn, Seeley, & Rohde, 
2001; Weissman et al., 1987; Weissman, Warner, Wickramaratne, Moreau, & 
Olfson, 1997; Weissman et al., 2005). The children of parents with MDD have three 
times the risk of developing MDD themselves in childhood or adolescence 
(Williamson, Birmaher, Axelson, Ryan, & Dahl, 2004). 
 
Over the last decade there have been attempts to model the developmental 
pathways through which numerous risk factors lead to depression in both men and 
women (Kendler et al., 2002, 2006a; Kendler, Kessler, Neale, Heath & Eaves, 1993). 
Kendler and colleagues (2002, 2006a) used structural equation modelling in samples 
of male and female twin pairs to identify pathways leading to major depression. 
Eighteen predictor variables were organised into five groups approximately 
reflecting developmental periods across the lifespan in order to model the 
relationships between individual risk factors for MDD. The resulting models 
included a large number of risk factors from multiple domains, however, these 
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models were only able to predict approximately 50% of MDD in twin pairs of both 
sexes. The results of this research serve to illustrate the aetiological complexity of 
MDD and the difficulty of capturing the nature of all potential risk factors over time. 
 
The models were able to clearly demonstrate that there were high correlations 
between risk factors and that many distal risk factors were predictive of more 
proximal risk factors for depression. For example, childhood sexual abuse in women 
predicted adolescent conduct disorder. Conduct disorder symptoms increased the risk 
of lifetime traumas, low social support and strongly predicted substance abuse, all 
risk factors for depression. A history of conduct disorder was a direct and 
independent risk factor for the onset of major depression (Kendler et al., 2002). 
These interactions were seen across multiple risk factors and domains in both men 
and women.  
 
This is an important finding in relation to identifying depression in ACS 
patients. Although there are multiple risk factors for depression, many of these risk 
factors may have been present from an early age and an increased ‘risk’ of 
depression may have been present over a period of many years and may subsequently 
have already resulted in an episode of MDD by the time that a patient has developed 
heart disease in adulthood. A questionnaire attempting to assess the risk factors for 
depression in an adult population would not necessarily need to include early risk 
factors because a past history of MDD itself is a very strong risk factor for a further 
episode. 
 
In summary, depression can be viewed as graduating from mild to severe 
disease. Major depression should be regarded as a chronic disease that may alter in 
severity in any individual and is often characterised by periods of remission and 
relapse. In clinical practice, a patient admitted to a Coronary Care Unit may already 
be suffering from a first-onset episode of depression prior to their admission and 
therefore have depressive symptoms in hospital, or they may have a history of 
depression and the acute admission may trigger a relapse. Alternatively, an 
admission for ACS can been regarded as a significant stressor and subsequently a 
patient following discharge may be vulnerable to adjustment disorder with depressed 
mood or be at risk of developing MDD. 
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Approximately one third of MDD cases can be attributed to a genetic risk 
(Kendler et al., 2006b), however, primarily environmental influences affecting 
individuals are likely to be responsible for the remaining variance (Sullivan et al., 
2000). Evidence from the extensive psychosocial literature indicates that depression 
has multiple, complex and diverse risk factors found across a number of domains and 
that these risk factors are highly correlated. Some of the patients that display 
depressive symptoms in hospital may have been vulnerable to depression over a 
number of years with distal risk factors, for example childhood adversity, leading to 
more proximal risk factors in adulthood. In such cases an episode of depression may 
have developed before an admission for ACS. 
 
Depression can be identified in cardiac patients using established, validated 
self-report questionnaires and additional confirmation of diagnosis by further in-
depth clinical interview. However, there is not a strong evidence base to inform 
screening protocols designed for clinical practice and it is unclear how and when to 
screen patients for depression once they are back in the community. Furthermore, 
there is criticism of recommendations to routinely screen for depression due to a lack 
of evidence indicating improved outcomes for cardiac patients (Thombs et al., 2008). 
 
The present screening model for identifying depression is restricted to 
detecting current disease. Arguably, a broader model is required including the 
identification of current disease in hospital, using established methods, and 
identification of patients who may be at risk of developing depression in the future. 
Such a model could detect those patients who have developed depression prior to 
admission for ACS and ensure that patients were offered appropriate, optimal, 
treatment and support. In addition, patients who have significant risk factors for 
depression would be identified and could be offered vital psychosocial support at an 
early stage before depressive disease is established. This screening model would 
need to be set in the context of collaborative partnerships between patients, primary 
healthcare providers and cardiac and mental health services. 
 
Patients are not routinely identified as being at risk of developing depression in 
the cardiac setting, therefore it is not known whether early intervention with patients 
at risk of depression can improve medical or mental health outcomes. However, an 
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integrated screening, treatment and collaborative care model may address many of 
the issues surrounding the detection and treatment of depression in cardiac patients. 
The relationship between depression and cardiac disease is highly complex and still 
poorly understood. Current evidence suggests that it is likely to require equally 
sophisticated, innovative models of care to ensure that patient health outcomes 
improve. 
 
Section 2 
 
Identifying Risk Factors for Depression in ACS: A Systematic Review of 
the Literature 
 
A systematic review has been described as a review of a clearly formulated 
question that uses systematic and explicit methods to identify, select and critically 
appraise relevant research and to collect and analyse data from the studies that are 
included in the review (Glasziou, 2010). In recent years the standard of reporting of 
published systematic reviews has been criticised in the literature. In particular, key 
information has not been clearly reported making it difficult for the reader to fully 
appraise the review process and the usefulness of the review (Dixon, Hameed, 
Sutherland, Cook, & Doig, 2005). In response to such criticism the PRISMA 
statement for reporting systematic reviews has been developed (Liberati et al., 2009) 
and consists of a 27 – item checklist and flow diagram of information deemed 
essential for transparent reporting. Although the PRISMA statement refers primarily 
to the reporting of randomised controlled trials, the format and reporting guidelines 
have provided a useful framework for the reporting of this systematic review.  
 
The review commences with a detailed description of the method undertaken in 
order to complete the literature search and provides a PRISMA diagram (figure 2.2). 
The quality assessment procedure and method of grading evidence is then outlined. 
The results are reported and discussed in light of findings from the wider 
psychosocial literature. Finally, the limitations of the review are acknowledged and 
conclusions discussed. 
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Purpose of the review. 
 
The risk factors for the development of depression in patients following an 
episode of ACS have not been fully described. The objective of this review was to 
identify risk factors for depression from the literature and critically evaluate the 
evidence base. This review was undertaken to address the question: What risk factors 
for depression have been identified in cross-sectional and prospective studies 
conducted in cardiac samples and what further supporting evidence can be found in 
the wider psychosocial literature? 
 
The purpose of the review within the context of the entire research project has 
been to identify risk factors with a sound evidence base that may be included in a 
risk assessment questionnaire for use in an acute clinical setting. To this purpose, risk 
factors were further assessed for clinical appropriateness and relevance to an adult 
population. 
 
Data sources. 
 
A search of the literature was conducted dating from January 1990 through to 
January 2010. Medline R, CINAHL, PubMed, EMBASE, Science Direct, Web of 
Science and PsychINFO were searched using a combination of the following key 
words or phrases: “coronary artery disease”; “unstable angina”; “myocardial 
infarction”; “acute coronary syndrome”; “cardiac”; “depression”; “depressive 
symptoms”; “depressive disorder”; “major depression”; “psychosocial”; “risk”; 
“factors”; “predictors”; “predictive”. Manual searching of the reference section of 
research articles found was also performed. 
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Figure 2.2 
Literature search strategy identifying risk factors for depression in ACS 
 
 
Records identified through 
database searching 
(n = 2,845) 
Additional records identified 
through other sources 
(n = 7) 
Records after duplicates removed 
(n = 2,645) 
Records screened 
(n = 2,645) 
Records excluded 
(n = 758) 
Incorrect definition 
of depression i.e. ST 
depression or 
Haemodynamic 
depression 
Full-text articles 
assessed for eligibility 
(n = 1,887) 
Full-text articles 
excluded 
(n = 1,860) 
• Not adult 
samples 
• Not primary 
research 
• Not quantitative 
methods 
• Not reporting 
risk factors for 
depression 
• Methodological 
issues  
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Eligibility criteria. 
 
To be included in the review articles had to be published in English, refer to 
research conducted with adult participants (> 18 years) of either sex, be a primary 
research article using a quantitative methodology, report results of risk factors for 
depression obtained from prospective data or correlations between factors obtained 
from cross-sectional data. 
 
During the search, 758 papers were excluded because the subject of the article 
was not related to a psychiatric definition of ‘depression’ e.g. ‘ST segment 
depression’ as found on ECG readings. The 207 duplicates of articles were similarly 
discarded. In total 1,887 full-text papers were assessed and 1,860 papers were 
excluded on eligibility and methodological grounds. Twenty-seven articles met the 
necessary criteria and were included in the review (figure 2.2). One of these papers 
contained a summary of the study in English but the main article was written in 
Dutch. This article was translated fully into English. 
 
To assist data synthesis, these papers were further divided into 3 groups: those 
that described cross-sectional studies designed to examine factors associated with 
depression in ACS; those that described research conducted to examine the 
prognostic effects of depression in cardiac disease but also reported cross-sectional 
findings regarding factors associated with depression and; those that described 
prospective studies reporting risk factors for the development of depression in 
cardiac samples. Although 27 papers have been included in the review, 3 papers have 
been written that describe the same research studies but refer to data at differing 
follow-up time points (e.g. Baseline, 3 months and 12 months post admission) or not 
previously described data. These studies are identified in appendix A. 
 
Critical Evaluation Process 
 
To effectively evaluate the evidence base it was necessary to find a method of 
grading that was well suited for the purpose. The Oxford Centre for Evidence-based 
Medicine Levels of Evidence (2009) offered a number of advantages in comparison 
with other grading methods (appendix B). This method provides a very detailed 
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hierarchy of grades from 1 down to 5 for studies conducted in relation to the 
aetiology of a disease and, importantly, offers a grading for the types of 
observational studies most likely to be undertaken to determine risk factors for 
depression i.e. prospective cohort and case-control studies (figure 2.3). 
 
Using the Oxford approach the researcher is required to assess the quality of 
individual studies. A study found to be of poor quality would be allocated a lower 
grade, for example, an individual observational cohort study would usually be graded 
‘2b’ but this may be reduced to grade ‘4’ following quality assessment. In addition to 
suggesting grades for individual studies, this system provides 4 overall Grades of 
Recommendation (A, B, C, D) to enable grading of a body of evidence based on a 
number of research studies.  
 
Assessing the internal and external validity of observational cohort studies in a 
systematic way is essential, however, there is a reported lack of consensus about the 
most appropriate methods of assessing the quality of observational studies and the 
criteria on which to make judgements regarding quality (Mallen, Peat, & Croft, 2006; 
Shamliyan, Kane, & Dickinson, 2010). Although various checklists and scales exist 
for the purpose their use has been criticised on the grounds that observational studies 
vary too greatly in design to suit a single checklist (Groenwold & Rovers, 2010). 
This view is similarly endorsed by the authors of the PRISMA statement (Liberati et 
al., 2009) who recommend quality is assessed on an individual study basis and that 
particular attention be paid to the risk of study bias which may often be specific to 
the study design or research topic. In this review, the issue of study bias was 
addressed by careful critique of the study design, the processes of participant 
selection, methods of data collection and specifically the temporal relationship 
between the outcome of depression and the risk factors being studied.  
 
Some further guidance to assessing quality may be found in the literature. In a 
critique of the quality assessments undertaken in 39 systematic reviews, Mallen et 
al., (2006) identified criteria commonly considered important and these include the 
use of accurate and appropriate outcome measures, adjustment for confounding, 
appropriate selection of controls where appropriate, assessment of loss to follow-up 
and relevant statistical analysis. In total, 30 criteria used to assess the quality of 
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observational studies were identified. In the absence of a recommended single 
checklist or scale, 19 of most relevant criteria have been used to guide the assessment 
of the quality of the individual studies in this review (table 2.1). Following 
assessment the studies were graded using the appropriate Oxford Centre for 
Evidence-based Medicine Levels of Evidence (2009) designated level 1 to 5. In total, 
seven of the included studies were found to have issues related to quality and 
therefore the grading for these studies was reduced. Details of the quality issues are 
outlined in table 2.2. 
 
Having established the quality of research on an individual basis, the risk 
factors positively associated with depression were identified and grouped by domain. 
This enabled the body of evidence in favour of each risk factor to be further assessed 
based on the number and quality of the studies and the type of the study design, 
either prospective or cross-sectional. An overall Grade of Recommendation was 
assigned to each risk factor based on data from cardiac studies and supporting 
evidence from the broader psychosocial literature (appendix C).  
 
Although the highest Oxford EMB grading category is 1a this is reserved for 
systematic reviews of randomised controlled trials. All observational studies are 
graded with a lower grade (2b) to reflect the potential for bias compared to 
randomised, controlled trials. Although randomised controlled trials are able to 
provide a high level of evidence, their design is primarily used to test an intervention 
and is not suited to the investigation of risk factors for depression on methodological 
grounds. Thus the most suitable studies (observational) with the highest level of 
evidence can only be given a 2b grade. 
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Figure 2.3  
Oxford Centre for Evidence-based Medicine Levels of Evidence (2009): 
Recommended levels for health research studies related to therapy, prevention, 
aetiology or safety 
 
 
 
 
 
Relevant notes  
Systematic Review of 
Randomised controlled trials 
(with homogeneity *) 
Type of research study Recommended level 
Individual Randomised 
Controlled Trial (with narrow 
Confidence interval ‡) 
 
Systematic Review of cohort 
trials (with homogeneity) 
Individual cohort study 
(including low quality RCT; 
e.g. < 80% follow-up) 
 
“Outcomes” Research; 
Ecological Studies 
Systematic Review of case-
control studies 
(with homogeneity) 
 
Individual Case-Control Study 
Case-series 
(poor quality cohort and case-
control studies §§) 
 
1a 
 
1b 
 
2a 
 
2b 
 
2c 
 
3a 
 
3b 
 
4 
Figure based on Oxford Centre for Evidence-based Medicine Levels of Evidence (2009) 
table produced by B Phillips, C Ball, D Sackett, D Badenoch, S Strauss, B Haynes, M 
Dawes, November, 1998 and updated March 2009 by J Howick. Full table included as 
appendix B. Reproduced with permission. 
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* By homogeneity we mean a systematic review that is free of worrisome 
variations (heterogeneity) in the directions and degrees of results between 
individual studies. Not all systematic reviews with statistically significant 
heterogeneity need be worrisome, and not all worrisome heterogeneity need 
be statistically significant. As noted above, studies displaying worrisome 
heterogeneity should be tagged with a "-" at the end of their designated 
level. 
‡ See note above for advice on how to understand, rate and use trials or other 
studies with wide confidence intervals. 
§§ By poor quality cohort study we mean one that failed to clearly define 
comparison groups and/or failed to measure exposures and outcomes in the 
same (preferably blinded), objective way in both exposed and non-exposed 
individuals and/or failed to identify or appropriately control known 
confounders and/or failed to carry out a sufficiently long and complete 
follow-up of patients. By poor quality case-control study we mean one that 
failed to clearly define comparison groups and/or failed to measure 
exposures and outcomes in the same (preferably blinded), objective way in 
both cases and controls and/or failed to identify or appropriately control 
known confounders. 
 
 
 
 
Grades of Recommendation 
 
A consistent level 1 studies  
B consistent level 2 or 3 studies or extrapolations from level 1 studies 
C level 4 studies or extrapolations from level 2 or 3 studies  
D level 5 evidence or troublingly inconsistent or inconclusive studies of any level 
 
Notes produced by B Phillips, C Ball, D Sackett, D Badenoch, S Strauss, B Haynes, M 
Dawes, November, 1998 and updated March 2009 by J Howick. Full table of notes 
included as appendix B. 
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Table 2.1 
Criteria used to assess the quality of observational studies 
 
Quality criteria 
Accurate and appropriate outcome measures in all participants 
Adjustment for confounding 
Case/controls recruited from same population 
Loss to follow-up (appropriate level) 
Appropriate statistical tests 
Participants representative of population 
Potential confounders described 
Recruitment of case/control over same time frame or point of disease 
Participants characteristics described 
Outcomes clearly described 
Appropriate follow-up period 
Response/non-response rate described 
Clear case/control definition 
Losses and completers described 
Reliable assessment of disease state 
Clear inclusion/exclusion criteria 
Type of study stated 
Main findings described 
Conclusion supported by findings 
 
 
 
 
 
Table based on quality criteria identified by Mallen, C., Peat, G., & Croft, P. (2006). 
Quality assessment of observational studies is not commonplace in systematic reviews. 
Journal of Clinical Epidemiology, 59, 765 - 769. 
  
Table 2.2 
Studies with identified quality issues 
 
Authors Study design Quality issue Grading post quality critique 
Aktar et al., 2004 Observational study • Failed to identify and control for known confounders EBM level 4 
Mendes de Leon et 
al., 2001 
Observational 
study 
• Reported small sub-set of another cohort. Not clear if the participants are 
representative of the cardiac population EBM level 4 
Bjerkeset et al., 2005 
 
Prospective, 
population-based 
cohort 
• Inadequate definition of depression at baseline (study specific composite 
index of anxiety and depression) 
• Depression assessed up to 5 years following MI, no contact between 
baseline and final assessment, no access to medical records. Episodes of 
depression may have occurred and remitted before final assessment. 
EBM level 4 
Dickens et al., 2008a 
Prospective, 
observational 
cohort 
• Questionnaire used to assess illness perceptions (IPQ) criticised in 
literature for limited internal consistency reliability EBM level 4 
Martens et al., 2008 
Prospective, 
observational 
cohort 
• Failed to report the baseline characteristics of the cohort 
• Unable to assess whether known confounders were appropriately 
controlled 
EBM level 4 
Mayou et al., 2000 
Prospective, 
epidemiological 
survey 
• Failed to clearly define the comparison groups 
• Reported the combined results of the HADS for the outcomes of anxiety 
and depression (reported as ‘emotional distress’) therefore failed to clearly 
describe the relationship between depression and possible risk factors 
EBM level 4 
Stafford et al., 2009 Prospective survey • Only 37% of patients treated during the period recruited to study –participants may not have been representative of the population EBM level 4 
 
Note. EBM = Evidence Based Medicine. 
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Results. 
 
In total 24 studies met the eligibility criteria (reported in 27 separately 
published articles) and were included in the final review. Of these studies, ten 
described cross-sectional findings of either studies designed specifically to examine 
factors associated or correlated with depression, or those that were designed to 
examine the prognostic effects of depression in cardiac disease but also reported 
factors associated with depression (Aktar, Mallik, & Ahmed, 2004; Cheok, Schrader, 
Banham, Marker, & Hordacre, 2003; Forrester, Lipsey, Teitelbaum, Depaulo, & 
Andrzejewski, 1992; Frasure-Smith, Lesperance, Juneau, Talajic, & Bourassa, 1999; 
Lesperance et al., 2000; Linfante, Allan, Smith, & Mosca, 2003; Mallik et al., 2006; 
Mendes de Leon et al., 2001; Naqvi et al., 2007; Watkins et al., 2003). 
 
The remaining 14 studies reported the findings from prospectively conducted, 
observational studies (Bjerkeset, Nordahl, Mykletun, Holmen, & Dahl, 2005; 
Dickens et al., 2008b; Dickens et al., 2004; Hammond et al., 2008; Lesperance et al., 
2000; Martens, Smith, Winter, Denollet, & Pederson, 2008; Mayou et al., 2000; 
Schrader et al., 2004; Schrader, Cheok, Hordacre, & Marker, 2006; Spijkerman et al., 
2005b; Spijkerman et al., 2005a; Stafford, Berk, & Jackson, 2009; Strik et al., 2001b; 
Strik, van Praag, & Honig, 2003a; van Melle et al., 2006; van Melle et al., 2005; 
Whitehead, Strike, Perkins-Porras, & Steptoe, 2005). 
 
The studies were conducted in samples of both male and female cardiac 
patients, with the exception of one study that recruited only females (Linfante et al., 
2003). Only four studies included samples with mixed diagnoses of AMI, ACS, 
CABG, PTCA, arrhythmia, and CHF. The majority of studies (n = 20) were 
conducted in samples with myocardial infarction; ACS; or unstable angina as the 
primary diagnosis and inclusion criterion. 
 
Most of the cross-sectional data were collected during hospital admission. 
Similarly, the majority of baseline data reported in the prospective studies were 
collected during acute cardiac admissions. The length of the follow-up period for 
prospective cohort studies ranged from three months to six years post admission, 
however, the majority of studies (n = 10) followed participants over a 12-month 
period. 
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Differing criteria were used to assess depression. Depressive symptoms were 
reported in 18 of the studies and a total of seven different self-report questionnaires 
were used for this purpose. In six further studies an initial screening for depressive 
symptoms was followed by a structured diagnostic interview in order to identify 
‘cases’ of depression. However, the diagnostic criteria used have differed (DSM-III; 
DSM-III-R; DSM-IV; ICD-10) primarily reflecting the time span over which the 
studies have been conducted. In total, 50 risk factors have been associated with 
depression in cardiac patients in either cross-sectional or prospectively conducted 
studies (table 2.3). 
 
Data evaluation issues. 
 
The amount and quality of evidence for each risk factor varies greatly with 
some risk factors having been extensively researched whilst others rely on evidence 
from a single study as detailed in appendix C. There are a few risk factors for which 
there is good evidence to be found in the cardiac literature and extensive supporting 
evidence available from the psychosocial literature, for example a past history of 
depression. However, for a number of risk factors there exists an ‘imbalance’ 
between available cardiac evidence and psychosocial evidence. For example, only 
one cross-sectional study (graded 2b) has examined negative life events in cardiac 
patients yet there is extensive psychosocial literature providing strong predictive 
evidence in support of this risk factor. Evaluating the evidence base for such risk 
factors has been problematic. To overcome this issue is was necessary to take a broad 
view of the evidence available from both the cardiac and psychosocial literature. 
 
The clinical context in which the risk factor has been studied has also raised 
important issues of how relevant the data is with regard to an acute cardiac setting in 
Australia today. This was an important issue for many of the medical risk factors 
identified. Due to the length of time lapsed between the study and the present day it 
was necessary to question whether the risk factor would be as significant in the 
context of current medical practice. For example, the prescription of sodium warfarin 
on discharge (Lesperance et al., 1996) may be less significant in light of current anti-
thrombotic and anti-platelet therapy guidelines. 
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Table 2.3 
Risk factors found to be associated with depression in ACS patients 
 
Psychological Social Demographic Behavioural Biomedical 
Past history of depression Socioeconomic status Female gender Smoking/unable to stop Previous MI /size of MI 
Symptoms of depression Lower level of education Younger age ↑Alcohol consumption Previous cardiac condition 
Anxiety Unemployment Older age Reduced level of exercise Comorbid conditions 
Distress/fear of dying  Marital status Ethnicity  Diabetes/ obesity 
Negative life events Having dependents (W)   Complications in hospital 
Illness perceptions Mother/child separation   Revascularization 
Neuroticism Living alone   Frequency of chest pain 
Introversion No close friends/confidant   Triple anti-ischaemic therapy 
Type ‘D’ personality Quality of relationships   Duration of hospital stay 
Benzodiazepines use Perceived social support   History of hypertension 
Pre–MI vital exhaustion    Prescription of warfarin/ diuretics 
Expressed anger    Hypercholesterolaemia 
    Killip class/CHF/impaired LVEF 
    Physical functional impairment 
    Lower exercise capacity/HRQOL 
 
Note. W = women; ↑ = increased; MI = myocardial infarction; Triple anti-ischaemic therapy = 3 types of medication prescribed for ischaemia; CHF = 
congestive heart failure; LVEF = left ventricular ejection fraction; HRQOL = health related quality of life.  
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Clinical appropriateness and relevance to an adult population. 
 
The purpose of the review has been to identify risk factors with a sound 
evidence base that may be included in a risk assessment questionnaire for use in an 
acute clinical setting. Risk factors were therefore further assessed for clinical 
appropriateness. Risk factors were excluded if they had been poorly defined, needed 
to be identified using additional lengthy questionnaires, or could not be accurately 
assessed within the time-frame of a hospital admission for ACS. As previously 
discussed at the beginning of this chapter, risk factors for depression can be distal or 
proximal to the episode of depression. The risk factors were further excluded if they 
were more relevant to depression in children. 
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Figure 2.4 
Schematic diagram illustrating exclusion of risk factors not meeting criteria for 
evidence, clinical appropriateness and relevance to an adult population 
Risk factors identified 
from a review of the 
cardiac literature 
Grading of the cardiac 
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EBM Levels of Evidence 
Risk factors assessed in 
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psychosocial evidence 
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insufficient 
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psychosocial 
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 Note. EMB = Evidence Based Medicine; ACS = acute coronary syndrome. 
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Summary of Evidence. 
 
The following is a summary of the main findings of the systematic review 
highlighting those risk factors that have met criteria based on evidence, clinical 
appropriateness and relevance to an adult population. The level of evidence is 
reported for these risk factors and discussed in light of supporting evidence from the 
broader psychosocial literature. A detailed table outlining the graded evidence for all 
of the risk factors is included as appendix C. 
 
History of depression. 
 
A past history of depression is a well-established risk factor for a further 
episode of depression. The results of six level 2b and one level 4 cross-sectional 
studies identified in the review showed a strong association between a past history of 
depression and depressive symptoms present during a hospital admission for a 
cardiac condition (Cheok et al., 2003; Dickens et al., 2004; Forrester et al., 1992; 
Lesperance et al., 1996; Mallik et al., 2006; Mayou et al., 2000; Spijkerman et al., 
2005a; Strik et al., 2001b). Evidence for the predictive nature of a past history of 
depression, or self-reported past history of ‘stress’, was found in a further seven 
prospectively conducted studies, four graded 2b, one graded 3b and two graded level 
4 (Bjerkeset et al., 2005; Lesperance et al., 1996; Martens et al., 2008; Schrader et 
al., 2004; Spijkerman et al., 2005a; Strik et al., 2001a; Strik et al., 2003a). Two of 
these studies using statistical models were able to demonstrate acceptable levels of 
predictive validity.  
 
This finding is consistent with the evidence from the broader psychosocial 
literature. It has been demonstrated in prospective, longitudinal studies that a past 
history of depressive illness is a strong and consistent risk factor for MDD and that a 
past history of depression can affect the outcome of a current episode. (Kennedy, 
Abbot, & Paykel, 2003; Solomon et al., 1997) These studies were able to 
demonstrate that following a first episode of major depression the risk of further 
episodes increases greatly with subsequent episodes. After a first episode, the risk of 
recurrence may be 50%, however, in patients who have three or more previous 
episodes (indicating severe disease) there may be a 90% chance of recurrence. 
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Prospective studies of patients with less severe disease still report a relatively short 
period of time between relapse. In a prospective study of people with a diagnosis of 
MDD followed-up over six years, the authors reported that 65% of the sample had a 
relapse indicated by sub-threshold symptoms by the 5th year (Kanai et al., 2003). 
This is clinically important in cardiac patients because mild symptoms of depression 
in patients with a past history of MDD can be an sign of relapse or recurrence of 
disease (Paykel et al., 1995). 
 
The presence of depressive symptoms in hospital. 
 
Four prospective studies (three level 2b grade and one level 4 grade) identified 
in the review of the cardiac literature reported the presence of depressive symptoms 
in hospital as a significant risk factor for future depression (Lesperance et al., 1996; 
Mayou et al., 2000; Schrader et al., 2004; van Melle et al., 2006). Depression, as 
previously discussed, may be regarded as graduating from mild to severe disease 
(Judd, 2000; Steptoe, 2007b). In a large US survey investigating the lifetime 
prevalence and correlates associated with both minor and major depression, the 
investigators found sub-clinical depression (the presence of depressive symptoms not 
meeting the full diagnostic criteria) to be an important risk factor for the subsequent 
development of major depression (Kessler et al., 1997a). Other studies have 
replicated this finding. Sub-clinical depression has been established as a significant 
risk factor for the development of MDD in prospective studies conducted in 
community samples of women, adolescents and elderly adults (Angst & Merikangas, 
1997; Brown et al., 1986a; Horwath et al., 1992; Kessler et al., 1997a; Lewinsohn et 
al., 2000). 
 
Long standing research exploring the aetiology of depression has established 
the predominately chronic nature of MDD. In addition, depression is now regarded 
as developing from mild to severe disease. This body of evidence offers additional 
support for a past history of depression, and the presence of mild depressive 
symptoms during admission, as two of the most significant risk factors for depression 
in cardiac patients. 
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In hospital anxiety. 
 
A limited number of studies have been undertaken to examine a range of 
negative emotional responses experienced by patients during admission for a cardiac 
condition. Anxiety was positively correlated with depression in one cross-sectional 
study graded 2b (Frasure-Smith et al., 1999) and ‘acute emotional distress’, fear of 
dying, and a surrogate marker of ‘anxiety’ (prescription of benzodiazepines in 
hospital) were found to be risk factors for depression in three prospective studies 
graded 2/3b conducted in cardiac samples (Strik et al., 2001b; Strik et al., 2003; 
Whitehead et al., 2005). However, comparison between studies was difficult because 
of the inherent heterogeneity of the studies, differing psychological constructs being 
studied and the diverse methods of measuring the constructs. For example, Frasure-
Smith, et al. (1999) used a well-validated questionnaire to measure anxiety 
(Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983) but in two of the prospective 
studies (Strik et al., 2001b; Strik et al., 2003) a prescription of benzodiazepines 
whilst in hospital was considered a marker of anxiety. Benzodiazepines can be 
prescribed for a number of reasons other than ‘anxiety’ and it is not clear to what 
extent anxiety is being captured as a risk factor for depression. These studies 
reported in the cardiac literature are very limited in their ability to provide sufficient 
evidence to identify ‘anxiety’ in hospital as a risk factor for depression due partly to 
methodological flaws related to the definitions of the construct of anxiety and study 
design. 
 
However, there exists extensive evidence for a strong relationship between 
anxiety and depression in the psychological literature. The association between 
anxiety disorders and major depression is well documented. In the general 
population, depression and anxiety are highly comorbid conditions, with almost 60% 
of individuals with major depression also meeting criteria for an anxiety disorder 
(Kessler, Berglund, & Demler, 2003).  
 
Anxiety disorders have been associated with an increased risk for major 
depression. (Andrade, Eaton, & Chilcoat, 1996). In a prospective study conducted in 
Germany a number of anxiety disorders were found to be primary to the diagnosis of 
major depression and therefore able to demonstrate an appropriate temporal 
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relationship between anxiety and depression (Wittchen, Kessler, Pfister, & Lieb, 
2000). The highest rates of comorbidity were seen in generalised anxiety disorder 
(GAD), separation anxiety disorder (SAD), and panic disorder with the rates for 
specific phobias only slightly less. Witchen and colleagues (2000) reported that in 
young adults with no history of an anxiety disorder the risk of developing major 
depression was relatively low, however, this risk increased considerably if they had 
developed a prior anxiety disorder. The risk of developing depression was greatest 
for GAD (OR 4.5).  
 
Life events. 
 
Very little research has been conducted to examine the association of serious 
negative life events and depression in cardiac patients. Only one study, graded 2b, 
(Dickens et al., 2004) provided cross-sectional evidence in support of a positive 
association between negative life events and depression and therefore there is 
insufficient evidence to determine whether it can be regarded as a risk factor from 
data obtained in cardiac samples.  
 
Negative life events refer to psychologically significant events that occur in a 
person’s life, for example death of a family member. Stressful negative life events 
have been established as a well-recognised risk factor for the on-set of depression in 
the general population (Kendler, Karkowski, & Prescott, 1999; Rijsdijk et al., 2001). 
Although a substantial proportion of the relationship between life-events and 
depression is thought to be causal, twin studies have demonstrated that part of this 
relationship is non-causal and mediated through a genetic liability for individuals to 
select themselves into high-risk environments (Kendler et al., 1999). 
 
There is also strong evidence of a dose-response relationship (Kessler, 1997b). 
Life events confer the greatest risk for the onset of depression within one month of 
their occurrence, however, severely stressful events occurring for longer periods 
prior to an episode are still strongly predictive (Kendler, Karkowski, & Prescott, 
1998). There is also evidence for an increased risk associated with the intensity of 
perceived threat and the number of events that occur within the same period (Kendler 
et al., 1998). 
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Such stressors have been associated with an initial increase in severity of 
depressive symptoms in adult community samples (Bebbington, Hurry, & Tennant, 
1988) and in adolescent depression (Mghir, Freed, Raskin, & Katon, 1995; Olsson, 
Nordstroem, & Arinell, 1999). Antecedent life events have also been found to predict 
poorer outcome in treated depression during the first 6 - 12 months in medical and 
community - based samples (Mundt, Reck, Backenstrass, Kronmueller, & Fiedler, 
2000; Spijker, Bijl, de Graft, & Nolen, 2001). 
 
It has been suggested in the psychological literature that the onset of 
psychiatric disorders, including depression, may be increased by two factors. Firstly, 
the proportion of the person’s usual activities in which uncontrollable negative 
change takes place following a major negative event. Secondly, how central the 
uncontrollable changes are to the individual’s important goals and values 
(Dohrenwend, 2000). Major negative events involving ‘loss’ and disappointment, 
e.g. marital separation or illness, have been most strongly associated with depression. 
 
Responses to negative events may differ between individuals and between 
genders. A study conducted in a sample of couples recently exposed to a negative life 
event found that women were at an increased risk for depression following events 
involving children, housing or reproductive problems but only if the couples did not 
share ‘responsibility’ equally for the event. It was suggested by the authors that by 
distancing themselves from the event, the men were able to reduce their risk of 
developing depression (Nazroo, Edwards, & Brown, 1997). However, there is 
evidence to suggest that men have an increased risk of depression following 
separation or divorce (Fuhrer, Stansfeld, Chemali, & Shipley, 1999; Kendler, 
Thornton, & Prescott, 2001).  
 
Negative life events can be viewed as strongly associated with the prospective 
development of depression in non-cardiac populations and this evidence adds 
considerable weight to support their role as a risk factor for depression both pre and 
post ACS. Within a cardiac context, patients may have experienced a stressful life-
event prior to admission for an episode of ACS and therefore may have some level of 
depressive illness on admission. Indeed, a stressful life-event may have precipitated 
an ACS event. Alternatively, an acute admission for ACS may be regarded as a 
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threatening life-event in itself. Furthermore, evidence from the literature would 
suggest that a stressful life-event occurring in close proximity to an acute hospital 
admission for ACS confers a heightened risk of depression in some individuals. 
 
Social support. 
 
Social support is a term encompassing a number of specific characteristics of 
an individual’s social world that may promote well-being and /or increase resistance 
to health problems (Cohen, Gottlieb, & Underwood, 2000). The perceived quality of 
social support with regard to a vulnerability to develop depression has been 
described in six cross-sectional studies (graded 2b) and one prospective study 
(graded 2b), although various measures and aspects of social support have been 
examined.  
 
In a study of patients admitted for a first myocardial infarction, Dickens et al. 
(2004) found an independent association with depressive symptoms and both social 
isolation and lack of a close confidant. Three further studies also demonstrated an 
association between a lack of close friends or confidants using cross-sectional data 
(Frasure-Smith et al., 1999; Lesperance et al., 2000; Lesperance et al., 1996). 
Frasure-Smith et al. (1999) were also able to demonstrate that perceived social 
support is strongly associated with depression. The remaining two studies found 
positive associations between depression and a reduced quality and satisfaction with 
personal relationships (Forrester et al., 1992), and living alone (Spijkerman et al., 
2005a). In addition, two further studies examined marital status in relation to 
depression and found that being male and single (Mallik et al., 2006) or being 
divorced or separated of either gender was significantly related to depression in 
cross-sectional data (Cheok et al., 2003). 
 
The only prospective data confirming a relationship between depression and 
social support was reported from a study conducted in a cardiac sample of patients 
aged > 60 years of age. The study recruited patients at the time of an acute hospital 
admission for mixed cardiac diagnoses and examined the cohort a second time one 
month following discharge from hospital (Hammond et al., 2008). Impaired 
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subjective social support was identified as an independent predictor of depression at 
one month. 
 
There are some methodological issues related to studying depression and 
reduced social support or social isolation. Depressive illness itself can lead people to 
withdraw socially and feel isolated so it is important to establish a temporal 
relationship between measures of social support and the onset of depression. A 
previous history of depression can also have a negative, on-going impact on an 
individual’s social support network. Preliminary findings of a study of depression 
and individual social networks initially found that weak networks were significantly 
associated with depression, however, the strength of the relationship was greatly 
reduced when the researchers controlled for a past history of depression (Kessler & 
Magee, 1994). 
 
Prospective studies examining social support and depression have reported 
mixed findings. In a sample of mothers from inner-city London the investigators 
found little evidence for a predictive relationship between a large array of social 
support markers and the onset of depression. However, unmarried mothers and 
women who had received poor levels of support at a time of crisis were found to 
have an increased risk of depression (Brown, Andrews, Harris, Adler, & Bridge, 
1986b). In a study investigating the onset of post–natal depression, a lack of social 
support from family, particularly in relation to becoming pregnant, was found to be 
significantly predictive of depression following adjustment for personal and family 
psychiatric history, antenatal depression, and neuroticism (Brugha, Sharpe, & 
Cooper, 1998).  
 
Studies undertaken in large community cohorts have reported conflicting 
results. A prospective study of adults conducted in the US interviewed participants at 
two time points eight months apart and measured three items of social support. 
Marital discord was the only significant predictive variable at T2, but this became 
non-significant following statistical control for life events and symptoms of 
depression at T1 (Lewinsohn, Hoberman, & Rosenbaum, 1988). A similar study 
conducted in adolescents found no significant relationship between low perceived 
support of family or friends and the onset of depression at T2 once depressive 
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symptoms and psychopathology had been statistically controlled at T1 (Lewinsohn, 
Roberts, Seeley, Rohde, & Gotlib, 1994b). A further prospective study conducted in 
a community sample of 1,900 women measured social support at two times over a 5 
year period (Wade & Kendler, 2000). The level of social support available for each 
of the women was assessed by examining the extent to which spouse, family and 
friends expressed interest in the participant’s well-being. In addition, the participants 
reported the presence of confidants and frequency of social contacts. Lower 
perceived support was associated with major depression at both time points in cross-
sectional analysis, however, no prospective association with the on-set of depression 
could be found following the statistical control of depression at T1. 
 
The evidence for a prospective relationship between various measures of social 
support and the onset of depression is inconsistent. Whilst cross-sectional evidence 
points to a strong relationship between depression and measures of social support, a 
predictive relationship has not been established in large community samples.  
 
The relationship between social support and depression is highly complex. 
There is evidence that social support maybe more relevant in specific groups of the 
population, for example in old age when declining social support networks coincide 
with an increasing likelihood of disability and chronic medical illness (Bruce, 2002). 
A systematic review of the literature examining risk factors for depression in the 
elderly reported significant associations between depression and being unmarried, 
having a smaller social network and qualitative aspects of social support (Vink, 
Aartsen, & Schoevers, 2008). 
 
Prospective studies conducted in the elderly have shown a more consistent 
relationship between measures of social support and depression. In one such study, 
late-life suicide was predicted by a lack of a relative or friend in whom the 
participant could confide (Turvey, Conwell, & Jones, 2002). In another study, poor 
social contact with friends was found to predict depression and modify the 
association between disability and depression (Prince, Harwood, Thomas, & Mann, 
1998). Functional disability is a strong independent risk factor for depression in older 
adults (Geerlings, Beekman, Deeg, & van Tilburg, 2000). Other studies have 
demonstrated an important modifying relationship between measures of social 
Chapter 2 – Literature Review 
48 
support and the impact of disability. Having a partner or good social support 
significantly reduced the impact of physical disability on depression in a sample of 
elderly Dutch people (Schoevers, Beekman, & Deeg, 2000).  
 
The level of social support available may also be more relevant to lower 
socioeconomic groups. Research has demonstrated that social support is unequally 
distributed across social classes with the lower classes lacking both social support 
and material resources (Brummett, Barefoot, Vitaliano, & Siegler, 2003; Mickelson 
& Kubansky, 2003; Stansfield, Head, Fuhrer, Wardle, & Cattell, 2003). Some studies 
have suggested that perceived social support may be partially responsible for the 
differences in mental health between higher and lower socio-economic groups 
(Stansfield et al., 2003). In a sample of adults Brummett et al., (2003) found the 
inverse relationship between social support and depression was more significant in 
lower socioeconomic groups than in higher income groups, although this finding was 
not replicated in a study of adolescents (Geckova, Dijk, Stewart, Groothoff, & Post, 
2003). A more recent longitudinal study following adolescents into adulthood found 
social support had a greater impact on depression in lower socio-economic groups 
but the relationship differed depending on the type of social support, life stage and 
gender (Huurree, Eerola, Rahkonen, & Aro, 2007). 
 
Whilst there is inconsistent evidence in favour of a prospective relationship 
between measures of social support and the onset of depression, there is stronger 
evidence for the modifying effect of perceived social support on the remission of 
depression. Several studies found that varying measures of perceived social support 
predicted remission rates (Brugha et al., 1990; George, Blazer, Hughes, & Fowler, 
1989; Hybels, Blazer, & Steffens, 2005; Lara, Leader, & Klein, 1997) although this 
relationship has not been replicated in all studies (Oldehinkel, Ormel, & Neeleman, 
2000). 
 
In summary, there is good evidence of a cross-sectional association between 
various measures of social support and depression in both cardiac and community 
samples. However, a strong predictive relationship between aspects of social support 
and the onset of depression has yet to be established. The evidence suggests that the 
strength of relationship between social support and depression may vary between 
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specific groups within the population and that social support may modify the impact 
of other risk factors for depression that may be significant for older cardiac patients. 
Lastly, there is some supporting evidence that higher levels of perceived social 
support may indicate a shorter duration of depressive episode. Evidence from the 
cardiac and psychosocial literature places social support as a risk factor of interest in 
cardiac depression, however, the evidence does not support a strong independent 
relationship with onset but is more suggestive of a mediating role. 
 
Socioeconomic position. 
 
The impact of various indicators of lower socioeconomic position in relation to 
cardiac depression has been examined in five cross-sectional studies (four graded 2b 
and one graded 4) and one prospective study (graded 2b). Socioeconomic position 
(SEP) has been described as a term that encompasses both social class, referring to 
ownership and control over productive assets, and socioeconomic status, referring to 
the ordering of people along a continuum of a valued socioeconomic attribute such as 
education or income (Muntaner, Eaton, Miech, & O'Campo, 2004). In cardiac 
samples, a lower level of education was found to be significantly associated in four 
cross-sectional studies (Cheok et al., 2003; Frasure-Smith et al., 1999; Mallik et al., 
2006; Watkins et al., 2003). A lower level of education in cardiac patients with a past 
history of depression was also found to be predictive of depression prospectively 
(Spijkerman et al., 2005b). Employment status has been studied in two cross-
sectional studies (Cheok et al., 2003; Mallik et al., 2006). Unemployment was 
significantly associated with depression in both studies. Perceived economic burden 
(Mallik et al., 2006) and lower SEP (Aktar et al., 2004) were also found to be 
significantly related to depression in cross-sectional data. 
 
Although there has been little prospective study of these social indicators as 
risk factors in cardiac populations, there has been extensive research conducted and 
reported in the psychosocial literature. A comprehensive literature review and meta-
analysis examining the relationship between socioeconomic status and depression 
found conclusive evidence of a strong relationship (Lorant et al., 2003). The results 
indicated that people of a low socioeconomic status had an increased risk of being 
depressed (odds ratio = 1.81, p<0.001) when compared to those with a higher status. 
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When the results where further analysed, the risk of persisting depression (odds ratio 
= 2.06, p< 0.001) was greater than the odds of a new episode (1.24, p = 0.004). A 
dose response was found for the individual indicators of education and income. 
Furthermore, the association of increased depression was not limited to the lowest 
socioeconomic groups but remained as a gradient throughout the social levels.  
 
The association between depressive illness and lower SEP may be explained by 
two opposing theories, social causation and social selection. Social causation 
suggests that aspects of SEP, such as financial adversity and environmental factors, 
may exert a causal influence on depression. Alternatively, social selection theory 
proposes that depressive illness leads to downward mobility through social levels or 
impairs upward mobility. There is evidence in support of both theories operating to 
some extent (Skapinakis, 2007), however, results from longitudinal studies suggest 
that the social causation model may have more explanatory power (Johnson, Cohen, 
& Brook, 1999; Power, Stansfeld, & Mathews, 2002; Ritsher, Warner, & Johnson, 
2001). 
 
Some research has examined the relationship of SEP and depression over the 
life course. There is support for both long-term influences of lower SEP dating from 
childhood and more short-term adult-specific influences such as job insecurity and 
financial hardship (Gilman, Kawachi, & Fitzmaurice, 2002, 2003; Power et al., 2002; 
Stansfield et al., 2003). A recent Australian longitudinal study demonstrated a strong 
association between current financial hardship and depression. The association 
remained independent following control for demographic characteristics, prior 
depressive symptoms and other measures of SEP (Butterworth, Rodgers, & Windsor, 
2009). 
 
A significant aspect of the relationship between depression and SEP is the 
‘clustering’ of other risk factors for depression that also occur in people of low SEP, 
for example interpersonal violence, humiliation, stressful life events and job 
insecurity (Muntaner et al., 2004). In addition, social support is unequally distributed 
across social classes resulting in less support in times of need for people from lower 
SEP (Brummett et al., 2003; Mickelson & Kubansky, 2003; Stansfield et al., 2003). 
Studies comparing the relationship of SEP, depression and gender have demonstrated 
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that women of low SEP have double the risk of developing depression compared to 
males of the same SEP (Kessler et al., 2003; Rutter, Caspi, & Moffatt, 2003). 
Women with less financial resources show higher rates of depression compared to 
women with higher incomes or women from community samples (Coiro, 2001; 
Danziger, Carlson, & Henley, 2001; Ritter, Hobfoll, & Lavin, 2000). Higher rates of 
debt and financial strain are also strongly related to depression in women of mixed 
socioeconomic backgrounds (O'Campo, Eaton, & Muntaner, 2004; Reading & 
Reynolds, 2001). 
 
Within the Australian context, low SEP is also modified by geographical 
location and social isolation. Whilst there are pockets of social deprivation found 
within Australian cities, rural and remote areas of Australia have not experienced the 
same levels of economic and social development of urban areas (Cheng, Spittal, Yip, 
& Pirkis, 2012). There are fewer GPs per head of population in rural and remote 
Australia compared to urban locations and there is evidence demonstrating lower 
levels of mental health services available to these communities (Judd, Cooper, 
Fraser, & Davis, 2006). In recent years, drought and decline in water availability 
have led to extreme levels of financial hardship for rural farming communities 
(Alston & Kent, 2004). A lack of employment opportunities and down turn in 
agriculture has led to a further decline of population in these areas (Judd et al., 2006).  
 
There have been devastating mental health consequences for rural and remote 
populations demonstrated most profoundly among males. Australian men are more 
than four times likely to die of suicide than women (ABS, 2005). Men in remote 
areas are three times more likely to suicide than males in urban locations (Page, 
Morrell, Taylor, Dudley, & Carter, 2007). Pockets with the highest rates of male 
suicide are found in communities with populations of under 4,000 people (Judd et al., 
2006). 
 
The evidence in support of lower SEP as a risk factor for cardiac related 
depression is limited, however, there exists strong supporting data from the wider 
psychosocial literature. Lower SEP is strongly associated with depression and certain 
aspects, such as current financial strain and financial hardship, have been shown to 
have a strong independent association with depression even after controlling for 
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other psychosocial variables. Low levels of SEP should be considered as a significant 
risk factor for depression in cardiac patients and an important indicator of the likely 
presence of concurrent risk factors for depression. 
 
Negative illness perceptions. 
 
Two prospective studies conducted in cardiac samples (both graded level 4) 
have found evidence in favour of an association between negative illness perceptions 
and depression (Dickens et al., 2008b; Stafford et al., 2009). Both studies were 
downgraded from a 2b grade because of methodological issues that may have caused 
bias, although to what extent the results may have been influenced was difficult to 
determine. One study (Dickens et al., 2008b) used the Illness Perception 
Questionnaire (Weinman, Petrie, & Moss-Morris, 1996) that was subsequently found 
to have psychometric problems with two subscales and required revising (Moss-
Morris, Weinman, Petrie, Cameron, & Buick, 2008). Stafford et al. (2009) had 
experienced recruitment issues with less than 37% of the clinical population included 
in the final sample.  
 
The proposed relationship between negative illness perceptions and the onset 
of depression is informed by the cognitive model of depression. This model suggests 
that personal negative beliefs or thoughts can lead to the development of depression 
(Kovacs & Beck, 1978). The cognitive model underpins cognitive therapy, a well-
established psychological treatment for depression where patients are encouraged to 
consider any negative thoughts and replace them with less negative or more realistic 
thoughts.  
 
Some additional relevant research has been conducted in cardiac samples with 
mixed results. The presence of negative beliefs about health and illness in patients 
undergoing coronary artery bypass graft surgery was associated with increased 
psychological stress (Hermele, Olivio, Namerow, & Oz, 2007). However, a 
prospective study examining the association between depressive symptoms and 
negative illness beliefs regarding angina was only able to demonstrate a trend 
towards significance. Negative illness beliefs have been associated with poorer 
health-related quality of life following myocardial infarction and in patients with 
CAD (Aalto et al., 2006; French, Lewin, Watson, & Thompson, 2005). 
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The evidence for the prospective association of negative illness perceptions and 
depression in cardiac patients is very limited. The two primary studies included in 
the review have both had methodological issues that have further reduced the quality 
of the evidence. However, cognitive theory underpinning the hypothesis that 
negative illness perceptions may predispose to depression is well-established and has 
led to the development of successful treatments for depression (Wampold, Miami, 
Baskin, & Callen, 2002). It has been difficult to determine whether this risk factor 
should be regarded as potentially significant. However, as this review represents an 
initial process in the development of a questionnaire, this risk factor was included for 
further review by an Expert Panel. 
 
Although the aetiology of depression is multi-factorial, as previously 
discussed, there exist a high correlation between risk factors within and across 
domains (Kendler et al., 2002, 2006a). This is particularly true regarding 
psychological and social factors leading to depression. Indeed, these risk factors 
often exert a mediating influence on one another. A combination of ‘psychosocial’ 
factors in particular plays a more prominent role in the development of depression 
than most other medical conditions (Stansfeld & Rasul, 2006). This was clearly 
reflected within the cardiac literature as the risk factors identified from these 
domains were supported by some of the strongest, most consistent evidence.  
 
Female gender. 
 
Gender has been one of the most studied risk factors for depression within the 
cardiac literature. Female gender has been significantly associated with depression in 
cross-sectional analysis in eleven studies, nine graded level 2b (Cheok et al., 2003; 
Dickens et al., 2004; Forrester et al., 1992; Frasure-Smith et al., 1999; Lesperance et 
al., 2000; Lesperance et al., 1996; Mallik et al., 2006; Naqvi et al., 2007; Watkins et 
al., 2003) and two graded level 4 (Aktar et al., 2004; Mendes de Leon et al., 2001). A 
further four studies have demonstrated a significant prospective association between 
female gender and depression, three studies graded 2b (Spijkerman et al., 2005b; 
Spijkerman et al., 2005a; Strik et al., 2003a) and one study grade 4 (Bjerkeset et al., 
2005). 
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Female gender can be considered a risk factor for depression. This finding is 
supported by a substantial body of evidence that has been reported in the wider 
psychological literature. Females are twice as likely to experience both major and 
minor depression when compared to males (Kuehner, 2003; Ustan, 2000). This 
disparity is evident during adolescence, middle age and into early old age (Kuehner, 
2003; Mojtabai & Olfson, 2004). The reason for a greater risk of depression in 
women has been the focus of considerable research, however, the reason are still not 
fully understood. 
 
In a study using the National Swedish Twin Registry, the researchers examined 
the risk of inheriting lifetime major depression and discovered a significant gender 
disparity between results with females displaying a higher genetic risk for major 
depression (42%) than males (29%) (Kendler et al., 2006b). Similar results in 
relation to gender have been found in other twin studies. A study using data from an 
Australian voluntary twin registry estimated the risk of lifetime major depression to 
be 44% in females and 24% in males (Beirut et al., 1999). This disparity has also 
been shown in elderly twin cohorts in two Scandinavian studies (Jansson et al., 2004; 
McGue & Christensen, 1997).  
 
Some researchers believe that a substantial part of the difference can be 
explained by gender role related stressors to which women are more exposed than 
males, for example, low socioeconomic status, lack of power, role overload (Frone, 
2000), and sexual abuse (Rodgers, 1994). Furthermore, women may be more 
psychologically vulnerable to depression with emotion-focused coping styles, more 
anxiety (Breslau, Schultz, & Peterson, 1995), and lower self-esteem (Moller-
Leimkuhler, 2007; Piccinelli & Wilkinson, 2000). The disparity may also be a 
reflection of the differences found between endocrine stress reactions which may 
influence depression (Piccinelli & Wilkinson, 2000). In addition, although women do 
not suffer more serious negative life events than men they may experience more 
stress related to the event (Nazroo et al., 1997). 
 
One important issue to be noted with gender-based research of depression is 
that men are often more reluctant than women to disclose symptoms of depression 
and seek treatment. Recent Australian research points to a tradition of ‘stoicism’ in 
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rural men fostering values of self-reliance, independence and a distrust of outside 
agencies leading to a reluctance to seek help for depression (Alston, 2012). 
 
Females are at greater risk of developing depression than males and this has 
been demonstrated in the limited cardiac literature. There is extensive support for the 
presence of a significant gender disparity in relation to the risk of developing 
depression. The reasons for this have not been clearly established but are likely to be 
multi-dimensional. Female gender may be viewed as a significant risk factor for 
depression in cardiac patients, however, there still exist a significant proportion of 
males at risk of depression who may not find it easy to disclose symptoms or seek 
appropriate help. 
 
Age. 
 
Younger age has been identified as a risk factor for depression following 
analysis of cross-sectional data from eight studies, five graded 2b (Cheok et al., 
2003; Dickens et al., 2004; Linfante et al., 2003; Mallik et al., 2006; Watkins et al., 
2003) and 3 level 4 studies (Aktar et al., 2004; Mayou et al., 2000; Mendes de Leon 
et al., 2001). Evidence of younger age as a risk factor was also found in 
prospectively collected data from four studies all graded 2b (Lesperance et al., 1996; 
Schrader et al., 2004; Spijkerman et al., 2005b; van Melle et al., 2006). The 
definitions of ‘younger age’ have ranged from less than 54 years of age to 65 years 
of age or below. Only one study graded 4 alternatively described ‘old age’ (not 
defined in years) as a risk factor (Bjerkeset et al., 2005). 
 
Depressive illness may occur at different times across a lifespan. MDD is 
found in young, middle aged and elderly adults (Andrade et al., 2003; Beekman et 
al., 1999; Forsell & Winblad, 1999). Epidemiological evidence points to a reduced 
level of depression among people aged in their 50’s and 60’s (Henderson, Korten, & 
Jacomb, 1997) but a higher incidence in older age that is strongly correlated to 
physical illness and disability (Cuijpers, Beekman, & Smit, 2006; Smit, Ederveen, & 
Cuipers, 2006; Smit et al., 2008).  
 
The development of depression in younger people has been associated with 
psychological risk factors, life stressors and genetic factors (Karel, 1997). The 
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cardiac studies demonstrating a strong association with younger age have been 
conducted primarily in samples of ACS patients. Risk within this group may be a 
reflection of family role strain, financial concerns due to disrupted work patterns, and 
psychological stress associated with early morbidity or increased mortality risk. In 
addition, it is suggested that psychological vulnerability to depression may decrease 
with passing years whereas physical disease and low social support may become 
more relevant risk factors in the elderly (Karel, 1997; Schoevers et al., 2000). 
 
Smoking. 
 
Both current smoking and difficulty in stopping smoking have been identified 
as risk factors for depression. Current smoking, defined as tobacco smoking daily or 
on admission to hospital, was identified as a risk factor for depression in four cross-
sectional studies graded 2b (Cheok et al., 2003; Lesperance & Frasure-Smith, 2000; 
Mallik et al., 2006; Naqvi et al., 2007) and one study graded 4 (Mayou et al., 2000). 
Current smoking at baseline was also shown to be prospectively associated with 
depression in two level 2b studies (Schrader et al., 2004; Spijkerman et al., 2005b) 
and in one level 4 study (Bjerkeset et al., 2005). 
 
Difficulty stopping smoking, defined as not being able to cease smoking after a 
MI, was a significant factor in cross-sectional analysis of the finding of a level 3b 
study (Strik, Honig, & Maes, 2001c) and in a prospectively conducted 2b study 
(Strik et al., 2003a). 
 
There is good evidence for a strong and consistent association between tobacco 
smoking and depression. Individuals with depressive illness have higher rates of 
smoking in comparison to those who are not depressed (Chang & Chiang, 2009; 
Fucito & Juliano, 2009). This association has been confirmed in a large, longitudinal 
cohort study conducted over a time span of 21 years (Fergusson, Goodwin, & 
Horwood, 2003). Importantly, in prospectively conducted studies this association has 
been found to be bi-directional. People with major depression at baseline increased 
their smoking and a history of daily smoking increased the risk of major depression 
(Breslau, Novak, & Kessler, 2004; Breslau, Peterson, Schultz, Chilcoat, & Andreski, 
1998). The results of a recently reported longitudinal cohort conducted over a 26-
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year period provided further evidence of a risk of depression in those who smoked 
and that the risk increased with greater tobacco use (Flensborg-Madsen et al., 2011). 
The underlying mechanisms explaining the strong positive association between 
smoking and depression have still to be fully understood. Possible explanations 
include a causal link between nicotine use and vulnerability to depression due to 
nicotine’s influence on neurochemical pathways (Carmody, Vieten, & Austin, 2007) 
and a common genetic vulnerability affecting the neurotransmitter systems that may 
increase the probability of both depression and smoking (Malhi & Berk, 2007). 
 
There is consistent evidence identifying smoking as a risk factor for depression 
in non-cardiac samples and this adds considerable weight to the cardiac evidence. 
Smoking may be regarded as an important factor in the development of depression, 
however, smoking is also a strong risk factor for the development of cardiovascular 
disease and it is likely that a highly complex relationship, yet to be fully elucidated, 
exists between smoking and these two diseases. 
 
The majority of risk factors identified and discussed thus far have been from 
the psychological, social, behavioural and demographic domains. These risk factors 
have been the primary focus of research in this field and there is evidence from both 
the cardiac literature and the wider literature to support an argument for their 
inclusion as risk factors for depression in cardiac patients. Indeed, the inclusion of 
these risk factors as ‘variables of interest’ in cardiac research projects may reflect the 
strength of known evidence gathered from research in non-cardiac samples. To some 
extent, research projects examining these risk factors have attempted to confirm 
whether these factors are as relevant in cardiac depression as in non-cardiac related 
depression. 
 
The evidence related to biomedical variables is more problematic to assess 
because of limited data. Although there have been twenty medical risk factors 
identified from the literature search, there is considerably less evidence to assess. 
Research examining medical risk factors for depression attempts to address the 
underlying question to what extent does poorer medical health increase the risk of 
depression? 
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Heart failure. 
 
Heart failure develops when the heart fails to adequately function as a pump. 
Systolic heart failure is the inability of the heart to squeeze enough blood from the 
ventricles to supply the body’s needs. Diastolic heart failure results from the inability 
of the heart muscle to relax in between heartbeats causing a backup of blood in the 
ventricles and blood vessels (Torpy, 2011). 
 
The relationship between left ventricular ejection fraction (LVEF), a marker of 
heart failure, and depression has been studied in four cross-sectional studies graded 
2b (Frasure-Smith et al., 1999; Lesperance & Frasure-Smith, 2000; Mallik et al., 
2006; Watkins et al., 2003) and two prospective studies graded 2b (Spijkerman et al., 
2005b; van Melle et al., 2005). An impaired LVEF has been found to be a significant 
risk factor for depression in all of the studies, however, the definitions of impairment 
have differed and range from less than 30% to less than 45% LVEF. Advanced Killip 
class (> 2) was also found to be significant in two cross-sectional studies (Frasure-
Smith et al., 1999; Mallik et al., 2006). Finally, Watkins et al., (2003) found that a 
diagnosis of congestive heart failure (CHF) documented in patient medical records 
was also significantly related to depression in a cross-sectional study. 
 
The prevalence rate for depression in CHF patients is similar to that found in 
post ACS patients, however, rates increase considerably in subgroups with greater 
levels of heart failure (NYHA Class III or IV) or worse physical symptoms 
(Freedland et al., 2003; Friedman & Griffin, 2001; Rutledge, Reis, Linke, Greenberg, 
& Mills, 2006).  The relationship between heart failure class may also be mediated 
by age with younger patients (≤ 60 years) more at risk of depression (Freedland et 
al., 2003). Depression is also more common in women with heart failure than men 
(Angermann et al., 2011; Freedland et al., 2003; Jiang et al., 2001). 
 
Within the psychosocial literature, disability and physical impairment are 
known risk factors for depression in community samples (Geerlings et al., 2000). 
However, there is also prospective evidence that the presence of depressive 
symptoms is an independent predictor of severe functional limitations in CHF 
patients following discharge from hospital (Shimizu, Yamada, Miyake, & Izumi, 
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2011). A bi-directional association between depression and function in heart failure 
further complicates the assessment of the limited cardiac evidence that relies on 
primarily cross-sectional data. Furthermore, it has been postulated that shared 
pathophysiologic pathways may be responsive for the association between 
depression and heart failure (Joynt, Whellan, & O'Connor, 2004). 
 
Studies suggest a bi-directional association between depression and heart 
failure but there is insufficient evidence to suggest a direct causal link between 
measures of heart failure and depression in ACS patients. In view of this complicated 
relationship, this risk factor was included for further review by an Expert panel as 
detailed in Chapter 4 (Methods) of this thesis. 
 
Past cardiac history. 
 
A past history of an AMI (or other cardiac condition) has been significantly 
associated with depression in four cross-sectional studies graded 2b (Cheok et al., 
2003; Lesperance et al., 2000; Mallik et al., 2006; Naqvi et al., 2007) and two 
prospectively conducted studies graded 2b (Schrader et al., 2004) and level 4 
(Martens et al., 2008) respectively. The limited available evidence is consistent with 
epidemiological data showing higher levels of depression in patients following 
cardiac illness than in those people without cardiac disease. Clinically significant 
depressive symptoms have been found in between 31% to 45% of patients with ACS. 
In addition, 20% of CAD patients may have depression that fulfils the criteria for 
MDD (Carney & Freedland, 2008; Thombs et al., 2006), a rate consistently higher 
than national community based surveys conducted in Australia (Wilhelm et al., 
2003).  
 
Ethnicity. 
 
The relationship between ethnicity and cardiac related depression has not been 
well researched. Only one study (graded 2b) conducted in the US (Mallik et al., 
2006) was found in the literature search. Mallik and colleagues (2006) demonstrated 
a cross-sectional relationship between African American ethnicity and depression in 
a large sample of over two thousand post-AMI patients. 
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Ethnicity has been recognised as an important contributing factor in relation to 
variation in levels of mental health in differing communities within the same country 
(Stansfeld & Rasul, 2006). In Australia, there is a well-documented difference in 
levels of mental health between Aboriginal and Torres Strait Islander peoples and 
non-indigenous Australians. Indigenous Australians are twice as likely to report high 
or very high levels of psychological distress when compared to non-Indigenous 
Australians (AIHW, 2009). Mental health disorders are a leading cause of disease 
burden among Indigenous people, second only to cardiovascular disease, and make a 
of 16% contribution to total disability adjusted life years (ABS, 2008). Hospital 
admission data also reflects this disparity with Indigenous Australians presenting 1.8 
times more with a principle diagnosis of a mental or behavioural disorder (ABS, 
2008). Many reasons have been cited for high levels of psychological distress among 
Indigenous communities. The numerous contributing factors reported include family 
violence, lack of employment, past government policies of removing family 
members, poverty, and substance abuse (Emden, Kowanko, De Crespigny, & 
Murray, 2005; O'brien, 2005). 
 
Although Indigenous Australians have a well-documented high burden of 
cardiovascular disease and mental health disorders (ABS, 2008), there has been no 
research conducted in ACS samples in order to examine ethnicity as a risk factor for 
depression. In particular, it is not known whether ‘ethnicity’ itself should be regarded 
as an independent risk factor for depression in cardiac patients or as a risk marker 
indicating the likelihood of a clustering of multiple risk factors related to SEP and 
other social factors. In spite of the paucity of data in this area, Indigenous Australians 
should be regarded as at greater risk of depression than non-Indigenous Australians.  
 
Limitations of the Review. 
 
The literature search has been primarily confined to studies published in 
English and therefore may be at risk of publication bias. Where key information 
likely to affect the quality assessment was absent, the Oxford EMB Grade was 
reduced. The authors of the paper were not contacted to clarify methods or supply 
missing data. The literature search, data extraction, quality critique and evidence 
grading were undertaken by one individual and therefore did not benefit from 
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additional independent assessment prior to review by an expert panel during 
questionnaire development. However, these processes were conducted with guidance 
from a supervisory team with extensive methodological and content knowledge. 
 
The 24 studies reviewed have been conducted over a 17 year period from 1992 
(Forrester et al., 1992) to 2009 (Stafford et al., 2009). During this time the diagnostic 
criteria for both depression and ACS have evolved and this represents a significant 
barrier to comparison of the studies across time. A high level of heterogeneity 
between studies is further illustrated by the differing study designs, the measures 
used to assess depression, the temporal relationship of the risk factor to depression 
(cross-sectional or prospective associations), the wide array of risk factors studied 
and the varying definitions of each risk factor. A high level of heterogeneity has 
precluded the use of meta-analysis and has not allowed meaningful comparisons of 
the strengths of associations between risk factors and depression across multiple 
studies.  
 
The design of the prospective studies has enabled the identification of risk 
factors for depression in ACS, however, only the main effects of these risk factors 
have been examined. There is insufficient evidence to determine from the current 
cardiac literature whether the simultaneous presence of multiple risk factors results in 
a cumulative increase in the risk of depression in cardiac patients.  
 
Finally, this review may be further limited because it is based on findings from 
prior studies that have primarily examined risk factors that have been identified and 
studied extensively in psychiatric or community populations. A number of risk 
factors for depression in patients with heart disease may not yet be identified. The 
paucity of data regarding biomedical risk factors identified has further reduced the 
scope of this review to comment on their relationship with cardiac depression. 
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Conclusions. 
 
This review was undertaken to address the question: What risk factors for 
depression have been identified in cross-sectional and prospective studies conducted 
in cardiac samples and what further supporting evidence can be found in the wider 
psychosocial literature? The purpose of the review within the context of the research 
project was to identify risk factors with a sound evidence base that may be included 
in a risk assessment questionnaire for use in an acute clinical setting. The risk factors 
were further assessed for clinical appropriateness and relevance to an adult 
population. 
 
The literature review identified 50 risk factors found to be associated with 
depression in cardiac patients. From this a further 13 risk factors were identified as 
likely to be highly relevant in regard to the risk of developing depression following a 
diagnosis of ACS.  
 
The strength of evidence has varied considerably between risk factors due to 
limited cardiac research. Some of the risk factors, for example a past history of 
depression, have an extensive research base and are strong, independent risk factors 
for the onset of depression. Other risk factors rely more on the psychosocial evidence 
and are relevant to cardiac depression because they are likely to play a mediating role 
or be more relevant to sub groups of cardiac patients, for example social support.  
 
In conclusion, the review has successfully identified relevant risk factors for 
cardiac related depression. This review has represented an important initial stage in 
the development of a risk assessment questionnaire. 
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Chapter 3 – A Conceptual Framework 
 
Introduction 
 
This chapter proposes a conceptual framework in order to describe the complex 
relationship between depression and ACS (figure 3.1). This framework has guided 
the instrument development for this study. The framework presents two interrelated 
pathways leading to an increased risk of both depression and acute coronary 
syndrome. This broad approach has been taken with the purpose of clearly 
acknowledging the significant relationship between two discrete pathophysiological 
processes whereby depression is a risk factor for ACS and ACS increases the risk of 
depression. Within this framework, a narrower conceptual pathway of risk for 
individual ACS patients is described (figure 3.2). 
 
The conceptual framework is based on current knowledge of the relationship 
existing between the two diseases. It is limited by our insufficient understanding of 
the biological, behavioural and psychosocial pathways thought to connect the 
depression and ACS. As noted in the preceding review of the literature, much of the 
research undertaken in this field to date has been correlational and therefore unable 
to provide the necessary strong evidence to establish causal links.  
 
Risk Factors  
 
The distal and proximal risk factors for depression are symbolised by the blue 
circle on the left hand side of the diagram. Evidence from the medical and 
psychosocial literature indicates that depression has multiple, complex and diverse 
risk factors and that these risk factors are highly correlated. It is generally 
acknowledged that depression may not have a single cause but is more likely to have 
a “causal chain” or multiple causal chains that include biological, psychological, 
environmental and social risk factors (Kraemer, Stice, Kazdin, Offord, & Kupfer, 
2001). 
 
The risk factors for cardiovascular disease have been symbolised by the yellow 
circle beneath the blue circle in the diagram. The majority of risk factors for 
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cardiovascular disease have been well described in the literature and include 
biological, social and behavioural factors. Significantly, many of the risk factors for 
depression are also risk factors for cardiac disease. This phenomenon has recently 
been described as “an intriguing and complex, bi-directional association” whereby 
psychological factors act as risk factors for cardiac disease and vice versa (de Jonge 
et al., 2010). Common risk factors are not confined to the psychological domain but 
can be observed across social, behavioural and biological domains (McCaffery et al., 
2006; Smith & Blumenthal, 2011; Steptoe et al., 2003). The concept of common risk 
factors has been illustrated in the diagram by the green area indicating overlapping of 
the two risk factor circles. 
 
An Antecedent Pathway – Depression Prior to acute coronary syndrome 
 
There is extensive evidence that depression is strongly associated with the 
subsequent development of CAD (Hippisley-Cox, Fielding, & Pringle, 1998; 
Rozanski, Blumenthal, & Davidson, 2005). Results from meta-analyses have found 
similar rates of increased risk for the development of ischaemic disease in depressed 
but otherwise healthy people (Rugulies, 2002; Van der Kooy et al., 2007; Wulsin & 
Singal, 2003). Increasing data suggests that depression is not only associated with 
clinical CAD but also sub-clinical disease. Depression has been associated with the 
prospective development of carotid atherosclerosis, a marker of coronary 
atherosclerosis (Faramawi et al., 2007); (Haas et al., 2005; Stewart et al., 2007) and 
other biological markers indicating increased cardiac risk (Seldenrijk et al., 2010). 
 
The diagram illustrates this pathway with a horizontal arrow pointing from the 
depression risk factor circle towards a purple box labelled ‘depressed mood’. 
Subsequent arrows in the same direction point to a yellow box representing the 
presence of behavioural, psychosocial, and biological factors known to increase the 
risk of cardiovascular disease and finally to a box labelled ‘episode of acute coronary 
syndrome’. 
 
  
Figure 3.1 
A diagram illustrating the theoretical relationship between depression and acute coronary syndrome 
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In clinical practice, the antecedent pathway may be demonstrated by the 
documented high levels of current cases of depression, symptoms of depression, or 
past history of depression found in patients admitted with ACS (Carney & Freedland, 
2008; Lesperance et al., 2000; Thombs et al., 2006). Admission to hospital for ACS 
therefore presents a significant opportunity to screen for depression. As previously 
discussed, a prior history of depression or the presence of depressive symptoms in 
hospital are not only common but both are strong risk factors for future depression in 
ACS patients. 
 
Consequence Pathway – Depression following acute coronary syndrome 
 
Prospective studies observing the natural course of depression following ACS 
report an additional 10 to 20% of patients develop depression following discharge 
from hospital (Dickens et al., 2004; Lesperance et al., 1996; Travella et al., 1994). 
 
This pathway is illustrated in the diagram by a horizontal arrow from the 
cardiac risk factor circle to a box labelled ‘acute coronary syndrome’. An arrow (left 
to right) points to a blue box representing the presence of psychosocial, behavioural, 
and biological factors thought to increase the risk of depression following ACS. It is 
these factors that have been identified through the systematic review and discussed in 
length in the previous chapter. A further arrow connects this box to a purple box 
labelled ‘depressed mood following ACS’. 
 
This pathway is perhaps the most easily recognised in clinical practice. There is 
substantial evidence that patients following admission for ACS are at increased risk of 
developing sub-clinical depression, adjustment disorder with depressed mood, or 
major depression. Identifying the risk factors for developing depression following 
ACS is important because of the detrimental affect of depression on a patient’s quality 
of life and ability to modify cardiac risk factors in order to prevent further events. 
Furthermore, although there is insufficient evidence for a causal link, a strong, 
consistent association exists between depression and poor prognosis following a 
myocardial infarction (Meijer et al., 2011). Evidence suggests that a depressive 
episode, directly after an acute cardiac event, is the most significant factor in relation 
to cardiac prognosis (Parashar et al., 2006; Parker et al., 2008).  
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Common Underlying Determinants of Disease? 
 
Whilst there is good evidence for the two pathways described in the conceptual 
framework, there is another explanation for the relationship between depression and 
ischaemic heart disease. Recent research focusing on the complex biological 
connections between the two diseases has lead researchers to propose a hypothesis 
that common underlying biological determinants are responsible for both diseases 
(Mosovich et al., 2008). In such a model the two diseases are two possible outcomes 
that result from a ‘prior stress related insult to the body’ and therefore a correlational 
association may exist between the diseases but no causal relationship. To date, there 
remains insufficient evidence to support this theory and therefore this possible 
pathway has not been included in the conceptual framework other than to note the 
common risk factors for both diseases.  
 
A Pathway Illustrating the Concept of Risk of Depression for individual ACS 
patients 
 
This section of the chapter narrows the focus from the broad framework, 
illustrating the relationship between depression and ACS, to the concept of risk 
related to depression at an individual level. The proposed conceptual pathway 
acknowledges that individuals may be vulnerable to depressive illness throughout 
their lives but that exposure to certain risk factors can precipitate depression in 
cardiac patients.  
 
It is proposed that patients can be stratified into high or low risk groups by 
identifying their current level of depressive symptoms, past history of depressive 
illness, and other key risk factors for depression. This thesis argues the need for such 
risk assessment due to the well-documented deleterious effects of depression in post 
ACS patients (Meijer et al., 2011). Risk stratification provides an opportunity to 
intervene early with psychosocial support or treatment for patients in need that could 
lead to improved health related quality of life and mental health outcomes. 
 
An individual admitted to hospital with an episode of ACS may have had 
recent exposure to risk factors for depression, such as a negative life event, or they 
may have been at risk of depression for many years due to psychosocial, behavioural 
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or genetic factors (Birmaher et al., 1996; Farmer, 2001; Lewinsohn et al., 1994a). 
This is illustrated in the diagram (figure 3.2) by the group of five blue figures on the 
left hand side of the page and the arrow pointing downwards from a blue box entitled 
‘exposure to risk factors for depression’. 
 
For some people exposure to risk factors will not necessarily lead to depressive 
illness due to other factors thought to protect the individual by mediating the risk of 
developing disease. This is illustrated by the arrow pointing from the yellow box 
with the title ‘protective factors’. However, some individuals will develop depression 
and may already have experienced a depressive episode prior to their admission or 
during their admission to hospital for ACS (Dickens et al., 2004). In order to convey 
this in the diagram, an arrow from the group points to a purple box with the title 
‘episode of depression’. 
 
An admission to hospital with a diagnosis of ACS can be viewed by 
individuals as a serious negative life event and is therefore a risk factor for 
depression in some cardiac patients (Kendler et al., 1998). This is illustrated in the 
middle of the diagram by an arrow from an orange box labelled ‘serious life event’ 
pointing to a box with the title ‘hospital admission for ACS event’.  
 
An admission to hospital can be regarded as a crucial opportunity to assess an 
individual’s psychological health. Although hospitalization represents a stressful 
period for patients, an accurate assessment of past psychological health, level of 
current depressive illness, recent history of life events and other social factors can 
provide valuable insight into a patient’s future psychological well-being. Such 
knowledge can help nurses identify those patients most at risk of depression 
following discharge into the community.  
 
Risk assessment is represented in the diagram (figure 3.2) by a vertical box 
coloured aqua blue and labelled ‘screening/identification of patients at risk of 
depression’. The stratification of patients into high or low risk groups is illustrated by 
three boxes, a purple box represented patients with current symptoms of depression, 
a blue box representing those patients with an increased risk of future depression, 
and a yellow box representing patients thought to be at low risk of depression. 
  
Figure 3.2 
A conceptual pathway illustrating the concept of risk for individual ACS patients 
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A key element of the proposed pathway is the opportunity for psychosocial 
assessment and intervention, not only for those with recognised depressive illness, 
but crucially for patients at risk of illness. This is a significant move away from a 
model of disease recognition and treatment by adopting a broader approach to 
psychological health for cardiac patients. Patients are not routinely identified as 
being at risk of developing depression in the cardiac setting, therefore it is not yet 
known whether early intervention with patients at risk of depression can improve 
medical or mental health outcomes. In the diagram, the psychosocial assessment is 
represented by arrows leading from the purple and blue boxes to a vertical box pink 
box labelled ‘early psychosocial assessment’. A further arrow points to a green box 
labelled ‘improved health outcomes’. 
 
This chapter has presented an overarching conceptual framework to illustrate 
the interrelationship between depression and an ACS event. The presence of both 
antecedent and consequence pathways provide an explanatory theory to underpin 
depression screening and risk assessment in the acute cardiac setting. 
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Chapter 4 – Methods 
 
Introduction 
 
In this study both quantitative and qualitative research methods have been 
employed. Quantitative methods were used to develop and test the psychometric 
properties of the questionnaire and qualitative methods were adopted to explore 
contextual aspects related to depression screening in an acute cardiac setting. This 
chapter provides a detailed outline of the methods undertaken following the various 
stages of instrument development illustrated in figure 4.1. 
 
Rationale 
 
A mixed method approach is a validated research method to explain 
phenomenon that are complex and multifaceted (Tashakkori & Teddie, 2003). 
According to Morse, (2003) different methods are best designed for, and used to 
answer, particular types of question. Combining and increasing the number of 
research strategies used within a particular project enables the dimensions and scope 
of the project to be broadened (Morse, 2003). This study is based on a multi-method 
design described by Morse (2003) as a combination of qualitative and quantitative 
projects that are relatively complete, but are used together to form essential 
components of one research program (Morse, 2003). This research project has 
incorporated a systematic review, qualitative interviews and data analysis, and 
questionnaire design methods. 
 
There are a number of features specific to a multi-method design: 
1. Each study is planned and conducted to answer a particular research 
question.  
2. Data are not usually combined within projects. 
3. The results of each method inform the overall research question. 
4. The underlying methodological assumptions of each paradigm are 
recognised and adhered to. 
5. The studies conducted may have an inductive or deductive drive depending 
upon the research question. 
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Figure 4.1 
Schematic diagram of the research design 
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Instrument Development 
 
Content validity is recognised as a key factor in instrument development (Grant 
& Davis, 1997). Content validity concerns the degree to which a sample of items 
contained in a questionnaire constitute an adequate operational definition of the 
construct and is representative of the domain of content (Grant & Davis, 1997; Polit 
& Beck, 2006a). According to Polit and Beck (2006a) content validity is largely a 
matter of judgement, involving two phases: a priori efforts by the instrument 
developer to enhance content validity through careful conceptualisation and domain 
analysis prior to item generation, and a posteriori efforts to evaluate the relevance of 
the scale’s content through expert assessment.  
 
The methods undertaken in the development of this instrument have reflected 
the need to establish a high level of content validity. This instrument has been 
developed following a systematic review of the literature and critique of the evidence 
base as discussed in Chapter 2. The concept of depression related to ACS has been 
explored and a detailed conceptual framework has been outlined in Chapter 3. The 
following section describes the methods undertaken to create a draft questionnaire 
for expert panel review. The design process followed is illustrated in figure 4.2. 
 
Design Process 
 
The items considered for inclusion in the draft risk assessment questionnaire 
were based on the 13 risk factors identified following the systematic review and 
critique. Item generation is an iterative process requiring considerable refinement to 
wording and content (Rattray & Jones, 2007). During a period of several weeks draft 
versions of the tool were created, reviewed by clinical colleagues and amended in 
order to improve clarity of wording, structure and to assess Face validity. This 
process is illustrated in figure 4.2 as the ‘revision cycle’. 
 
Chapter 4 – Methods 
74 
Figure 4.2 
Instrument design process 
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First the items were divided into those that would be best answered by the 
patients themselves and those that would require clinical staff to source information 
from medical records. For example, an item regarding life events was identified as a 
‘patient’ question whereas confirmation of a clinical diagnosis was regarded as more 
appropriately answered by members of staff. Initially all of these questions were 
contained within the same questionnaire but as separate components. During the 
revision cycle, the patient and staff questions were divided into separate 
questionnaires. 
 
The type of question, language used and order of items may bias question 
response (Rattray & Jones, 2007) and this was taken into consideration during the 
design process. A closed question design was used for all of the items and sentences 
were worded to gain a ‘yes’ or ‘no’ response. An affirmative response indicated the 
presence of the risk factor. To allow patients to clarify their responses, a section for 
‘free text’ was included at the end of the questionnaire. 
 
Four questions regarding past history of mental health problems also requested 
more details if known by the patient. The sentences were kept as short as possible 
and used plain language for clarity. The order of questions was considered and the 
most important and least sensitive items were place at the start of the questionnaire.  
 
In total 15 questions were included in the final draft of the patient 
questionnaire and seven questions in the staff questionnaire. The structure, layout 
and choice of question type were influenced by the need to consider a high level of 
clinical utility. All of the questions were included on a single A4 page for ease of 
administration for staff and to reduce the perceived response burden for patients.The 
final drafts of both questionnaires were forwarded to the expert panel for content 
review. 
 
Expert Review. 
 
Review of an instrument by a panel of experts is an important measure to 
enhance content validity (Polit & Beck, 2006a). The literature suggests that various 
criteria may be used to determine the ‘expertise’ of panel members including 
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relevant training, clinical or research experience related to the phenomenon of 
interest, and familiarity with the theoretical basis for the instrument (Davis, 1992; 
Grant & Davis, 1997; Grant & Kinney, 1992). The recommended number of panel 
members varies considerably in the literature and can be influenced by the level and 
range of expertise required (Grant & Davis, 1997), however, a minimum of three 
panel members is advised (Lynn, 1986).  
 
The panel members invited to review the questionnaires were selected because 
of their clinical expertise and active research profiles. All had extensive clinical 
experience with cardiac patients and held professional qualifications related to 
mental health or cardiology. Four of the panel members also held academic 
appointments in universities in Australia or the United Kingdom. A further two 
members worked with The National Heart Foundation in Australia. Initially 11 
people were invited to participate with eight agreeing to be members of the panel. 
The final panel consisted of two psychiatrists, two psychologists, one cardiologist, 
and three Registered Nurses with expertise in Cardiac Rehabilitation. 
 
The eight panellists were sent an invitation to participate by email. A cover 
letter explained the purpose of the research, how the final questionnaire might be 
used in clinical practice and briefly outlined what would be required for participation 
(appendix D). To address the issue of consent, panel members were advised that by 
completing and returning the attached documentation the researcher would assume 
they had consented to participate. Participants were informed that they may be 
identified as panel members in the PhD thesis but that no specific data would be 
linked to them personally and they would not be identified in any subsequent 
publication. In addition to the cover letter, the panel members were sent a review 
document (appendix E) and the two draft questionnaires as email attachments 
(appendix F and appendix G). 
 
To establish item content validity the panel of experts were asked to rate each 
item in terms of its relevance as a risk factor for depression in cardiac patients using a 
4-point scale ranging from 1 (not relevant) to 4 (very relevant). Panel members were 
asked to provide recommendations for individual item revision in a ‘free text’ box 
under each listed item. To assess comprehensiveness the panellists were asked if any 
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significant risk factors were not represented in the questionnaires. The experts were 
also asked if they considered any of the questions to be redundant. In recognition of a 
paucity of data regarding ethnicity, experts were asked if they considered any 
particular ethnic group at increased risk of depression following ACS. 
 
The content validity index (CVI) (Martuza, 1977) was computed for individual 
items (I-CVI). The I-CVI is calculated as the number of experts giving a score of 3 
(relevant but may need minor alteration) or 4 (very relevant) divided by the total 
number of experts (Polit & Beck, 2006a). For a panel of at least 6 experts, 0.78 is 
considered acceptable (Lynn, 1986). Items were modified in response to the expert 
advice and removed if the I-CVI was not satisfactory. The content validity of the total 
instrument was assessed by calculating the scale-level content validity index (S-CVI). 
This was calculated by summing the individual I-CVI totals and dividing by the 
number of items in the instrument (Polit & Beck, 2006a). Thus far this chapter has 
described the research methods undertaken by the researcher whilst based at the 
university. The remainder of the chapter describes the research methods undertaken at 
a separate clinical site. 
 
Research Setting. 
 
The following research has been conducted in the Cardiovascular Medicine 
Department (CVMD) of a large tertiary referral hospital within the public health 
system of Western Australia (WA). The state of WA has a land mass of 2.5 million 
km 2 (ABS, 2007) and a population of approximately 2.3 million people (ABS, 
2012). The hospital admits patients from the North Metropolitan Health Area in 
Perth and accepts transfers from regional hospitals throughout the state. 
Approximately 20% of patients admitted to the department reside in rural or remote 
areas of WA.  
 
The CVMD provides advanced management of acute and chronic heart 
conditions. The cardiovascular invasive laboratory supports angioplasty, 
electrophysiology studies, pacing device implants and provides a 24-hour primary 
angioplasty service. In the 12-month period from 1st July 2010 to 30th June 2011, 928 
ACS patients were admitted to the department. Of these patients 34% had a diagnosis 
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of USA, 46% NSTEMI and 20% STEMI. Percutaneous coronary intervention (PCI) 
was performed for 780 patients, 27% of these patients received primary PCI. Recent 
advances in medical therapy have reduced the average length of hospital stay for 
patients admitted with ACS to 72 hours, patients without complications could be 
discharged into the community after 48 hours of care. 
 
Patients admitted to the department also receive support through the nurse-led, 
multidisciplinary Cardiac Rehabilitation and Heart Failure Services. The teams offer 
assessment, education, and counselling to patients during admission and following 
discharge into the community.  
 
Ethical Approval. 
 
The research described in this thesis has been submitted for ethical review and 
gained approval from the Human Research Ethics Committees (HREC) at both 
Curtin University (appendix H) and the hospital research site. The entire project was 
deemed too large to be reviewed for ethics approval at the site and the researcher 
subsequently obtained HREC approval for the project divided into two separate 
studies, the qualitative contextual data component (appendix I) and the questionnaire 
testing component (appendix J). Specific details regarding the ethical considerations 
for each individual research component are described separately. 
 
Contextual Data - Determining the Barriers and Facilitators to Depression 
Screening at the Research Site. 
 
Qualitative data was collected in order to gain insight into factors that may 
have influenced the assessment of patients for their risk of depression at the research 
site. This component of the study was conducted to address the following research 
objective: 
 
To determine the barriers and facilitators to the introduction of a 
screening intervention.  
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Sample. 
 
Clinical personnel from the CVMD were approached to participate in the 
study. A purposive sampling strategy was adopted to allow the researcher to recruit 
participants that were able to contribute to the informational needs of the study (Polit 
& Beck, 2006b). This non-random method is often used to sample a group of people 
based on a particular characteristic or predetermined criterion (Bowling, 1999). For 
this study participants were selected because they were involved in the care of 
patients with a diagnosis of ACS. The sample included staff of varying experience 
and clinical role. Participants from the acute clinical area included two Consultant 
Cardiologists, two Senior Medical Registrars, and two Senior Registered Nurses. The 
remaining participants worked primarily with patients following discharge and 
included experienced Registered Nurses from the Cardiac Rehabilitation and Heart 
Failure Services. 
 
The size of the sample (n = 10) was guided by data saturation, the point at 
which no new information was obtained and redundancy was achieved (Polit & 
Beck, 2006b). Redundancy may be achieved with a relatively small number of 
informants in studies where the scope of the research question is narrow and 
participants are able to reflect on their experiences and communicate effectively 
(Morse, 2000). The clinical staff were able to clearly define major barriers to 
depression screening in the department and identify various strategies that would 
facilitate depression screening. Recurrent major themes were identified in the 
interview transcripts indicating a high level of concordance of opinion amongst the 
members of staff. No new themes were identified from the tenth interview and 
therefore recruitment stopped at that point. 
 
Ethical considerations. 
 
A Participant Information Sheet and Consent Form were provided to the 
participants of the qualitative study (appendix K) and informed consent obtained. 
The information sheet advised the staff of the purpose of the study, why they were 
being asked to participate, and what their participation would involve. 
Confidentiality was a particular ethical issue given the relatively small number of 
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clinical staff working in the department. All personal data collected was kept 
confidential, and individual study documents, transcripts, and digital audio files were 
de-identified and coded with a study number. Study related information was stored 
on a password-protected computer accessible by the researcher alone. The Master 
Study Participation Log containing the names of participants and their allocated 
study numbers was kept separately in a locked cabinet within a private research 
office.  
 
After completion of the data analysis, all study related material was archived 
within a secure archive room in the Heart Research Institute of WA located at the 
research site. This material will be archived on site for a minimum of five years and 
then archived in a secure archive facility off site in accordance with the Department 
of Health (WA) Retention and Disposal Schedule.  
 
Data collection. 
 
Staff members were recruited to the study over a 5 month period between 4th 
March and 27th August 2010. Following informed consent, a small amount of 
demographic and job related information was collected from participants. Interviews 
were conducted in a private office at the research site in an area separate from the 
CVMD. Qualitative data was generated by semi-structured interviews with individual 
participants. Semi-structured interviews are considered most suitable when a 
researcher knows enough about a topic to develop questions in advance of the 
interview, but not enough to be able to anticipate the answers (Morse & Richards, 
2002). The researcher asked pre-determined, open-ended questions as indicated by an 
interview guide (appendix L). This technique of interviewing allowed the researcher 
to explore different aspects of the topic by using verbal probes such as what, where, 
when and how. The interviews were digitally recorded, saved as audio files, and 
subsequently transcribed verbatim by the researcher prior to analysis. Transcripts 
were saved as Microsoft Word documents. 
 
Qualitative data analysis. 
 
The interview transcripts were analysed using Framework Analysis (Ritchie & 
Spencer, 1994). This method of analysis has been specifically designed for applied 
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policy research where the aim of the research is to gather specific information with a 
potential to create actionable outcomes. Framework analysis is well suited to 
research that has specific questions, a limited time frame, a pre-designed sample, and 
a priori issues. Although Framework Analysis may generate theories, its prime 
objective is to describe and interpret what is happening in a particular setting.  
 
The Framework Analysis technique is divided into five key stages: 
 
• Familiarization 
• Identifying a thematic framework 
• Indexing 
• Charting 
• Mapping and interpretation  
(Ritchie & Spencer, 1994) 
 
During the initial stage of analysis the researcher became familiar with the data 
whilst listening to the audio recordings during the transcription process and through 
reading the final interview transcripts. At this point notes were taken when apparent 
themes were identified from the data. The second stage of analysis required the 
researcher to place the identified themes and issues into a thematic framework. 
According to Richie and Spencer (1994) this involves making judgements about the 
meaning, relevance and importance of issues and being aware of implicit connections 
between ideas. The identified themes were listed in a table in a Microsoft Word 
document. Specialised computer software was not used for this purpose because the 
data was relatively easy to manage using basic computer files and programs.  
 
Indexing refers to the third stage of analysis where portions of data that 
correspond to individual themes in the framework are identified. Themes within the 
framework were given reference codes and individual transcripts were read again and 
codes attached to the relevant segments of data.  
 
The fourth stage of analysis involved rearranging the coded data according to 
the relevant theme in the framework. This was achieved by creating charts for each 
key theme, for example all data related to the ‘barriers to depression identification’ 
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was contained in a chart. During this stage data synthesis occurred and verbatim text 
data was summarised within the chart. The final stage, mapping and interpretation, 
involved analysing the data in order to define the core concepts related to the 
perceived barriers and facilitators to depression screening at the research site. 
 
Issues of trustworthiness. 
 
The concept of trustworthiness refers to the extent to which the findings are a 
true reflection of the personal or lived experiences of the phenomenon under 
investigation (Barbour, 1998). A number of strategies were employed within the 
study to address this issue: 
 
• Transcripts were compared with the digital audio files and checked for 
accuracy.  
• Notes of the data collection and analysis process were kept to provide a 
clear and transparent description of the methods used.  
• Following analysis of the data, the results were presented to the staff that 
participated in the research in order to confirm the interpretation.  
 
Instrument Modification and Psychometric Testing in a Clinical 
Population 
 
The Expert Panel findings and the contextual data were reviewed and guided 
the creation of a single risk assessment questionnaire for patients. Items that failed to 
achieve a satisfactory CVI rating were removed leaving a total of nine questions. 
This questionnaire was then given the title Depression Risk Assessment 
Questionnaire (DRAQ) (appendix M). This version of the questionnaire was then 
submitted for HREC approval at the research site. 
 
Following analysis of the contextual data it became apparent that it would be 
difficult to involve the staff further in the testing of a staff specific questionnaire due 
to clinical time constraints. Limited time available to perform depression screening 
was perceived as a significant barrier by clinical staff. This instrument was not 
developed further in this project but formed the basis of a separate research project 
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that has been commenced at the research site. Those items that had been included in 
the staff questionnaire involved confirming data from the patient’s medical records. 
This data was subsequently collected by the researcher herself during the testing of 
the DRAQ in a sample of ACS patients. 
 
Psychometric Testing of the DRAQ in a Clinical Population. 
 
This section describe the methods undertaken in order address the following 
research aims and objectives: 
 
To perform preliminary assessment of the psychometric properties of the 
instrument following application in a sample of ACS patients. 
 
• To test the DRAQ for internal consistency reliability, test-retest reliability 
and structural validity. 
 
To establish the extent to which patients find the questionnaire acceptable as 
part of clinical care. 
 
• To establish the acceptability and readability of the DRAQ as perceived by 
a sample of ACS patients. 
 
The study methods are illustrated in figure 4.3. 
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Figure 4.3 
Schematic diagram of study methods 
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Note. ACS = acute coronary syndrome; PHQ-9 = Patient Health Questionnaire-9;  
T2 = time 2; DRAQ = Depression Risk Assessment Questionnaire;  
GP = General Practitioner. 
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Participant recruitment. 
 
Consecutive patients admitted to the CVMD were screened for eligibility to 
participate in the study. Patients were eligible if they were admitted with a diagnosis 
of unstable angina, NSTEMI or STEMI, of either gender, aged 18 years or above and 
were able to provide informed consent. Patients were excluded if they were non-
English speaking, unable to communicate or to read the questionnaire due to physical 
limitation. Patients with a head injury or suspected impaired cognitive function likely 
to affect informed consent or compliance were also excluded. 
 
The researcher approached patients following confirmation of their diagnosis 
by clinical staff. The details of patients approached were recorded in the study 
screening log. If the patient was ineligible the reasons was noted in the log. During 
the recruitment period, 31st October 2010 to 21st July 2011, 348 patients were 
screened for the study.  
 
A predetermined sample size of 220 participants was proposed and 
subsequently recruited to the study. It was anticipated that the sample size would be 
sufficient to enable statistical methods based on correlation to be used for 
psychometric testing of the questionnaire. Data from a minimum of 100 participants 
was required to enable a test-retest coefficient to be calculated. 
 
Ethical issues. 
 
The cardiac patients admitted to the CVMD were not routinely screened for 
depression either during hospitalisation or following discharge. In consultation with 
the Psychiatric Department and the Cardiac Rehabilitation Service, a plan for the 
clinical management of patients found to have depressive symptoms was developed 
and the details provided as part of the HREC application at the research site. Patients, 
their GPs and the Cardiac Rehabilitation Team were all advised of the results of the 
depression screening.  
 
Participants were provided with both verbal and written information regarding 
the study. The Participant Information Sheet specifically included details regarding 
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the potential risks and any benefits of taking part, how data would be collected and 
stored, and clearly defined the patient’s right to withdraw from the study without 
prejudice (appendix N). Patients were approached to participate during their 
admission to the coronary care unit (CCU), in the last days before discharge when 
their medical condition had stabilized. Patients were given verbal information about 
the study and then allowed to read the Participant Information Sheet themselves. The 
researcher returned later to answer any study related questions prior to obtaining 
written consent. 
 
Permission to conduct the research within the CVMD was obtained as part of 
the Institutional and HREC approval process. Prior to recruitment the researcher 
presented the study protocol at a departmental meeting. 
 
Study procedures. 
 
Following the informed consent procedure, patients were asked to answer the 
questions contained in the DRAQ and The Patient Health Questionnaire - 9 (PHQ-9) 
(appendix O). The PHQ-9 is an established, brief, self-administered questionnaire 
that has been shown to have acceptable properties for detecting depression in 
hospitalized cardiac patients (McManus, Pipkin, & Whooley, 2005) and has been 
recommended for depression screening by the American Heart Association 
(Lichtman et al., 2008). This questionnaire was included because it was necessary to 
identify patients that had current symptoms of depression. The researcher marked 
and discussed the results of the PHQ-9 questionnaire with the patient. No results 
were given to the patient regarding the DRAQ because it has not been fully 
validated.  
 
Demographic details and data regarding the patients past medical history, 
current smoking status and LVEF were retrieved from the patient’s medical notes by 
the researcher using standardized data extraction methods. A purposive sample (N = 
11) of participants were also asked to review the DRAQ in detail and complete a 
questionnaire to determine appropriateness. The participants were asked to complete 
the following questions regarding the nine individual DRAQ questions: 
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1. What is the meaning of the question? 
2. How clear is the question?  
3. How applicable is the question? 
4. Are the possible responses appropriate? 
5. Is this question embarrassing to answer? 
 
Data were entered into a Microsoft Access Database in order to manage the 
data for study purposes. Data relating to the PHQ-9 were entered and used to 
generate results letters in order to inform patients, their GPs and Cardiac 
Rehabilitation staff of the results. Other data were entered into tables and later 
converted into spreadsheets for statistical analyses. 
 
Test-retest procedure. 
 
Test-retest reliability is used to establish that a questionnaire is capable of 
measuring a variable with consistency (Portney & Watkins, 2000, p. 67). The DRAQ 
and PHQ-9 were sent to the participant’s home address two weeks following their 
discharge from hospital. The participants were asked to complete the questionnaires 
and return them in the stamped, addressed envelope provided. Returned 
questionnaires were reviewed and the data entered into the database for subsequent 
analysis. 
 
Data analysis. 
 
Following completion of the study, the database was examined for missing or 
inaccurate data by performing a 100% comparison between hardcopy study records 
and the electronic data. The data stored in Microsoft Access database tables were 
converted into Microsoft Excel spreadsheets for statistical analysis. 
 
Raw data from 220 participants was analysed using the Statistical Analysis 
Software program, version 12.1. Standard demographics of the sample were 
calculated at T1 and T2 for both the DRAQ and the PHQ-9 questionnaires. Data 
from the PHQ-9 were analysed according to the level of depressive symptoms and 
counts and percentages obtained for mild, moderate, moderately severe, and severe 
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scores. These data were further analysed in relation to sex and past history of 
depression. 
 
Internal consistency reliability, the extent to which all items measure a similar 
construct, was determined by calculating Cronbach’s alpha for both the DRAQ and 
PHQ-9 questionnaires. Test-retest reliability, a measure of an instrument’s precision 
over time, was calculated for the DRAQ using the kappa statistic, a chance-corrected 
measure of agreement. 
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Chapter 5 – Results 
 
Introduction 
 
The chapter is divided into three sections. The first section described the 
findings from the Expert Panel convened to assess the content validity, 
comprehensiveness and face value of the DRAQ. The second section describes the 
themes generated from qualitative analysis of contextual data. The final section 
describes the results of preliminary psychometric testing of the DRAQ to assess 
internal consistency reliability, test-retest reliability and readability. 
 
Expert Panel Findings 
 
An eight-member expert panel reviewed 22 items for content validity. Items 
were divided into two categories, those items for inclusion in a questionnaire 
designed for patients to complete (n = 15) and those items for inclusion in an 
instrument designed to confirm medical information to be completed by staff (n = 7).  
 
Items were given a rating between 1 - 4 by the experts and the content validity 
assessed by calculating an I-CVI score (appendix E). This was achieved by 
calculating the number of experts rating an item 3 or 4 (relevant; very relevant) 
divided by the total number of experts (Polit & Beck, 2006a). Items that scored 
below 0.75 were considered to have failed to reach a satisfactory level of content 
validity. A total of seven unsatisfactory items were discarded from the patient 
questionnaire leaving a total of 8 items (table 5.1) and two items were discarded from 
the staff instrument leaving a total of 5 items (table 5.2). Minor word revision was 
undertaken for six items. No further items were removed due to redundancy. 
 
One item, “Are you an Aboriginal or Torres Strait Islander person?” failed to 
reach a satisfactory level of content validity (I-CVI = 0.66) but was not discarded 
from the patient questionnaire (item 11, table 5.1). The item was retained because 
two of the international exert panellists stated that they were not familiar enough 
with the literature to fully comment on the item and did not give a rating for the item 
at all. In total, four of the remaining six experts scored the item as relevant or very 
relevant. 
  
Table 5.1 
Content validity index scores per item (Patient questions) 
 
Number of experts in each response category  
Question number not relevant unable to assess without item revision 
relevant but may 
need minor revision very relevant 
Content Validity 
Index 
1. 0 1 3 3 0.86∗ 
2. 0 2 4 2 0.75 
3. 0 0 2 6 1.00 
4. 1 0 5 2 0.88 
5. 1 3 4 0 0.50 
6. 0 3 3 1 0.57∗ 
7. 2 1 0 4 0.57∗ 
8. 2 2 2 2 0.50 
9. 0 4 3 1 0.50 
10. 1 2 4 0 0.57 
11. 1 1 1 3 0.66∗ 
12. 1 6 0 1 0.14 
13. 1 1 2 4 0.75 
14. 0 1 3 4 0.88 
15. 0 1 5 2 0.88 
 
Note.∗ = CVI calculated with fewer than eight expert panellist’s responses. 
  
Table 5.2 
Content validity index scores per item (Staff questions) 
Number of experts in each response category  
Question number not relevant unable to assess without  item revision 
relevant but may 
need minor revision very relevant 
Content Validity 
Index 
1. 1 2 3 2 0.63 
2. 1 1 3 3 0.63 
3. 0 1 4 3 0.88 
4. 0 2 4 2 0.75 
5. 0 1 3 3 0.86∗ 
6. 0 0 0 8 1.00 
7. 0 0 1 5 1.00∗ 
 
Note.∗ = CVI calculated with fewer than eight expert panellist’s responses. 
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Following the removal of items that failed to meet the CVI threshold, the 
content validity of each instrument was assessed by calculating the S-CVI. This was 
calculated by summing the individual I-CVI totals and dividing by the number of 
items in each instrument (Polit & Beck, 2006a). The S-CVI for the eight-item patient 
questionnaire was 0.83 and the S-CVI for the five-item staff instrument was 0.90. A 
S-CVI of 0.80 or higher is considered an acceptable level of content validity for a 
total instrument (Davis, 1992; Grant & Davis, 1997). 
 
In order to assess comprehensiveness, experts were asked to comment on 
whether any significant risk factors for depression in people with heart disease were 
not represented. Seven of the eight panellist suggested risk factors that might be 
included, however, there was no consensus between the experts on any of these 
items. One item asking the patient whether they had been prescribed antidepressant 
medication was added to the DRAQ making a final total of nine questions. The other 
suggestions were carefully reviewed, however, further items were not included 
because assessing the risk factor would be difficult in the acute clinical environment 
or the risk factor was not supported by sufficient evidence relevant to an acute 
coronary syndrome population. Following the item amendments, two related 
instruments were created, a nine-item instrument for patients (appendix M) and a 
five-item instrument for staff. This process of item selection lead to the formation of 
a provisional DRAQ as is illustrated in Figure 5.1. 
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Figure 5.1 
A figure illustrating item selection included in DRAQ following expert panel 
review 
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DRAQ (Staff) 
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testing) incorporates a 
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Draft DRAQ based on literature review 
Note. DRAQ = Depression Risk Assessment Questionnaire;  
CVI = Content Validity Index. 
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Findings from Contextual Data Analysis – Barriers and Facilitators to 
Depression Screening 
 
The aim of this research has been to develop a brief screening instrument 
designed to assess the risk of developing depression that can be used by clinical staff 
in the acute healthcare setting. To address the need for a high level of clinical utility 
it was considered important to develop an understanding of the clinical context in 
which the instrument would be used. This section describes the findings from a 
qualitative review undertaken to define current practice and perceived barriers or 
facilitators to depression screening. 
 
Study Participants. 
 
Ten members of clinical staff with varying professional roles and length of 
service were recruited. Participant’s characteristics are listed in Table 5.3. Data were 
obtained from ten semi-structured, individual interviews. The interview question 
guide is shown in appendix L. Participants were asked to respond to the interview 
questions based on their own professional experience gained whilst working in the 
Cardiovascular Medicine Department at the research site.  
 
Thematic Framework. 
 
Analysis identified themes related to three core categories; current clinical 
practice, perceived barriers to identifying depression, and perceived facilitators to 
identifying depression through screening. The categories, themes and subthemes 
identified from the data are illustrated in figure 5.2. In total 12 main issues related to 
current practice and barriers or facilitators to the implementation of depression 
screening were identified. The findings of the analysis indicated strong associations 
between the lack of a systematic depression screening process and perceived time 
constraints, poor access to psychiatric support services, and lack of mental health 
related skills and knowledge. The lack of knowledge about depression and research 
related to patients with CAD was also reflected in the staff identifying education and 
strong evidence as a prerequisite for the successful implementation of a screening 
programme. 
  
Table 5.3 
Participant characteristics 
 
    Length of service (years) 
Participant 
Number Age (years) Gender Professional role CVMD 
Total cardiac 
experience 
1. 33 M Senior Registrar 2 6 
2. 34 M Consultant Cardiologist 5 8 
3. 48 F Cardiac Rehabilitation Nurse 7 12 
4. 53 F Cardiac Rehabilitation Nurse 1 1 
5. 43 F Cardiac Rehabilitation Nurse 1.5 6 
6. 27 F Cardiac Rehabilitation Nurse 2 6 
7. 43 F Clinical Nurse 18 18 
8. 32 M Senior Medical Registrar 1.5 5.5 
9. 35 F Clinical Nurse 11 12 
10. 61 M Consultant Cardiologist 23 36 
 
Note. CVMD = Cardiovascular Medicine Department (Research Site) 
 
 
  
Figure 5.2 
Development of categories using Framework Analysis 
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Indexing: 
Systematic application of the thematic framework to portions of textual data. Individual transcripts were read again and codes attached 
to segments of data. 
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Data synthesis occurred and verbatim text data was summarised within individual charts. 
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The themes and subthemes are described in the following section, including 
text quotations identified by the appropriate participant code. 
 
Current clinical practice. 
 
Lack of systematic identification of current depression. 
 
Participants reported differing methods of determining whether a patient was 
depressed on admission to the department and how successful the strategy was in 
identifying depressed patients. Clinical nurses referred to their admission procedures:  
 
“On our initial assessment questionnaire and risk factor questionnaire we 
ask the patients if they have a history of depression or anxiety and I think 
confronting people with that question often gives you the answer” (P9). 
 
The senior medical staff reported a less formal approach:  
 
“It would not be very often that you would formally assess it (depression) 
so it would really be the very obvious patient that’s clearly apparently 
depressed or the family tell us that they think that they are depressed and 
that would be the only assessment of it at that stage” (P8). 
 
“With regards to picking up depression in the patients as they arrive, we 
usually just pick it up from what they describe as their history and from 
what medicines they are on… which is probably not enough but that’s 
the way we do it” (P2). 
 
The cardiac rehabilitation nurses voiced their concerns that depressed patients 
were not being identified: 
 
“Patients ‘slipping through the net’. A lot of these patients … the reason 
why they have the risk factors they have…so they’re smoking, they are 
overweight…may be down to the fact that they are depressed …on a 
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general basis, these patients are… as the process is, the patients are not 
being picked up” (P3). 
 
Cardiac rehabilitation staff pointed to the lack of an assessment tool to aid 
identification of depressed patients: 
 
“It would be good to have some sort of questionnaire to ask…when the 
patients go to their GP, the GP has an assessment tool…we don’t have 
that and we don’t use anything…just go on anecdotal. … it’s very 
difficult to ask every single patient that comes through the door because 
there is a high turnover of patients but I think it would be good to have 
some sort of assessment tool” (P3). 
 
Lack of psychiatric liaison support. 
 
Both senior medical staff and cardiac rehabilitation staff described difficulty 
accessing specialised psychiatric support services for patients during admission and 
following discharge: 
 
“…unless they are so depressed they are a threat to themselves…they’re 
going to abscond…we probably wouldn’t get psych (psychiatric liaison 
services) involved…we certainly don’t have ready access to an inpatient 
psychologist… not in that time frame so basically it gets ignored” (P2). 
 
“I can’t do anything, my hands are tied…I can’t refer them anywhere 
independently so now the only thing I can actually do is direct them back 
to their GP… I have not got any other avenues to refer the patients to. I 
guess we used to have a clinical psych (psychologist) that we could refer 
them to but we haven’t got that avenue now” (P5). 
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Reliance on GPs for depression management. 
 
There was a general concern reported that, whilst there was a reliance on GPs 
for the management of depression in the community setting, not all GP’s were 
interested in the on-going care of depressed patients: 
 
“I suppose you can always leave them (the patient) with their GP but that 
depends on whether the GP is interested in following up and managing 
depression.., you know, some are and some aren’t, that would be a 
shortfall I would think” (P1). 
 
Perceived barriers to identifying depression. 
 
Time constraints. 
 
A lack of available time was cited as a major barrier to formally identifying 
depressed patients both in hospital and following discharge. Time constraints were 
thought to impact in a number of ways. Firstly, patients would not develop 
depression during their short stay in hospital but were more likely to become 
depressed following discharge: 
 
“Part of the problem is their short stay… our turnover is pretty quick, it’s 
three days so someone is likely to get depressed after they are discharged 
from hospital… it’s likely they are going to get depressed after they leave 
hospital or become depressed when they lose the support of being in 
hospital” (P1). 
 
The short length of stay in hospital also reduced the time available for all staff 
to complete patient education, perform nursing care or medical procedures. This was 
thought to impact on both the time available for staff themselves to talk to patients 
but also time available when a patient was ‘free’ to talk: 
 
“I think staff time is what I’m thinking but also sometimes access to be 
able to interview the patients. There might be a procedure or they are 
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speaking to someone else… relatives or….just like with any screening 
that you do for patients” (P6). 
 
The participants reported the need to prioritise patient care because of time 
constraints: 
 
“To be honest we don’t concentrate on it at all. We don’t do any work on 
depression as inpatients… the length of stay now is so short and we 
concentrate so much on getting the medical stuff sorted out and some 
education that we …I don’t think that we make any effort at all into it” 
(P2). 
 
“I think it’s ‘level of priority’ …I don’t know that I’ve ever heard a 
doctor on an assessment ask a patient specifically (about depression) and 
the only time most nurses would bring it up would be on the assessment 
(when completing the cardiac risk factor assessment form) so it’s 
certainly not a daily thing” (P9). 
 
“Even my work load… I… touch on it (depression) and I talk to people 
about it but I’m trying to get through a phone call (to a patient in the 
cardiac rehabilitation programme) so I can phone the next one. I don’t 
spend ages discussing the ‘touchy, feely things’. I’ve got a big list of 
things I’ve got to go through” (P5). 
 
Limited human resources. 
 
Both medical staff and nursing management participants’ raised the issue of 
nursing workload as a potential barrier: 
 
“…workload for the nurses is one issue…obviously, every unit is 
different but I think you would be able to do it … you would miss a few 
people based on the fact that the nurses get busy” (P1). 
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The high percentage of nursing staff working part-time was also reported as a 
barrier to the delivery of education and likely to impact on the introduction of new 
procedures: 
 
“…the need for education… the big challenge…you know there’s 55 
nurses in CCU now because there’s 80% part-time work force…so it 
takes you time to get around all those nurse” (P7). 
 
Stigma. 
 
Participants described the stigma associated with mental illness as a significant 
barrier to the recognition of depression: 
 
“We live in a society where it’s still frowned upon to have a mental 
health condition and we need to knock down those barriers first and 
make it wide open in the community to say that if people have got this 
it’s ok, that there’s treatment, that there is help out there, support out 
there” (P4). 
 
Participants also reported that some patients experienced difficulty 
acknowledging a diagnosis of depression: 
 
“To admit depression is like admitting that they’re weak or something 
and they think this is all an acute thing (admission for ACS) and the 
practitioners (GPs) who should be dealing with that…picking it up…are 
probably not skilled and I always feel if you mention a psychiatrist to 
them (the patient) it’s like a red flag and they think they’ve been ‘pigeon 
holed’ with the diagnosis and they really don’t like that” (P10).  
 
Change management issues. 
 
Staff described a lack of knowledge about depression in relation to ACS and 
the need for a strong evidence base in order to support a change of practice in the 
department: 
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“…part of the barriers I think is education as to why you are doing it, 
what the importance is. Probably we don’t learn enough about depression 
and its relation to ACS so we don’t think about it and we don’t probably 
perceive it as important as it is… the ‘clinical importance’, getting the 
education out there is an important thing” (P2). 
 
“I think for clear cut evidence, medical evidence, like published in major 
journals that kind of thing then it’s (new clinical practice) very quickly 
taken up. …you’d want to see the evidence… especially in cardiology… 
if there’s evidence for it you do it…if there’s no evidence for it you don’t 
do it. That’s very important” (P8). 
 
Perceived lack of mental health related skills. 
 
Consultants, clinical nurses and cardiac rehabilitation staff expressed concern 
that they lacked appropriate skills: 
 
“I previously had a patient on the telephone that was threatening to do 
harm and I have no ability to cope with that…. I certainly don’t have the 
skills, I think, to deal with that sort of reaction” (P3). 
 
“I don’t think personally most of us Consultants are actually skilled to 
delve more into it so at the moment I think probably the best way would 
be to apply questionnaires to patients… the biggest problem that I have 
with it is that you’ve got to then do something about it” (P10). 
 
“I think a lot of staff aren’t comfortable discussing depression (with a 
patient)” (P9). 
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Perceived facilitators to identifying depression through screening. 
 
Support for screening from staff. 
 
Staff indicated that there would be support for the introduction of depression 
screening in the department: 
 
“I don’t think you’d get any negative feedback from the staff. I think the 
nurses would be quite open to it …and the doctors would as well” (P1). 
 
“I don’t see it as a major barrier to adding a depression screening tool 
into the admission. You may get a little bit of resistance from the nurses 
but as long as it’s streamlined and it’s not a major inconvenience to 
them… then I think that wouldn’t be an issue” (P2). 
 
Strong nurse leadership. 
 
Senior clinical nurses were viewed as strong advocates for change in the 
department: 
 
“I think locally, certainly the CNS (Clinical Nurse Specialists) are good 
change advocates” (P9). 
 
“I think strong leadership from the nursing side of things. The nurse 
managers, they have a pretty tight reign on how things are run” (P1). 
 
Programme development issues. 
 
Participants suggested three important issues related to the development of a 
depression screening intervention in the department; the need for a clear depression 
management plan, the need to demonstrate to staff the link between depression and 
improved patient outcomes, and the need to have a dedicated person to ‘drive’ the 
change in practice: 
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“…you need the doctors on side because the nurse is going to come with 
a score…whatever the scoring system is… so there needs to be a plan in 
place, everyone needs to have a clear idea of the algorithm …if you get 
this result, this is what you need to do”. 
 
“…if you just ask people (staff) to instigate something they are often 
resistant to change but if you actually ‘sell it’ as …this is going to make a 
change to patient’s quality of life and reduce the risks of them returning 
to hospital …then usually, if you work with the staff you will get the 
positive results” (P3). 
 
“I think if you wanted to do depression screening in the department you 
would have to have a dedicated person who’s going to take that 
responsibility for getting the ball rolling… you have to give education 
sessions to the nurses …and somebody’s got to evaluate it in 3 months… 
if there’s somebody ‘policing’ it…facilitating, it is probably a better 
word …‘driving it’ then once it becomes a norm, we’ll do it” (P5). 
 
Psychometric Properties of the DRAQ 
 
This final section of the chapter describes the results of preliminary 
psychometric testing of the DRAQ to assess readability, internal consistency 
reliability, and test-retest reliability. The data were obtained from 220 ACS 
participants admitted to the CVMD with a diagnosis of ACS. Test-retest reliability 
was based on data obtained from 136 participants who completed the DRAQ at two 
time points; during admission and two weeks following discharge. In addition, 
eleven participants were invited to respond to a questionnaire designed to assess 
readability and acceptability of the DRAQ.  
 
Participant Characteristics. 
 
Participant characteristics data derived from the DRAQ at time 1 and time 2 
are shown in Table 5.4. Data collected from the medical records of participants by 
the researcher during admission are shown in Table 5.5. The sample of 220 
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participants had a mean age of 61 years at time of consent (minimum 21.5; maximum 
87.6; SD 11.4). Gender was unequally distributed with females representing 22.7% 
of the sample. The majority of participants lived within the metropolitan boundaries 
of Perth (69%) and approximately one quarter of the participants reported living 
alone (26.3%). All participants were recruited during a hospital admission for ACS. 
Only a small number of the participants had a diagnosis of UA (6.36%), the 
remaining participants had a diagnosis of AMI (NSTEMI = 56.82%; STEMI = 
36.82%). LVEF was measured during echocardiogram and was routinely recorded in 
the clinical report. Not all participants required an echocardiogram for clinical 
reasons therefore the data for LVEF in not available for the entire sample. 
 
.
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Table 5.4 
Participant characteristics (self-report, DRAQ) at time 1 and time 2 data collection points) 
 
 Time 1 
(n = 220) 
Time 2 
(n =136) 
Characteristic Count Percentage Count Percentage 
Living alone 58 26.36 31 23.31 
ATSI 10 4.55 3 2.26 
Self-report history of depression 59 26.82 31 23.31 
Self-report history of antidepressants 52 23.64 33 24.81 
 
 
Note. ATSI = Aboriginal or Torres Strait Islander person. 
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Table 5.5 
Participant data collected from medical records at time 1 and time 2 data collection points 
 
 Time 1 
(n = 220) 
Time 2 
(n =136) 
Characteristic Count Percentage Count Percentage 
Female gender  50 22.73 29 21.32 
Current smoking 68 30.91 32 23.53 
Lives in Perth 152 69.09 94 69.12 
NSTEMI 125 56.82 75 55.15 
STEMI 81 36.82 52 38.24 
UA 14 6.36 9 6.62 
History of MI 38 17.27 22 16.18 
History of CABG 17 7.73 9 6.62 
CHF on admission 17 7.73 8 5.88 
 
 
Note. NSTEMI = Non ST elevated myocardial infarction; STEMI = ST elevated myocardial infarction; 
UA = unstable angina; MI = myocardial infarction; CABG = coronary artery bypass graft; CHF = congestive heart failure. 
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Assessment of depressive symptoms. 
 
The PHQ-9 was completed by all 220 participants during admission in order to 
define the current level of depressive symptoms in those participants. The presence 
of current depressive symptoms is a strong risk factor for future depression. 
 
In the PHQ-9 questions one to nine relate to depressive symptoms or 
‘problems’ experienced during the previous two weeks. The severity of depressive 
symptoms was determined by the length of time a participant reported experiencing 
the ‘problem’. Each question received a possible score ranging from 0, not 
experiencing the problem at all, to 3, experiencing the problem nearly every day 
(Table 5.6). The total scores were interpreted as recommended by the questionnaire 
authors (Kroenke, Spitzer, & Williams, 2001) (Table 5.7). 
 
Table 5.6 
PHQ-9 scoring method for severity determination 
 
Length of time ‘problem’ experienced Score 
Not at all 0 
Several days 1 
More than half of the days 2 
Nearly every day 3 
 
 
Table 5.7 
PHQ-9 interpretation of total score 
 
Total questionnaire score Depression severity 
0 – 4 Minimal depression 
5 – 9 Mild depression 
10 – 14 Moderate depression 
15 – 19 Moderately severe depression 
20 – 27 Severe depression 
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Depression severity scores for the entire sample during hospital admission (T1) 
are reported in Table 5.8. 
 
Table 5.8 
PHQ-9 Depression severity scores 
 
 Time 1 
(n = 220) 
Level of depressive symptoms Count Percentage 
No significant level 107 48.64 
Mild level  55 25.00 
Moderate level 25 11.36 
Moderately severe level 19 8.64 
Severe level 14 6.36 
 
Over half of the participants recorded scores indicating at least mild levels of 
depressive symptoms. Of this group, 25% scored between 5 - 9 points indicating a 
mild level and the remaining 26% scored 10 or above indicating moderate to severe 
levels of depressive symptoms (Table 5.7). A quarter of the sample reported having 
previously been told by a doctor that they had depression and 23% of the sample had 
been prescribed antidepressants by a doctor in the past. Depressive symptoms were 
unequally distributed between genders (Table 5.9). The sample is representative of a 
broad range of depressive symptoms. The clinical management of participants 
identified as possibly suffering depression based on the PHQ-9 was managed as 
described in the Ethics section of Chapter 4. 
 
Chapter 5 – Results 
111 
Table 5.9 
PHQ-9 Depression severity scores by gender 
 
 Time 1 
(n = 220) 
 Male Female 
Depressive symptoms Count %* Count %** 
No significant level 90 52.94 17 34 
Mild level 42 24.70 13 26 
Moderate level 18 10.58 7 14 
Moderately severe level 11 6.47 8 16 
Severe level 9 5.29 5 10 
 
Note: * = percentage of all males in the sample; ** = percentage of all females in the sample. 
 
Psychosocial variables. 
 
Data about psychosocial variables of the sample were obtained from the 
DRAQ during admission (T1). Nearly half of the sample reported recent events that 
had caused them to feel depressed prior to their admission for ACS. An equally high 
level of participants reported often feeling anxious. Approximately one quarter of the 
participants reported living alone (26.3%) but a relatively few participants reported a 
lack of emotional support from friends or family (Table 5.10). 
 
Table 5.10 
Psychosocial variables (self-report, DRAQ) 
 
 Time 1 
(n = 220) 
Psychosocial variable Count Percentage 
Self/family life event in past 12 months 105 47.73 
Reported often feeling anxious 106 48.18 
Other mental health problems 7 3.18 
Lack of friend/family for emotional support 13 5.91 
Living alone most of the time 58 26.36 
Reported heart condition would negatively 
impact their financial situation 54 24.55 
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Internal Consistency Reliability. 
 
Internal consistency reliability of the DRAQ was determined by calculating the 
Cronbach’s alpha for the instrument based on both raw and standardised variables 
(Table 5.11). This statistic evaluates the items in a scale to determine whether they 
are measuring the same construct (Portney & Watkins, 2000). The value of 
Cronbach’s alpha is affected by the number of the items in a scale. The longer the 
scale, the more homogenous it will appear due to the larger number of items (Portney 
& Watkins, 2000). The value of alpha will be reduced in an instrument with fewer 
items (Cortina, 1993; Nunnally & Bernstein, 1994). 
 
Reported alpha values indicating acceptable levels of internal consistency 
reliability range from 0.70 to 0.95 (Bland & Altman, 1997; De Vellis, 2003; 
Nunnally & Bernstein, 1994). The Cronbach’s coefficient alpha for the DRAQ was 
calculated as 0.71 based on raw variables and 0.68 based on standardized variables 
and can be considered to have an acceptable level of internal consistency reliability 
(De Vellis, 2003). 
 
Temporal Stability. 
 
Test-retest reliability was assessed by calculating the kappa statistic. Kappa has 
been defined as the agreement beyond chance divided by the amount of possible 
agreement beyond chance (Dawson & Trapp, 2001). The level of agreement between 
nine individual items on two separate occasions was calculated and is shown in Table 
5.12. The test-retest reliability varied across individual items. Question 5 had the 
lowest calculated kappa of 0.28. This result is thought to be as a result of very few 
participants from the total sample (n = 5) answering yes to the question at T1 and T2. 
Kappa is affected by the prevalence of the finding under consideration. For a small 
number of observations or rare findings very low values of kappa may not 
necessarily reflect low rates of overall agreement (Viera & Garrett, 2005). The 
remaining questions had kappa scores ranging from 0.47 to 1.00. 
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Table 5.11 
Cronbach’s coefficient alpha for the DRAQ 
 
 Cronbach’s coefficient alpha with deleted variable  
 Raw Variables Standardized Variables 
Deleted variable Correlation with total alpha Correlation with total alpha 
Question 1 0.519766 0.650651 0.476123 0.632582 
Question 2 0.406996 0.679897 0.377694 0653494 
Question 3 0.705347 0.608446 0.663459 0.590423 
Question 4 0.641596 0.622757 0.618798 0.600760 
Question 5 0.291030 0.703021 0.314936 0.666396 
Question 6 0.198424 0.719852 0.228764 0.683577 
Question 7 0.220216 0.706222 0.190822 0.690948 
Question 8 0.359880 0.686673 0.327880 0.663762 
Question 9 0.040139 0.720244 0.080139 0.711796 
 
Note: Cronbach’s coefficient alpha for the DRAQ = 0.71 (raw variables = 0.707158; standardized variables = 0.683790) 
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Table 5.12 
Kappa statistic agreement DRAQ T1 and T2 
 
  95% CI 
DRAQ kappa Lower Limit Upper limit 
Question 1 0.572615 0.432141 0.713090 
Question 2 0.472362 0.322555 0.622168 
Question 3 0.836588 0.727234 0.945942 
Question 4 0.836588 0.727234 0.945942 
Question 5 0.228571 -0.173523 0.630665 
Question 6 0.936607 0.865722 1.000000 
Question 7 0.647303 0.359959 0.934647 
Question 8 0.630555 0.470546 0.790564 
Question 9 1.00000 1.000000 1.000000 
 
Note: CI = confidence interval 
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The following guidelines have been used to aid interpretation of the kappa 
results (Byrt, 1996) and are illustrated in Table 5.13. 
 
Table 5.13 
Guidelines for interpretation of kappa score 
 
Range of kappa result Proposed level of agreement 
0.93 – 1.00 Excellent agreement 
0.81 – 0.92 Very good agreement 
0.61 – 0.80 Good agreement 
0.41 – 0.60 Fair agreement 
0.21 – 0.40 Slight agreement 
0.01 – 0.20 Poor agreement 
<0.00 No agreement 
 
The kappa scores for individual questions were interpreted as follows: 
questions 6 and 9 showed ‘excellent agreement’, questions 3 and 4 showed ‘very 
good agreement’, questions 7 and 8 showed ‘good agreement’ and questions 1 and 2 
showed ‘fair agreement’. 
 
Assessment of Readability, Clarity and Appropriateness. 
 
Purposeful sampling was used to recruit participants to review the DRAQ for 
readability, clarity and appropriateness of individual questions. The sample (n = 11) 
was asked to participate following informed consent to the main study. The sample 
included six men and five women thought to broadly represent differing levels of 
education, and socio-economic status found in the community. Only one member of 
the Aboriginal and Torres Strait Islander community participated due in part to the 
overall low participation rate in the main study (10 participants). The exclusion 
criteria of the main study precluded patients who were non-English speaking. The 
participant’s ages ranged from 45 years to 67 years. Nine participants lived within 
the metropolitan boundaries of Perth, one lived in a rural farming community and the 
remaining participant lived in a remote mining location.  
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There was an overall very high level of agreement between the responses of the 
participants regarding clarity, relevance and appropriateness of possible responses to 
each DRAQ question. Two of the 11 participants stated that they found questions 
about their mental health and financial situation embarrassing. Question 9 “Are you 
an Aboriginal or Torres Strait Islander person” was thought not relevant to 
depression by four of the 11 participants. All of the participants agreed when asked if 
they felt it was appropriate to be asked questions about mental health and social 
situation whilst in hospital for heart problems. No changes were made to the 
structure or wording of the DRAQ based on the results of the qualitative assessment. 
 
This chapter has described the results of validation and preliminary 
psychometric testing of the DRAQ. Building on the initial findings of the systematic 
literature review, the content validity of the DRAQ was further assessed by an expert 
panel. Results from psychometric testing have shown that the DRAQ has an 
acceptable level of internal consistency reliability and, with the exception of question 
5, the DRAQ showed an overall good level of temporal stability over two time 
points. Assessment of the DRAQ by study participants revealed a high level of 
positive agreement regarding the clarity, relevance and appropriateness of the 
DRAQ. 
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Chapter 6 – Discussion and Conclusions 
 
The aim of this research was to develop a brief screening instrument designed 
to assess the risk of developing depression following a diagnosis of ACS for use in 
the acute clinical setting using a three stage approach based on current literature, 
expert opinion and initial research validation. The DRAQ has been designed to 
achieve this aim. The development process was guided by the following objectives: 
 
1. To identify the risk factors for depression related to ACS from the 
literature and critically evaluate the evidence base. 
 
Chapter Two of this thesis describes a systematic review of the literature and 
critical appraisal of the evidence for individual risk factors. Initially, 50 
psychological, social, demographic and behavioural risk factors associated with 
depression were identified from 24 research studies. Following a critical evaluation 
process, 13 risk factors meeting criteria for quality of evidence, clinical 
appropriateness and relevance to an adult clinical population were identified as being 
highly relevant.  
 
2. To define the concept of depression in patients with a diagnosis of ACS, 
and develop a theoretical framework illustrating potential risk factors for 
post ACS depression. 
 
Chapter Three outlines an explanatory conceptual framework in order to 
describe the complex relationship between depression and ACS. Within that 
framework, a conceptual pathway (figure 3.2) illustrates risk associated with 
developing depression and indicates the potential role of a previous episode of 
depression and a recent life event. Whilst it is not possible to comment on the 
predictive nature of these risk factors, some support for their inclusion in the 
pathway can been seen from this study’s findings. In the subsequent study sample 
from this research of 220 ACS patients, over 25% reported having previously been 
told by a doctor that they had depression and 23% had been prescribed 
antidepressants in the past. In addition, nearly 48% of participants reported 
experiencing a life event in the past 12 months that had made them feel depressed. 
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These findings are consistent with the literature documenting high levels of 
depressive symptoms, past history of depression, and recent life events found in 
patients admitted to hospital with ACS (Carney & Freedland, 2008; Dickens et al., 
2004; Lesperance et al., 2000; Thombs et al., 2006). Not surprisingly, given this 
background of pre-existing depression and recent depressive events, over 20% of 
study participants reported moderate to severe levels of depressive symptoms during 
hospital admission. 
 
3. To determine the barriers and facilitators to the introduction of a screening 
intervention as perceived by the key members of a clinical team and to use 
this contextual data to aid the development of the questionnaire. 
 
This objective was addressed using qualitative research methods and analysis 
described in Chapters Four and Five. Data was generated by semi-structured 
interviews with ten members of a cardiology clinical team and analysed using 
Framework Analysis. Interpretation of the data revealed 12 major interrelated issues. 
Staff reported a lack of a systematic approach to identifying depression, in particular 
the need to introduce appropriate depression screening tools, and a lack of access to 
specialised psychiatric support services for both inpatients and patients discharged 
into the community. These important issues have been raised in the literature and 
appear to interfere with the identification of depression in cardiac patients within 
Australia and other countries where there has been a reported limited transfer of 
current evidence into practice and poor levels of psychiatric support (Goldston & 
Baillie, 2008; Lichtman et al., 2008; Ziegelstein et al., 2005). 
 
Other key barriers to the introduction of a screening intervention were 
perceived time constraints, stigma, lack of mental health related skills and knowledge 
related to depression in cardiac patients. These issues have also been recognised and 
reported as potentially significant barriers within the Australian healthcare system 
(Hickie et al., 2002; Savard, 2004). 
 
Although the staff described a number of barriers to screening, there was also 
strong support for depression screening from all levels of staff. Strong nursing 
leadership was reported as a significant advantage to changing practice in the 
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department. Staff identified education, the requirement for strong evidence related to 
screening, demonstrated improved patient outcomes and an integrated management 
plan as specific needs that, once addressed, would facilitate change. 
 
4. To develop a risk assessment instrument for post ACS depression with 
high clinical utility that can be used by nurses in hospital. 
 
Chapters Two, Four and Five have detailed the methods and results of the 
instrument development process. Early in the design process, risk factors were 
assessed by the researcher for clinical appropriateness. Risk factors were excluded if 
they had been poorly defined, needed to be identified using additional lengthy 
questionnaires, or could not be accurately assessed within the time-frame of a 
hospital admission for ACS. Based on the 13 identified risk factors for depression, 22 
items were developed and reviewed for content validity by an eight-member expert 
panel. Following this process a nine-question draft version of the DRAQ was created 
for further testing. This version of the DRAQ has a simple layout and has been 
designed as a self-report instrument that can be completed by patients within a few 
minutes by answering ‘yes’ or ‘no’ to individual questions. 
 
5. To perform preliminary assessment of the psychometric properties of the 
instrument following application in a sample of ACS patients. 
 
Preliminary psychometric testing of the DRAQ to assess validity was 
completed in a sample of ACS patients and has been described in Chapters Four and 
Five. Internal consistency reliability was determined by calculating the Cronbach’s 
coefficient alpha based on raw (0.71) and standardized (0.68) variables. The DRAQ 
is a unique risk assessment instrument in the early stages of development and 
therefore direct comparison between other instruments designed for the same 
purpose is not possible. However, literature regarding instrument development 
suggests that it may be considered to have an acceptable level of internal consistency 
reliability (De Vellis, 2003).  
 
Temporal stability of the DRAQ was assessed by calculating the kappa statistic 
based on data collected at two time points. The level of agreement was shown to vary 
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across individual items. The kappa result for Question 5 was a negative value 
indicating no agreement. This question asked participants “Have you ever been told 
by a doctor that you had any other mental health problems?” Only 7 of 220 
participants answered ‘yes’ to this question. This result is difficult to interpret 
because the very low numbers of patients answering ‘yes’ to the question may have 
affected the kappa value (Viera & Garrett, 2005). 
 
Questions 3, 4, 6, 7, 8 and 9 showed ‘good’ to ‘excellent agreement’ indicating 
that these questions may be considered to have demonstrated good temporal stability. 
Questions 1 and 2 showed ‘fair agreement’. This may be interpreted as showing a 
lower level of stability, however, as these questions ask patients about recent life 
events and their level of anxiety, these results could also indicate a sensitivity to 
change in the patient’s emotional state or circumstances and not necessarily indicate 
measurement error (De Vellis, 2003). 
 
6. To establish the extent to which patients find the questionnaire acceptable 
as part of clinical care. 
 
The method and results of this stage of questionnaire validation are described 
in Chapters Four and Five. This objective was achieved by asking 11 participants to 
review the DRAQ in detail. The results indicated a very high level of agreement 
between the responses of the participants regarding clarity, relevance and 
appropriateness of possible responses to questions. Significantly, all of the 
participants felt that it was appropriate to be asked questions about mental health and 
their social situation whilst in hospital for heart problems. This finding is important 
and can give some insight into the perceived issue of stigma as a barrier to 
identifying depression in the acute setting as reported as a potential issue in the 
contextual survey. 
 
Discussion 
 
This thesis supports the case for an integrated approach to identifying 
depression in ACS patients that includes screening for current depressive symptoms, 
a past history of depression and identifying patients at risk of future depression. The 
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DRAQ has specifically been developed to address the need to identify patients at risk 
of becoming depressed so that early, appropriate support may be provided to those 
most in need.  
 
Whilst it has not been possible to fully validate an integrated screening system 
within the scope of this research, there is evidence from the research conducted to 
support the need for such an approach. Over 20% of the study participants reported 
moderate to severe levels of depressive symptoms experienced during the two weeks 
prior to admission as measured by the PHQ-9. This finding is consistent with other 
research demonstrating depressive disorders may be present before an ACS event. 
Dickens and colleagues (2004) found 20% of participants experiencing a MI for the 
first time had depressive disorders that had been present for at least one month before 
admission. Significantly, nearly 48% of participants reported experiencing a life 
event in the past 12 months (not including their current admission) that had made 
them feel depressed and 25% reported a prior history of depression. Current 
symptoms of depression, recent life events and a past history of depression are 
significant risk factors for future depression and serve to illustrate a burden of risk 
not only of mental ill health but also poorer medical outcomes (Meijer et al., 2011). 
 
These findings also provide support for the conceptual pathway proposed in 
Chapter Three of this thesis (Figure 3.2). This pathway indicates the presence of risk 
factors for depression prior to an admission for ACS. A large proportion of study 
participants reported both recent exposure to risk factors for depression, such as a 
negative life event affecting their mood, or they reported a past history of depression 
indicating that they may have been at risk of depression for many years due to 
psychosocial, behavioural or genetic factors (Birmaher et al., 1996; Farmer, 2001; 
Lewinsohn et al., 1994a). The findings also demonstrated key risk factors for 
depression were reported by significant proportions of the sample, for example, 48% 
of participants reported ‘often feeling anxious’ and 24% reported that their heart 
condition would impact negatively on their financial situation. Figure 6.1 illustrates 
where the conceptual pathway has been supported by study data. 
 
Depression is important to identify following an ACS event because it is a 
prevalent comorbid diagnosis that affects a patient’s quality of life (Beck et al., 2001) 
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and is strongly associated with a poor prognosis following a myocardial infarction 
(Meijer et al., 2011; Parashar et al., 2006; Parker et al., 2008). Making behavioural 
change to modify cardiac risk factors is particularly challenging for depressed 
patients (Meyers et al., 2012). Recent studies have suggested that a significant 
proportion of the excess risk of mortality associated with depressive symptoms can 
be explained by behavioural mechanisms such as smoking and physical inactivity 
(Win et al., 2011; Ye et al., 2013). 
 
Critics of depression screening in cardiac populations point to a lack of 
evidence demonstrating that screening for depression improves outcomes in 
cardiovascular populations (Hasnain et al., 2011). However, some promising studies 
of collaborative care programmes adapted for cardiac patients have demonstrated 
significant improvements in mental health outcomes, adherence to medical 
treatments, reduced number and intensity of cardiac symptoms and improved health-
related quality of life (Huffman et al., 2011; Rollman et al., 2009). Collaborative care 
can be particularly effective when a nurse care manager works with the primary care 
provider to improve treatment of both depression and cardiovascular risk factors 
(Katon et al., 2010). Whilst it is still not known whether such programmes can 
reduce the high mortality risk, early detection and support of vulnerable patients can 
improve important outcomes related to quality of life and adherence to treatments. 
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Figure 6.1 
Conceptual pathway supported by study findings 
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Figure 6.2 illustrates the role the DRAQ would play in an integrated depression 
screening and management programme based on a collaborative care model. Patients 
admitted to hospital following an ACS event would be screened for depressive 
symptoms and risk factors for depression. Risk stratification would identify a large 
proportion of patients who did not have significant symptoms of depression and were 
considered at low risk of developing depression based on known risk factors. This 
group of patients would still require support and further education to modify their 
cardiac risk factors, however, they may be able to use community-based cardiac 
rehabilitation or on-line/telephone support programmes effectively in order to meet 
these needs. The “Coaching patients On Achieving Cardiovascular Health 
Programme (COACH)” is an example of such a programme that has been proven to 
increase adherence to cardiac medications and reduce risk factors in participants up 
to 18 months following cessation of the programme (Jelinek et al., 2009). In 
combination with GP and Consultant Cardiologist medical follow-up, community 
based rehabilitation could represent a cost-effective and appropriate secondary 
prevention strategy for this group of patients. 
 
Based on current evidence, the patients who were identified as having 
depression or at risk of depression, should be regarded as a group vulnerable to 
adverse-medical and social outcomes in need of greater support to modify cardiac 
risk factors. Following assessment of their psychosocial needs, these patients could 
be referred to a collaborative care programme providing a high level of 
psychological support and management of depression and cardiac risk factors. 
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Figure 6.2 
A depression screening and management programme based on a collaborative care 
model 
 
 
  
  
  
 
 
 
 
Patients with 
current depression 
or significant 
depressive 
symptoms 
 
Patients at 
increased risk of 
future depression 
following discharge 
 
Patients at low 
risk of depression 
following 
discharge 
 
Assessment of psychosocial needs Support to modify cardiac 
risk factors and 
ongoing 
observation for 
signs of mood 
change 
Support to modify cardiac risk factors 
and additional appropriate 
psychosocial intervention and 
management 
 
Collaborative care programme with 
nurse care manager, GP and 
psychiatrist liaison 
Community –
based cardiac 
rehabilitation 
programme and 
GP liaison 
Hospital admission for ACS 
Note. ACS = acute coronary syndrome; PHQ-9 = Patient Health Questionnaire-9; 
DRAQ = Depression Risk Assessment Questionnaire; GP = General Practitioner. 
  
 
 
Screening for depressive symptoms and risk factors for depression 
DRAQ PHQ-9 
Stratification based on current symptoms and risk factors 
Chapter 6 – Discussion and Conclusions 
126 
Another benefit of risk stratification of patients whilst in hospital relates to 
more effective use of resources compared to repetitive screening of low risk patients 
once discharged into the community. It is acknowledged that the low risk group of 
patients may still develop symptoms of depression following discharge. However, 
raising awareness of the prevalence and symptoms of depression, through education 
of the patient and their family, may help to identify changes in mood requiring 
formal screening. The early recognition of patients at risk of developing depression 
affords an important opportunity for proactive psychosocial, medical and cardiac risk 
modification strategies. Identifying patients at risk of depression is a novel concept in 
cardiology settings and therefore the benefits of early identification have yet to be 
demonstrated in patients with ACS. One such benefit may be the prevention of 
depression in post-ACS patients. Evidence of the role of selective serotonin reuptake 
inhibitors (SSRIs) in prevention of depression has been found in studies of post-
stroke patients (Chen, Patel, Guo, & Zhan, 2007) and more recently in post-ACS 
patients (Hansen et al., 2012). The latter evidence came from a randomised, placebo-
controlled trial of 240 non-depressed post-ACS patients. The trial was able to 
demonstrate that 12 months treatment with escitalopram, an SSRI, prevented the 
development of depression in post-ACS patients. The trial was not sufficiently 
powered to analyse the effects of treatment on cardiac mortality or morbidity and 
therefore further research is required in this promising field of inquiry. Hansen et al., 
(2012) recommended the identification of ‘high-risk’ patients, defined as those with 
depressive symptoms following ACS but not yet depressed, who might benefit from 
early preventive antidepressant treatment. Assessing risk factors for depression using 
the DRAQ, in addition to assessing the presence of depressive symptoms alone, is 
likely to enhance the detection of such high risk patients.  
 
Contextual Data 
 
The instrument development process described in this thesis has included a 
qualitative research component in recognition of the importance of practice context 
to the development of effective and relevant tools. This is regarded by the researcher 
as particularly important with respect to the slow uptake of guidelines recommending 
depression screening for cardiac patients (Lichtman et al., 2008). The DRAQ is 
intended for use in conjunction with the PHQ-9 and as part of an integrated 
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screening, risk stratification and depression management programme. Exploring the 
barriers and facilitators to the uptake of depression screening is therefore regarded as 
an essential process that has strengthened the development the DRAQ and prevented 
the development of the tool in isolation of relevant issues related to current practice. 
 
The findings from the qualitative component of this research have highlighted 
a number of issues that are significant to practice and have previously been identified 
in the literature. The lack of a systematic approach to depression screening at the 
research site is consistent with other research suggesting that, although validated 
screening instruments exist, patients are not routinely screened for depression 
(Herridge et al., 2005; Huffman et al., 2006a). 
 
Complex changes in practice often involve barriers at various levels and 
include characteristics of the professionals and patients involved as well as the social, 
organisational, economic and political context (Grol & Wensing, 2004). This point is 
reflected in the qualitative research findings of this study. The lack of a systematic 
screening protocol was related to the perceived time-constraints and nursing staff 
work-load, a potential organisational or economic barrier. However, a lack of mental 
health skills and knowledge was perceived as equally important by staff, reflecting a 
characteristic of the clinical staff. Poor access to specialised psychiatric support 
services and lack of mental health related knowledge and skills have also been 
identified as significant barriers to the identification of depression in Australia 
(Goldston & Baillie, 2008; Hickie et al., 2002; Savard, 2004). 
 
The staff also viewed the role of stigma as a potential barrier to the uptake of 
screening suggesting that patients would not wish to discuss a diagnosis of 
depression or any possible mental health problems. Interestingly, this was not a 
viewpoint expressed by patients themselves. During assessment of the DRAQ for 
acceptability, only two of the 11 participants stated that they found questions about 
their mental health and financial situation embarrassing. All of the participants 
agreed that it was appropriate to be asked questions about mental health and social 
situation whilst in hospital for heart problems. 
 
It is interesting that many of the findings regarding barriers to implementation 
of a depression screening protocol have previously been discussed in relation to 
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screening for post-stroke depression (White, Towers, Turner, & Hambridge, 2013). 
Identifying depression in post-stroke patients parallels many of the challenges found 
in the cardiac setting. For example, depression is common following a stroke but it is 
not often identified and frequently remains untreated in clinical settings (Herrmann et 
al., 2011). Health professional compliance to recommended guidelines has similarly 
been reported as inconsistent and influenced by both individual factors, such as belief 
in the effectiveness of screening and knowledge deficit, as well as organizational 
barriers, such as perceived time-constraints and support from colleagues (Hart & 
Morris, 2008).  
 
In a recent Australian study the investigators conducted semi-structured 
interviews with seven clinicians, five neurologists and two rehabilitation physicians, 
in order to identify factors relating to screening for post-stroke depression (White et 
al., 2013). The results were remarkably similar to the contextual study findings 
discussed in this thesis. All of the doctors reported relying on recognising the 
symptoms or unusual characteristics as prompts to explore a diagnosis of depression 
but none used routine screening methods or tools. Equally, the physician’s 
acknowledged the possibility that only the severe cases would be identified in this 
way with milder cases being missed. A lack of routine screening for post-stroke 
depression was also attributed to time constraints, in particular the need to focus on 
the physical implications of a stoke and secondary prevention treatments during 
consultations. Similarly, the physician’s identified low levels of confidence and 
experience in mental health skills. All participants acknowledged a lack of training 
and related mental health education. As a consequence, the physicians preferred to 
leave the management of depression to the patient’s GP, who was perceived as 
having a more established relationship with the patient. 
 
It is clear that the barriers to depression screening identified in a cardiac setting 
can been seen elsewhere and relate to both individual factors such as education and 
training as well as structural factors related to medical priorities and healthcare 
settings. The advantage of identifying common barriers is that it is possible to 
observe how these barriers may have been overcome in similar clinical settings.  
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A promising new area of research would involve the provision of electronic 
decision support systems for depression screening and individualized treatment 
guidelines. Decision support systems have been found to improve adherence to 
recommended clinical guidelines and enhance the delivery of preventive care 
services (Kawamoto, Houlihan, Balas, & Lobach, 2005). Touchscreen computers 
could be used to streamline assessments and provide real time feedback of not only 
screening results but also recommended management for the individual patient based 
on their results and depression risk factor profile (Kawamoto et al., 2005). This is a 
type of clinical innovation that may be required to overcome the reported time 
constraints and lack of mental health related skills. 
 
Limitations of the DRAQ Design 
 
Whilst the process undertaken to design the DRAQ has been based on a robust 
and systematic research methodology, as with all research, it is important to discuss 
the limitations of the research undertaken and clearly identify areas of potential 
weakness. The systematic literature search was limited to studies published in 
English and therefore may be at risk of publication bias. If key information likely to 
affect the quality assessment was absent, the Oxford EMB Grade was reduced. 
Authors were not contacted by the researcher regarding methods or to supply missing 
data. The literature search, data extraction, quality critique and evidence grading 
were undertaken by one researcher alone and therefore did not benefit from a full 
independent assessment. However, these processes were undertaken with guidance 
from a supervisory team with methodological and relevant content knowledge. 
Furthermore, the expert panel review concurred with the initial findings from the 
literature review covering the majority of items associated with depression in cardiac 
patients. 
 
The studies reviewed have been conducted over a 17-year period from 1992 
(Forrester et al., 1992) to 2009 (Stafford et al., 2009). Over this time period the 
diagnostic criteria for both depression and ACS have evolved and this represents a 
significant barrier to comparison of the studies. Heterogeneity between studies is 
demonstrated by the differing study designs, the measures used to assess depression, 
the temporal relationship of the risk factor to depression (cross-sectional or 
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prospective associations), the wide array of risk factors studied and the varying 
definitions of each risk factor. A high level of heterogeneity between studies has 
precluded the use of meta-analysis and comparisons of the strengths of associations 
between risk factors and depression across multiple studies has not been possible. 
 
There is insufficient evidence to determine from the current cardiac literature 
whether the simultaneous presence of multiple risk factors results in a cumulative 
increase in the risk of depression in cardiac patients. 
 
A number of risk factors for depression in patients with heart disease may not 
yet be identified. The paucity of data regarding biomedical risk factors identified has 
further reduced the scope of this review to comment on their relationship with 
cardiac depression. This thesis has described the early stages of the development and 
psychometric testing of the DRAQ. Underpinning the design of the DRAQ has been 
a careful critique of the available evidence regarding risk factors for depression in 
ACS patients and a strong focus on both the content validity and clinical utility of the 
questionnaire. 
 
The DRAQ still requires additional psychometric testing to assess the 
predictive validity of the questionnaire and this will require a larger sample of ACS 
patients recruited to a prospective, longitudinal study. Assessment of the predictive 
validity of the DRAQ will also allow the development of a method to score the 
questionnaire to indicate high, medium or low risk categories. Further instrument 
development needs to focus on the five-item staff assessed instrument and future 
research is required to assess its clinical utility. 
 
Recommendations for Practice 
 
The research conducted has given rise to the following recommendations for 
future practice: 
 
1. The adoption of a systematic approach to the identification of depression 
in ACS patients using valid screening tools. This requires the identification 
of depressive symptoms in hospital and stratification of patients into high 
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and low risk groups based on the assessment of the risk of developing 
depression. Such a screening approach would be an essential part of a 
depression management strategy based on a collaborative care model that 
focussed on both improving the patient’s psychological health outcomes 
and cardiac risk profile. 
 
2. Provision of education and support for increased knowledge regarding 
depression and mental health related skills across both medical and nursing 
disciplines. A knowledge deficit associated with the care of mental health 
issues in an acute medical setting seemed to also be common across 
medical specialities and therefore this issue could be addressed at both a 
local level but also may require changes to medical and nursing curricula 
at a university level. 
 
3. Improved staff and patient access to psychiatric support services. Such 
issues need to be addressed at both local levels through State Health 
Department policy but also at a Federal level where funding should be 
directed towards supporting mental health education and improving the 
funding of mental health services in the community. 
 
Recommendations for Research 
 
1. Further psychometric testing is required to assess the predictive validity of 
the DRAQ. This requires a large sample (n = 300) of ACS patients to be 
recruited to a prospective, longitudinal, observational study requiring a 
minimum following up period of four months. Predictive validity would be 
established by comparing the results of the DRAQ during admission in 
patients who subsequently developed depression following discharge from 
hospital. Questions indicating a high predictive validity would remain in 
the questionnaire, those found to have a poor level of predictive validity 
would be removed. 
 
2. The 5-item staff tool requires additional development and predictive 
validity testing in a sample of ACS patients. Ideally, nurses would be 
involved in the use of the tool and an additional qualitative study 
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conducted to establish how the nurses perceived the clinical utility of the 
tool and how best to integrate its use in the clinical setting. 
 
3. Future research could focus on the development of novel pharmacological 
therapies to prevent the onset of depression following an ACS event and 
examine whether preventing depression through pharmacological or 
psychotherapy support can improve mortality or morbidity in this high-risk 
group. 
 
4. Further research is required in the area of collaborative care based 
depression management. In particular, large randomised controlled trials 
are required that are sufficiently powered to examine the effect of such 
programmes on morbidity and mortality as well as health related quality of 
life, adherence to medical therapies and cardiac risk factor modification. 
 
5. Finally, continued and sustained research into the barriers preventing the 
uptake of depression screening in the cardiac setting should be a priority. 
In particular, research exploring new technological solutions for the 
provision of depression screening should be investigated as a matter of 
urgency in order to address a well-established evidence to practice gap. 
 
Conclusions 
 
This thesis has described the initial development and psychometric testing of 
the DRAQ in response to the increasing recognition of psychological factors 
mediating health outcomes. Results of the research programme have confirmed that 
ACS patients are at considerable risk of poor psychological health and thus worse 
medical health outcomes following a hospital admission for ACS. Whilst findings 
indicated nursing and medical staff were very supportive of depression screening, 
much research is needed to establish a systematic approach to depression screening 
and the identification of high risk patient groups. Beyond screening is the importance 
of intervening appropriately to achieve optimal health outcomes. Detecting such 
groups creates opportunities to explore preventive therapies rather than observing the 
onset of depression and then treating the disease. 
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Appendix A: Summary of Included Articles 
 
Authors Study design/ evidence grade/definition of ‘depression’ Participants 
Setting/Cardiac 
diagnosis 
Risk factors associated 
with depression 
Aktar et al., 2004 
Paskistan 
 
Cross-sectional data 
observational study 
EBM level 4 
Depressive symptoms (HADS) 
100 During admission, AMI Female, younger age, low 
socio-economic status 
 
 
Cheok et al., 2003* 
Australia 
Cross-sectional data 
Prospective, observational cohort  
EBM level 2b 
Depressive symptoms (HADS; CES-D) 
833 During admission, AMI, 
CHF, arrhythmia, CABG, 
angioplasty 
Female, younger age, 
lower education, divorce, 
unemployment 
 
Frasure-Smith et.al., 
1999 
Canada 
Cross-sectional combined data 
from 2 observational studies 
EBM level 2b 
Depressive symptoms (BDI) 
896 During admission, AMI Female, advanced Killip 
Class, impaired LVEF  
(≤ 35%) 
 
Forrester et al., 1992 
USA 
Cross-sectional data 
observational study 
EBM level 2b 
Structured clinical interview (DSM III) 
129 During admission (within 
10 days), AMI 
Female, prior mood 
disorder, large MI, 
functional impairment, 
quality of relationships 
Lesperance et al., 
2000 
Canada 
Cross-sectional data, 
observational study 
EBM level 2b 
Depressive symptoms (BDI) 
430 During admission, 
unstable angina 
Female, current smoking, 
prior CABG, prescription 
of nitrates (anti-anginal 
drugs) 
 
Note. * = One of three papers describing the IDACC study data at baseline, 3 months and 12 months; AMI = acute myocardial infarction; BDI = Beck 
Depression Inventory; CABG = coronary artery bypass grafts; CES- D= Center for Epidemiological Studies Depression Scale; CHF = congestive heart 
failure; DSM = Diagnostic and Statistical Manual of mental disorders; EBM = Evidence Based Medicine; HADS = Hospital Anxiety Depression Scale; 
LVEF = left ventricular ejection fraction; MI = myocardial infarction. 
 
   
 
Authors Study design/ evidence grade/definition of ‘depression’ Participants 
Setting/Cardiac 
diagnosis 
Risk factors associated 
with depression 
Linfante et al., 2003 
USA 
Cross-sectional data, 
observational study 
EBM level 2b 
Depressive symptoms (PRIME-MD) 
304 
(females only) 
During admission,  
ACS, angina, CABG, 
PTCA 
Younger age (≤ 65 years), 
reduced exercise (30 mins 
≤ 3x per wk), having 
dependents 
Mallik et al., 2006 
USA 
Cross-sectional data, 
observational study 
EBM level 2b 
Depressive symptoms (PHQ-9) 
2,498 During hospital admission, 
AMI 
Afr. American, younger 
age, lower social support, 
low SE indicators, prior 
MI, comorbid conditions 
Mendes de Leon et 
al., 2001 
USA 
Cross-sectional data, 
observational study 
EBM level 4 
Depressive symptoms (BDI) 
88 AMI Younger aged females, 
females with lower levels 
of social support 
 
Naqvi et al., 2007 
USA 
Cross-sectional data 
survey design 
EBM level 2b 
Depressive symptoms (ZSDS) 
944 Recently discharged, 
ACS 
Female, prior MI, history 
of smoking, diabetes 
mellitus 
 
Watkins et al., 2003 
USA 
Cross-sectional data 
observational study 
EBM level 2b 
Depressive symptoms (BDI) 
2, 481 During hospital admission, 
AMI 
 
 
Female, younger age, 
lower education, medical 
comorbidity,  
 
Note. ACS = acute coronary syndrome; Afr. = African; AMI = acute myocardial infarction; BDI = Beck Depression Inventory; CABG = coronary artery 
bypass grafts; EBM = Evidence Based Medicine; MI = myocardial infarction; PHQ-9 = Patient Health Questionnaire 9; PRIME-MD = Prime Care 
Evaluation of Mental Disorders; PTCA = percutaneous transluminal coronary angioplasty; SE = socio-economic; wk = week; ZSDS = Zung Self-rating 
Depression Scale. 
 
 
   
 
Authors Study design/ evidence grade/definition of ‘depression’ Participants 
Setting/Cardiac 
diagnosis 
Risk factors associated 
with depression 
Bjerkeset et al., 
2005 
Norway 
 
Prospective, 
population-based cohort 
EBM level 4 
Depressive symptoms (HADS) 
512 Community health survey,  
First MI between baseline 
and 5 year follow-up visit 
 
Female, past history of 
depression, daily smoking,  
Obesity (BMI ≥ 30)  
Dickens et al., 
2004  
UK 
 
 
Prospective,  
observational cohort 
EBM level 2b 
Depressive symptoms (HADS) 
314 Retrospective assessment 
of depression, baseline 
during admission for AMI, 
12 months follow-up visit 
Female, younger age, no 
close confidant, Life 
events, psychiatric ph, 
separation from mother, 
health problems, angina 
Dickens et al., 
2008 
UK 
 
Prospective, 
observational cohort 
EBM level 4b 
Depressive symptoms (HADS) 
269 During admission for first 
MI, 6 months and 12 
month follow-up visit 
Negative illness 
perceptions at base-line 
Hammond et al., 
2008 
Australia 
Prospective,  
observational cohort 
EBM level 2b 
Depressive symptoms (GDS-15) 
155 
> 60 years 
During acute admission 
for ACS, CHF, 
arrhythmia,  
Hospitalised in the 
previous 6 months, angina, 
hospital stay >4 days, 
impaired level of 
subjective social support 
Lesperance et al., 
1996 
Canada 
 
Prospective,  
observational cohort 
EBM level 2b 
Modified interview schedule (DIS; BDI) 
222 During admission for 
AMI, 6 months and 12 
month follow-up visits 
Younger age (≤ 65 yrs), 
Prior history of depression, 
Presence of depressive 
symptoms in hospital 
 
Note. ACS = acute coronary syndrome; AMI = acute myocardial infarction; BDI = Beck Depression Inventory; BMI = Body Mass Index; CHF = 
congestive heart failure; DIS = Diagnostic Interview Schedule; EBM = Evidence Based Medicine; GDS = Geriatric Depression Scale; HADS = Hospital 
Anxiety Depression Scale; MI = myocardial infarction; ph = past history. 
 
   
 
Authors Study design/ evidence grade/definition of ‘depression’ Participants 
Setting/Cardiac 
diagnosis 
Risk factors associated 
with depression 
Martens et al., 
2008 
Netherlands 
 
Prospective,  
observational cohort 
EBM level 4 
Depressive symptoms (BDI) 
287 During admission for 
AMI, 2 months and 12 
months follow-up 
 
Type – D personality, 
previous cardiac history, 
past history of MDD, 
medical comorbidity 
Mayou et al., 2000 
UK 
 
 
Prospective,  
epidemiological survey 
EBM level 4 
Depressive symptoms (HADS) 
347 During admission for MI, 
3 months and 12 months 
follow-up  
Younger age, prior 
psychological difficulties, 
longer hospital stay, in-
hospital distress 
Schrader et al.,  
2004* 
Australia 
 
Prospective,  
observational cohort 
EBM level 2b 
Depressive symptoms (HADS; CES-D) 
833 3 month follow-up post 
admission for AMI, CHF, 
arrhythmia, CABG, 
angioplasty 
Depressive symptoms in 
hospital, younger age, 
smoking, cardiac ph, self-
report ph depression/stress 
Schrader et al., 
2006* 
Australia 
 
Prospective,  
observational cohort 
EBM level 2b 
Depressive symptoms (HADS; CES-D) 
739 12 month follow-up post 
admission for AMI, CHF, 
arrhythmia, CABG, 
angioplasty 
Depression during index 
admission, self-report ph 
depression/stress, smoking  
Spijkerman et al., 
2005a 
Netherlands 
 
 
Prospective,  
observational cohort 
EBM level 2b 
Depressive symptoms (BDI) 
502 During admission for MI, 
3, 6 and 12 month follow-
up 
Pre-MI vital exhaustion, 
ph. depression, living 
alone, ↓ e.s.t. work load, 
female, admission length, 
LVEF (< 40%) 
 
Note. * = One of three papers describing the IDACC study data at baseline, 3 months and 12 months; AMI = acute myocardial infarction; BDI = Beck 
Depression Inventory; CABG = coronary artery bypass grafts; CES = Center for Epidemiological Studies Depression Scale; CHF = congestive heart 
failure; EBM = Evidence Based Medicine; e.s.t. = exercise stress test; HADS = Hospital Anxiety Depression Scale; LVEF = left ventricular ejection 
fraction; MDD = major depressive disorder; MI = myocardial infarction; ph = past history; ↓ = reduced/lower. 
 
   
 
Authors Study design/ evidence grade/definition of ‘depression’ Participants 
Setting/Cardiac 
diagnosis 
Risk factors associated 
with depression 
Spijkerman et al., 
2005b 
Netherlands 
 
 
Prospective,  
observational cohort 
EBM level 2b 
Structured clinical interview  
(ICD-10 criteria for depressive disorder) 
468 
 
During admission for MI,  
3, 6, and 12 months 
follow-up 
**↓ education, smoking, 
↑neuroticism score. 
*** Female, in hospital 
revascularization, LVEF 
(< 40%), arrhythmic 
events. Younger age.  
Stafford et al., 
2009 
Australia 
 
Prospective survey 
EBM level 4 
Depressive symptoms (HADS) 
193 3 months and 9 months 
post-admission for MI, 
PTCA, CABG 
Negative illness beliefs re: 
poorer personal control 
and more serious life 
consequences, neuroticism 
Strik et al., 2001a 
Netherlands 
Prospective, matched,  
case-control study design 
EBM level 3b 
Clinical interview (DSM-III-R; SCL-90; 
Zung) 
35 Following first AMI,  
Sample with diagnosed 
depression vs matched 
non-depressed controls 
Benzodiazepines use, 
cardiac complications, 
prior depression, smoking  
Strik et al., 2003 
Netherlands 
 
 
Data from prospective,  
consecutive cohorts 
EBM level 2b 
Structured clinical interview (DSM-IV; 
HADS; BDI; SCL-90, ZSDS) 
412 During admission for MI, 
follow-up visits every 3 
months over a 1 to 6 year 
period 
Female, ph depression,  
Personality traits, old age, 
smoking, complications, 
benzodiazepines use 
 
Note. ** = In patients with a past history of depression; *** = In patients with no past history of depression; AMI = acute myocardial infarction; BDI = 
Beck Depression Inventory; CABG = coronary artery bypass grafts; DSM = Diagnostic and Statistical Manual of mental disorders; EBM = Evidence 
Based Medicine; HADS = Hospital Anxiety Depression Scale; ICD-10 = International Classification of Diseases, 10th revision; LVEF = left ventricular 
ejection fraction; MI = myocardial infarction; ph = past history; PTCA = percutaneous transluminal coronary angioplasty; SCL-90 = Symptom Check List 
90; ZSDS = Zung Self-rating Depression Scale; ↑ = increased; ↓ = reduced/lower. 
   
 
Authors Study design/ evidence grade/definition of ‘depression’ Participants 
Setting/Cardiac 
diagnosis 
Risk factors associated 
with depression 
van Melle et al., 
2005**** 
Netherlands 
 
Prospective,  
observational cohort 
EBM level 2b 
Structured clinical interview (ICD-10; 
BDI) 
1, 989 During admission for 
AMI, 3, 6, 9 and 12 
months follow-up 
Graded relationship 
between LV dysfunction 
and depression 
van Melle et al., 
2006 **** 
Netherlands 
 
Prospective,  
observational cohort 
EBM level 2b 
Structured clinical interview (ICD-10; 
BDI) 
2, 177 
 
During admission for 
AMI, 3, 6, 9 and 12 
months follow-up 
Depressive symptoms in 
hospital, younger age (< 
60 years), reduced LVEF 
(≤ 30%) 
Whitehead et al., 
2005 
UK 
 
Prospective,  
observational cohort 
EBM level 2b 
Depressive symptoms (BDI) 
184 During admission for 
ACS, 1 week and 
3 months follow-up 
High levels of in-hospital 
distress and fear of dying  
   
Note. **** = One paper from same MIND-IT study data; ACS = acute coronary syndrome; AMI = acute myocardial infarction; BDI = Beck Depression 
Inventory; EBM = Evidence Based Medicine; ICD-10 = International Classification of Diseases, 10th revision; LV = left ventricular; LVEF = left 
ventricular ejection fraction. 
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Appendix B: Oxford Centre of Evidence-Based Medicine Levels of Evidence 
(2009) 
 
Level Therapy/Prevention, Aetiology/Harm Prognosis Diagnosis 
Differential 
diagnosis/symptom 
prevalence study 
Economic and decision 
analyses 
1a 
SR (with 
homogeneity*) of 
RCTs  
SR (with 
homogeneity*) of 
inception cohort 
studies; CDR† 
validated in 
different populations 
SR (with 
homogeneity*) of 
Level 1 diagnostic 
studies; CDR† with 
1b studies from 
different clinical 
centres 
SR (with 
homogeneity*) of 
prospective cohort 
studies  
SR (with 
homogeneity*) of 
Level 1 economic 
studies 
1b 
Individual RCT 
(with narrow 
Confidence 
Interval‡) 
Individual inception 
cohort study with > 
80% follow-up; 
CDR† validated in a 
single population 
Validating** cohort 
study with good††† 
reference standards; 
or CDR† tested 
within one clinical 
centre 
Prospective cohort 
study with good 
follow-up**** 
Analysis based on 
clinically sensible 
costs or alternatives; 
systematic review(s) 
of the evidence; and 
including multi-way 
sensitivity analyses 
1c All or none§ All or none case-series 
Absolute SpPins and 
SnNouts†† 
All or none case-
series 
Absolute better-value 
or worse-value 
analyses †††† 
2a 
SR (with 
homogeneity*) of 
cohort studies 
SR (with 
homogeneity*) of 
either retrospective 
cohort studies or 
untreated control 
groups in RCTs 
SR (with 
homogeneity*) of 
Level >2 diagnostic 
studies 
SR (with 
homogeneity*) of 2b 
and better studies 
SR (with 
homogeneity*) of 
Level >2 economic 
studies 
2b 
Individual cohort 
study (including low 
quality RCT; e.g., 
<80% follow-up) 
Retrospective cohort 
study or follow-up 
of untreated control 
patients in an RCT; 
Derivation of CDR† 
or validated on split-
sample§§§ only 
Exploratory** cohort 
study with good††† 
reference standards; 
CDR† after 
derivation, or 
validated only on 
split-sample§§§ or 
databases 
Retrospective cohort 
study, or poor 
follow-up 
Analysis based on 
clinically sensible 
costs or alternatives; 
limited review(s) of 
the evidence, or 
single studies; and 
including multi-way 
sensitivity analyses 
2c 
"Outcomes" 
Research; 
Ecological studies 
"Outcomes" 
Research   Ecological studies 
Audit or outcomes 
research 
3a 
SR (with 
homogeneity*) of 
case-control studies 
 
SR (with 
homogeneity*) of 3b 
and better studies 
SR (with 
homogeneity*) of 3b 
and better studies 
SR (with 
homogeneity*) of 3b 
and better studies 
3b Individual Case-Control Study  
Non-consecutive 
study; or without 
consistently applied 
reference standards 
Non-consecutive 
cohort study, or very 
limited population 
Analysis based on 
limited alternatives 
or costs, poor quality 
estimates of data, but 
including sensitivity 
analyses 
incorporating 
clinically sensible 
variations 
4 
Case-series (and 
poor quality cohort 
and case-control 
studies§§) 
Case-series (and 
poor quality 
prognostic cohort 
studies***) 
Case-control study, 
poor or non-
independent reference 
standard  
Case-series or 
superseded reference 
standards 
Analysis with no 
sensitivity analysis 
5 
Expert opinion 
without explicit 
critical appraisal, or 
based on 
physiology, bench 
research or "first 
principles" 
Expert opinion 
without explicit 
critical appraisal, or 
based on 
physiology, bench 
research or "first 
principles" 
Expert opinion 
without explicit 
critical appraisal, or 
based on physiology, 
bench research or 
"first principles" 
Expert opinion 
without explicit 
critical appraisal, or 
based on physiology, 
bench research or 
"first principles" 
Expert opinion 
without explicit 
critical appraisal, or 
based on economic 
theory or "first 
principles" 
 
Produced by Bob Phillips, Chris Ball, Dave Sackett, Doug Badenoch, Sharon Straus, Brian Haynes, Martin Dawes since 
November 1998. Updated by Jeremy Howick March 2009. 
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Notes 
Users can add a minus-sign "-" to denote the level of that fails to provide a conclusive answer because:  
 
 EITHER a single result with a wide Confidence Interval 
OR a Systematic Review with troublesome heterogeneity.  
Such evidence is inconclusive, and therefore can only generate Grade D recommendations.  
 
* 
By homogeneity we mean a systematic review that is free of worrisome variations (heterogeneity) in the directions and 
degrees of results between individual studies. Not all systematic reviews with statistically significant heterogeneity need 
be worrisome, and not all worrisome heterogeneity need be statistically significant. As noted above, studies displaying 
worrisome heterogeneity should be tagged with a "-" at the end of their designated level. 
† Clinical Decision Rule. (These are algorithms or scoring systems that lead to a prognostic estimation or a diagnostic category.) 
‡ See note above for advice on how to understand, rate and use trials or other studies with wide confidence intervals. 
§ Met when all patients died before the Rx became available, but some now survive on it; or when some patients died before the Rx became available, but none now die on it. 
§§ 
By poor quality cohort study we mean one that failed to clearly define comparison groups and/or failed to measure 
exposures and outcomes in the same (preferably blinded), objective way in both exposed and non-exposed individuals 
and/or failed to identify or appropriately control known confounders and/or failed to carry out a sufficiently long and 
complete follow-up of patients. By poor quality case-control study we mean one that failed to clearly define comparison 
groups and/or failed to measure exposures and outcomes in the same (preferably blinded), objective way in both cases 
and controls and/or failed to identify or appropriately control known confounders. 
§§§ Split-sample validation is achieved by collecting all the information in a single tranche, then artificially dividing this into "derivation" and "validation" samples. 
†† An "Absolute SpPin" is a diagnostic finding whose Specificity is so high that a Positive result rules-in the diagnosis. An "Absolute SnNout" is a diagnostic finding whose Sensitivity is so high that a Negative result rules-out the diagnosis. 
‡‡ Good, better, bad and worse refer to the comparisons between treatments in terms of their clinical risks and benefits. 
††† 
Good reference standards are independent of the test, and applied blindly or objectively to applied to all patients. Poor 
reference standards are haphazardly applied, but still independent of the test. Use of a non-independent reference 
standard (where the 'test' is included in the 'reference', or where the 'testing' affects the 'reference') implies a level 4 
study. 
†††† Better-value treatments are clearly as good but cheaper, or better at the same or reduced cost. Worse-value treatments are as good and more expensive, or worse and the equally or more expensive. 
** Validating studies test the quality of a specific diagnostic test, based on prior evidence. An exploratory study collects information and trawls the data (e.g. using a regression analysis) to find which factors are 'significant'. 
*** 
By poor quality prognostic cohort study we mean one in which sampling was biased in favour of patients who already 
had the target outcome, or the measurement of outcomes was accomplished in <80% of study patients, or outcomes were 
determined in an unblinded, non-objective way, or there was no correction for confounding factors. 
**** Good follow-up in a differential diagnosis study is >80%, with adequate time for alternative diagnoses to emerge (for example 1-6 months acute, 1 - 5 years chronic) 
Grades of Recommendation 
 
A consistent level 1 studies  
B consistent level 2 or 3 studies or extrapolations from level 1 studies 
C level 4 studies or extrapolations from level 2 or 3 studies  
D level 5 evidence or troublingly inconsistent or inconclusive studies of any level 
 
"Extrapolations" are where data is used in a situation that has potentially clinically important differences than the original 
study situation. 
 
 
 
 
   
Appendix C: Risk Factors for Depression with Oxford Centre of EBM Grades of Recommendation (2009) 
 
Risk factors for depression by 
domain 
Number of studies where the 
risk factor is associated with 
depression in cross-sectional 
data 
Number of studies where the 
risk factor is associated with 
depression in prospective data 
Oxford Centre of EBM 
Grades of Recommendation and 
comments 
Psychological 
History of depressive disorder, 
self reported stress or anxiety 
 
Differing criteria/measurement: 
Self-report history of previous 
depression diagnosis, anxiety or 
stress 
Lifetime diagnosis of MDD 
according to DSM-III-R, DSM-IV 
or ICD-10 criteria. 
 
 
6 level 2b studies: 
Dickens et al. (2004) 
(prior to MI; in hospital) 
Lesperance et al. (1996) 
Spijkerman et al. (2005a) 
Forrester et al. (1992) 
Mallik et al. (2006) 
Cheok et al. (2003) 
1 level 4 study: 
Mayou et al. (2000) 
4 level 2b studies: 
Schrader et al. (2004) 
Spijkerman et al. (2005a) 
Lesperance et al. (1996) 
Strik et. al. (2003)  
1 level 3b study: 
Strik et al. (2001a) 
2 level 4 studies: 
Bjerkeset et al. (2005) 
Martens et al. (2008) 
 
• Consistent level 2b/3b studies 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• Large amount of supporting 
evidence from prospective 
studies in psychiatric literature 
• EBM grade B 
Depressive symptoms present in 
hospital 
Various scales used to measure 
depressive symptoms: CES-D; 
BDI; HADS 
 3 level 2b studies: 
Schrader et al. (2004) 
Lesperance et al. (1996) 
van Melle et al. (2006) 
1 level 4 study: 
Mayou et al. (2000) 
• Consistent level 2b studies 
• Prospective studies in cardiac 
samples 
• Supporting evidence from 
prospective studies in 
psychiatric literature 
• EBM grade B 
 
Note. BDI = Beck Depression Inventory; DSM = Diagnostic and Statistical Manual of mental disorders; EBM = Evidence Based Medicine; HADS = 
Hospital Anxiety Depression Scale; ICD-10 = International Classification of Diseases, 10th revision; MDD = major depressive disorder; MI = myocardial 
infarction. 
   
 
Trait Neuroticism 
as measured by NEO-FFI; 
Eysenck Personality 
Questionnaire 
 
 2 level 2b studies: 
Strik et al. (2003) 
Spijkerman et al. (2005b) 
1 level 4 study: 
Stafford et al. (2009) 
• Some limited level 2b studies 
• Prospective studies in cardiac 
samples 
• Supporting evidence from 
psychiatric literature 
• Limited grade B evidence 
Introversion 
as measured by Eysenck 
Personality Questionnaire 
 1 level 2b study: 
Strik et al. (2003) 
 
• Limited level 2b evidence 
• Prospective study in cardiac 
sample 
• Supporting evidence in 
psychiatric literature 
• Limited grade B evidence 
In hospital anxiety 
as measured by State-Trait  
Anxiety Inventory 
 
 
 
 
Prescription of benzodiazepines 
in hospital (alprazolam, 
oxazepam, temazepam, 
lorazepam, and nitrazepam 
1 level 2b study: 
Frasure-Smith et al. (1999) 
 
 
 
 
 
 
 
 
 
 
 
1 level 3b study: 
Strik et al. (2001a) 
1 level 2b study: 
Strik et al. (2003) 
• Limited level 2b evidence 
• Cross-sectional study in 
cardiac sample 
• Supporting evidence in psych. 
literature for co-morbidity of 
depression and anxiety 
 
• Limited level 2b/3b evidence 
• Prospective studies in cardiac 
sample 
• Limited grade B 
 
Note. NEO-FFI = NEO Five-Factor Inventory. 
 
   
 
Acute distress/fear of dying in 
hospital assessed by 3 items: 
“I was frightened when the 
symptoms came on,” “I thought 
that I might be dying when the 
symptoms came on”, and “I found 
my cardiac event stressful”. 
 1 level 2b study: 
Whitehead et al. (2005) 
• Limited level 2b evidence 
• Prospective study in cardiac 
sample 
• Large amount of supporting 
evidence in psychiatric 
literature for co-morbidity of 
depression and anxiety 
• Limited grade B 
Negative perceptions re cardiac 
diagnosis as measured by the 
Illness Perception Questionnaire 
(IPQ) and IPQ-R (revised because 
of psychometric problems with 
IPQ) 
 2 level 4 studies: 
Dickens et al. (2008) 
Stafford et al. (2009) 
• Limited level 4 evidence 
• Prospective studies in cardiac 
sample 
• Limited grade C evidence 
Life event in year prior to MI 
retrospectively assessed by the 
Life Events and Difficulties 
Schedule 
1 level 2b study: 
Dickens et al. (2004) 
(data collected retrospectively 
not prospectively) 
 • Limited level 2b evidence 
• Cross-sectional study in 
cardiac sample 
• Large amount of supporting 
evidence in psychiatric 
literature for life events as risk 
factor for depression 
• Limited level B evidence 
 
Note. IPQ = Illness Perception Questionnaire; IPQ-R = Illness Perception Questionnaire Revised; MI = myocardial infarction. 
 
   
 
Pre MI vital exhaustion 
Defined by Appels (author of 
Maastrict Questionnaire) as a state 
which is present when an 
individual complains of unusual 
fatigue, decreasing energy and 
feeling dejected or defeated. 
 1 level 2b study: 
Spijkerman et al. (2005a)  
• Maastrict Questionnaire issues 
and retrospective data 
collection that has limited the 
quality of evidence 
specifically regarding vital 
exhaustion as RF for 
depression 
• Limited level D evidence 
Expressed anger as measured by 
Spielberger Anger Expression 
Scale 
1 level 2b study: 
Frasure-Smith et al. (1999) 
 • Limited level 2b evidence 
• Cross-sectional study in 
cardiac sample only 
• Supporting evidence for anger 
and irritability as symptoms of 
current depression in psych 
literature. 
• Limited level B evidence 
Type ‘D’ personality as 
measured the Type-D Scale 
(Denollet, 2005) based on 2 sub-
scales, negative affectivity and 
social inhibition. 
 1 level 4 study: 
Martens et al. (2008) 
 
• Limited level 4 evidence 
• Prospective study in cardiac 
sample 
• Limited level C evidence 
 
Note. MI = myocardial infarction; RF = risk factor. 
 
   
 
Demographic 
Female gender 
 
 
 
9 level 2b studies: 
Dickens et al. (2004) 
(prior to MI) 
Lesperance et al. (1996) 
Forrester et al. (1992) 
Frasure-Smith et al. (1999) 
Mallik et al. (2006) 
Watkins et al. (2003) 
Naqvi et al. (2007) 
Cheok et al. (2003) 
Lesperance et al. (2000) 
 
2 level 4 studies: 
Mendes de Leon et al. (2001) 
Aktar et al. (2004) 
3 level 2b studies: 
Spijkerman et al. (2005a) 
Spijkerman et al. (2005b) 
Strik et al. (2003) 
1 level 4 study: 
Bjerkeset et al. (2005) 
 
• Consistent level 2b studies 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• Large amount of supporting 
evidence from prospective 
studies in psychiatric 
literature 
• EBM grade B 
 
 
Note. EBM = Evidence Based Medicine; MI = myocardial infarction. 
   
 
Younger age 
Differing definitions: 
• <54 yrs 
Schrader et. al. (2004); Cheok           
et. al. (2003)  
• < 60 yrs 
van Melle et. al. (2006) 
• < 60 yrs 
Mendes de Leon et. al. (2001) 
• < 65 yrs 
Lesperance et. al. (1996) 
Linfante et. al. (2003) 
5 level 2b studies: 
Dickens et al. (2004) 
(depression prior to MI 
admission; 
depression in hospital) 
Mallik et al. (2006) 
Watkins et al. (2003) 
Linfante et al. (2003) 
Cheok et al. (2003) 
3 level 4 studies: 
Mendes de Leon et al. (2001) 
Mayou et al. (2000) 
Aktar et al. (2004) 
4 level 2b studies: 
Schrader et al. (2004) 
Lesperance et al. (1996) 
van Melle et al. (2006) 
Spijkerman et al. (2005b) 
• Consistent level 2b studies 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• EBM grade B 
 
Older age  
(Not accurately defined in paper) 
 
 
 1 level 4 study: 
Bjerkeset et al. (2005) 
 
• Limited level 4 evidence 
• Prospective study in cardiac 
sample 
• Evidence for late-onset 
depression in psych literature 
• Age poorly defined 
• Limited level C evidence 
Ethnicity  
African Americans 
1 level 2b study: 
Mallik et al. (2006) 
(US study) 
 • Limited level 2b evidence 
• Cross-sectional study in 
cardiac sample 
• Not directly applicable to 
Australian population 
• Limited level B evidence 
 
Note. EBM = Evidence Based Medicine; MI = myocardial infarction. 
   
 
Behavioural 
Smoking: 
defined as current smoking on 
admission or daily smoking at 
baseline 
 
 
 
 
 
Difficulty stopping smoking 
defined as not being able to stop 
smoking after MI 
4 level 2b studies: 
Mallik et al. (2006) (RF for 
women only) 
Naqvi et al. (2007) 
Cheok et al. (2003) 
Lesperance et al. (2000) 
1 level 4 study: 
Mayou et al. (2000) 
 
 
2 level 2b studies: 
Schrader et al. (2004) 
Spijkerman et al. (2005b) 
1 level 4 study: 
Bjerkeset et al. (2005) 
 
 
 
 
1 level 2b: 
Strik et al. (2003) 
1 level 3b: 
Strik et al. (2001a) 
• Consistent level 2b studies 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• Large amount of supporting 
evidence from psychiatric 
literature for association of 
smoking with depression 
• EBM grade B 
• Consistent level 2b /3b studies 
• Both prospective studies in 
cardiac samples 
• Large amount of supporting 
evidence in psychiatric 
literature 
• EBM grade B 
Increased alcohol consumption 
defined as alcohol intake above 
the 97th percentile (frequency of 
intake) during the previous month 
 1 level 4 study: 
Bjerkeset et al. (2005) 
• Limited level 4 evidence 
• Prospective study in cardiac 
sample 
• Support for increased alcohol 
intake in those already 
depressed in psychiatric 
literature 
• Limited level C evidence 
 
Note. EBM = Evidence Based Medicine; MI = myocardial infarction; RF = risk factor. 
   
 
Reduced level of exercise 
(differing definitions) 
Physically active < once per 
week; Exercise < three days per 
week 
2 level 2b studies: 
Lesperance et al. (1996) 
Linfante et al. (2003) 
(female sample only) 
 • Limited level 2b evidence 
• Cross-sectional data in 
cardiac samples only 
• Reduced activity a symptom 
of current depression 
• No strong prospective data 
• Differing definitions 
• Limited level C evidence 
Social 
Lower level of education 
< 7 years 
 
Years of education 
High school or less, 
Left school before the age of 
14yrs 
4 level 2b studies: 
Frasure-Smith et al. (1999) 
Mallik et al. (2006) (Men only) 
Watkins et al. (2003) 
Cheok et al. (2003) 
1 level 2b study: 
Spijkerman et al. (2005b) 
(in those with a history of 
depression) 
• Consistent level 2b evidence 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• Support for association with 
lower level of education and 
depression in psych literature 
• EBM grade B 
Childhood separation from 
mother 
 
1 level 2b study: 
Dickens et al. (2004) 
 • Limited level 2b evidence 
• Cross-sectional study in 
cardiac sample 
• Some supporting evidence as 
risk factor for early onset 
depression in psych literature 
• Limited level B evidence 
 
Note. EBM = Evidence Based Medicine. 
 
   
 
Marital status: 
Single 
 
 
Divorced; separated 
 
2 level 2b studies: 
Mallik et al. (2006) 
(Men only) 
Lesperance et al. (2000) 
 
1 level 2b study: 
Cheok et al. (2003) 
 • Limited level 2b evidence 
• Cross-sectional studies in 
cardiac sample 
• Support for an association 
between divorce/separation (as 
a significant life event) and 
depression in psych. literature 
• Limited level B evidence 
Unemployed 2 level 2b studies: 
Cheok et al. (2003) 
Mallik et al. (2006) 
 • Limited level 2b evidence 
• Cross-sectional studies in 
cardiac sample 
• Good support for 
unemployment associated with 
low family income/ stress 
/socioeconomic indicators and 
depression 
• Limited level B evidence 
Lower socioeconomic position 
 
 
1 level 2b study 
Mallik et al. (2006) 
1 level 4 study 
Aktar et al. (2004) 
 
 • Limited level 2b/4 evidence 
• Cross-sectional data in cardiac 
samples 
• Good support for lower SEP 
and financial strain associated 
with depression and other risk 
factors for depression 
• Limited level b evidence 
 
Note. psych. = psychiatric; SEP = socio-economic position. 
   
 
Having dependents as a woman 
Child, spouse, parent, or other for 
whom subject had full 
responsibility 
1 level 2b study: 
Linfante et al. (2003) 
(female sample only) 
 • Limited level 2b evidence 
• Cross-sectional study in 
cardiac sample 
• Support for social role of 
women increasing risk of 
depression in some 
women/circumstances but not 
a significant risk factor in 
isolation of other RFs 
• Limited level C evidence 
Social isolation  
 
 
No close friends or confidant 
 
 
 
 
Living alone 
 
 
Reduced quality and 
satisfaction with personal 
relationships 
 
Lower perceived social support 
(as measured by PSSS) 
1 level 2b study: 
Dickens et al. (2004) 
 
4 level 2b studies: 
Dickens et. al (2004) 
Lesperance et al. (1996) 
Frasure-Smith et al. (1999) 
Lesperance et al. (2000) 
1 level 2b study: 
Spijkerman et al. (2005a) 
 
1 level 2b study: 
Forrester et al. (1992) 
 
1 level 2b study: 
Frasure-Smith et al. (1999) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 level 2b study: 
Hammond et al. (2008) 
• Consistent level 2b evidence 
• Cross-sectional and 
prospective studies in cardiac 
samples 
• Support for association 
between reduced social 
support as a mediating factor 
and depression in psych. 
literature 
• EBM grade B 
 
 
Note. EBM = Evidence Based Medicine; PSSS = Perceived Social Support Scale; RF = risk factors. 
   
 
Lower scores on the SF-36 
completed in hospital based on 
retrospective recall of the four 
weeks prior to admission 
1 level 4 study: 
Mayou et al. (2000) 
 • Limited level 4 evidence 
• Cross-sectional study in 
cardiac sample 
• Retrospective data collection 
• Limited level C evidence 
Medical 
Impaired Left Ventricular 
Ejection Fraction (LVEF)  
 
van Melle et al. LVEF <30% 
Spijkerman et al. LVEF <40% 
Lesperance et al. LVEF <45% 
Watkins et al. LVEF <40% 
Mallik et al. LVEF <40% 
Frasure-Smith et al. LVEF <35% 
 
Advanced Killip class 
Frasure-Smith et al. > 2 
Mallik et al. > 2 
 
Diagnosis of CHF (recorded in 
medical records) 
4 level 2b studies: 
Frasure-Smith et al. (1999) 
Mallik et al. (2006) 
(RF for men only) 
Watkins et al. (2003) 
(past history of MI) 
Lesperance et al. (2000) 
 
2 level 2b studies: 
Frasure-Smith et al. (1999) 
Mallik et al. (2006) 
 
 
Watkins et al. (2003) 
2 level 2b studies: 
van Melle et al. (2006)  
Spijkerman et al. (2005b) 
(no history of depression) 
 
 
 
• Consistent level 2b evidence 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• Supporting evidence of high 
prevalence of depression in 
heart failure patients 
• EBM grade B 
 
 
Note. CHF = congestive heart failure; EBM = Evidence Based Medicine; LVEF = left ventricular ejection fraction; MI = myocardial infarction. 
   
 
History of a MI or cardiac 
condition 
 
4 level 2b studies: 
Mallik et al. (2006) 
Naqvi et al. (2007) 
Cheok et al. (2003) 
Lesperance et al. (2000) 
1 level 2b study: 
Schrader et al. (2004) 
1 level 4 study: 
Martens et al. (2008) 
 
• Consistent level 2b evidence 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• EBM grade B 
Other co-morbid condition  
Watkins et. al.: rhematological 
disease, pulmonary disease, CHF, 
diabetes (type not specified), 
peripheral vascular disease. 
Naqvi et al.: diabetes (type not 
specified) 
Malik et al.:diabetes (type not 
specified) 
Cheok et al. :obesity (BMI > 40), 
chronic conditions not defined  
Martens et al.: arthritis, renal 
insufficiency, COPD 
Pre-existing non-cardiac 
condition not defined 
Marked health difficulty in self 
or others: defined as by Life 
Events & Difficulties Schedule 
4 level 2b studies: 
Watkins et al. (2003) 
Naqvi et al. (2007) 
Cheok et al. (2003) 
Malik et al. (2006) 
 
 
 
 
 
 
 
 
 
 
 
1 level 2b study 
Dickens et al. (2004) 
1 level 4 study: 
Martens et al. (2008) 
 
 
 
 
 
 
 
 
 
 
 
1 level 2b study: 
Dickens et al. (2004) 
 
• Limited level 2b/4 evidence 
• Differing definitions of co-
morbid conditions 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• Limited level B evidence 
 
Note. BMI = Body Mass Index; CHF = congestive heart failure; COPD = chronic obstructive pulmonary disease; EBM = Evidence Based Medicine; MI = 
myocardial infarction. 
   
 
Obesity  
Bjerkeset et al. (BMI ≥ 30) 
Cheok et al. (BMI > 40) 
Mallik et al. (BMI ≥ 30) 
2 level 2b studies: 
Cheok et al. (2003) 
Mallik et al. (2006) 
1 level 4 study: 
Bjerkeset et al. (2005) 
• Limited level 2b/4 evidence 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• Limited level C evidence 
Revascularization in  
hospital (PTCA; CABG) 
 
 
 
1 level 2b study 
Mallik et al. (2006) 
(Men only) 
1 level 2b study 
Spijkerman et al. (2005b) 
(patients without a history of 
depression) 
• Limited level 2b evidence 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• Limited level B evidence 
Arrhythmic event in hospital 
(AF; VF; VT) 
 1 level 2b study: 
Spijkerman et al. (2005b) 
(patients without history of 
depression) 1 level 3b study 
Strik et al. (2001a) 
• Limited level 2b evidence 
• Prospective association in 
cardiac sample with history of 
depression 
• Limited level B evidence 
Complications in hospital  
Strik et al. recurrent angina, 
prescription of benzodiazepines 
Hammond et al. Discharge 
diagnosis of angina 
 1 level 2b study: 
Strik et al. (2003) 
Hammond et al. (2008)  
1 level 3b study: 
Strik et al. (2001a) 
• Limited level 2b/3b evidence 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• Limited level B evidence 
Duration of admission 
The longer the hospital stay > risk 
for depression 
1 level 4 study: 
Mayou et al. (2000) 
2 level 2b studies: 
Spijkerman et al. (2005b) 
Hammond et al. (2008) 
• Limited level 2b/4 evidence 
• Both prospective and cross-
sectional studies in cardiac 
samples 
• Limited level C evidence 
 
Note. AF = atrial fibrillation; BMI = Body Mass Index; CABG = coronary artery bypass grafts; PTCA = percutaneous transluminal coronary angioplasty; VF 
= ventricular fibrillation; VT = ventricular tachycardia. 
   
 
Frequency of chest pain at 12 
months as reported by patients for 
one month prior to study visit 
 1 level 2b study: 
Dickens et al. (2004) 
• Limited level 2b evidence 
• Prospective association in 
cardiac sample 
• Limited level B evidence 
History of 
Hypercholesterolaemia 
 
No definition for 
hypercholesterolaemia reported 
1 level 2b study: 
Mallik et al. (2006) 
(RF for women only) 
 • Limited level 2b evidence 
• Cross-sectional study in 
female cardiac sample only 
• Limited level B evidence 
Prescription of nitrates and 
triple anti-ischaemic therapy 
(combination calcium channel 
blockers, β-blockers, nitrates) 
1 level 2b: 
Lesperance et al. (2000) 
(UA sample only) 
 • Limited level 2b evidence 
• Cross-sectional studies in 
cardiac sample 
• Limited level B evidence 
Treatment with diuretics  
(during admission) 
 1 level 4: 
Martens et al. (2008) 
• Limited level 4 evidence 
• Related to CHF evidence 
• Prospective association in 
cardiac sample 
• Limited level C evidence 
Prescribed sodium warfarin on 
discharge 
 
1 level 2b study: 
Lesperance et al. (1996) 
 • Limited level 2b evidence 
• Cross-sectional study in 
cardiac sample 
• Limited level B evidence 
 
Note. CHF = congestive heart failure; RF = risk factor; UA = unstable angina. 
   
 
CK ≥ 1500 u/L 
 
1 level 2b study: 
Forrester et al. (1992) 
 • Limited level 2b evidence 
• Cross-sectional study in 
cardiac sample 
• Limited level B evidence 
History of treatment for 
hypertension 
No definition of hypertension 
 
2 level 2b studies: 
Mallik et al. (2006) 
(Men only) 
Frasure-Smith et al. (1999) 
 • Limited level 2b evidence 
• Cross-sectional studies in 
cardiac sample 
• Limited level B evidence 
Physical functional impairment 
as measured by the Johns Hopkins 
Functioning Inventory  
1 level 2b study: 
Forrester et al. (1992) 
 • Limited level 2b evidence 
• Cross-sectional study in 
cardiac sample 
• Support for functional 
impairment/disability as risk 
factor for depression in psych 
literature 
• Limited level B evidence 
Reduced maximum work load 
on exercise testing 
1 level 2b study: 
Spijkerman et al. (2005a) 
 • Limited level 2b evidence 
• Cross-sectional study in 
cardiac sample 
• Limited level B evidence 
Health Related Quality of life, 
frequency of angina, and physical 
limitations as measured by the 
Seattle Angina Questionnaire 
 
1 level 2b study: 
Mallik et al. (2006) 
 
 • Limited level 2b evidence 
• Cross-sectional study in 
cardiac sample 
• Limited level B evidence 
 
Note. CK = total serum creatine kinase. 
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Appendix D: Invitation Letter for Expert Panel 
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Appendix E: Review Document for Expert Panel 
 
 
Please review the questions and rate each item for relevance as a risk factor for 
depression in cardiac patients by placing x in the appropriate box. Under each item, 
please provide any suggestions/recommendations for item revision.  
 
Ratings:    1 = not relevant  
      2 = unable to assess relevance without item revision 
      3 = relevant but may need minor alteration 
      4 = very relevant 
Risk Factor: Life events in year prior to admission 
to hospital for acute myocardial infarction 
(Limited grade B evidence in ACS samples) 
Q1 Not including your admission to hospital, have 
things happened to you or your family in the past 12 
months that have caused you to feel very stressed or 
depressed? 
 
   1 
 
   2 
 
   3 
 
  4 
Risk Factor: Self reported stress or anxiety   
(Oxford EBM level of evidence grade B) 
Q2 In the past have you often felt stressed or 
anxious? 
  
   1 
   
  2 
    
  3 
   
  4 
Comment 
 
Risk Factor: Past History of depressive disorder 
(Oxford EBM level of evidence grade B) 
Q3 Have you been told by a doctor that you were 
depressed? 
  
   1 
    
  2 
    
  3 
    
  4 
Comment 
 
Risk Factor: History of other mental health 
disorders 
(Oxford EBM level of evidence grade B) 
Q4 Have you been told by a doctor that you have any 
other mental health problems? 
  
   1 
    
   2 
    
   3 
   
  4 
Comment 
 
Risk Factor: Acute distress associated with event 
(Oxford EBM level of evidence grade B) 
Q5 Were you very frightened when you had your 
heart attack or severe chest pain? 
   
   1 
    
   2 
    
   3 
 
   4 
Comment 
 
Risk Factor: Fear of dying  
(Oxford EBM level of evidence grade B) 
Q6 Did you think that you might die when you had 
your heart attack or severe chest pain? 
   
   1 
   
   2 
    
  3 
    
   4   
Comment 
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Risk Factor: In hospital anxiety 
(limited grade B evidence in ACS samples) 
Q7 Have you felt very stressed by your illness? 
    
   1 
    
   2 
    
  3 
    
   4 
Comment 
 
Risk Factor: In hospital anxiety 
(limited grade B evidence in ACS samples) 
Q8 Have you felt confused or found it difficult to 
make a decision? 
    
   1 
    
   2 
   
    3 
    
   4 
Comment 
 
Risk Factor: Negative perceptions regarding cardiac 
diagnosis 
(limited grade C evidence in ACS samples) 
Q9 Do you feel that your current heart problem will 
last a long time? 
   
   1 
 
   2 
   
    3 
    
   4 
Comment 
 
Risk Factor: Negative perceptions regarding cardiac 
diagnosis 
(limited grade C evidence in ACS samples) 
Q10 Are you concerned that you will not get better? 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
 
Risk Factor: Ethnicity. Insufficient research in 
cardiac samples to assess evidence base  
 
Q11 Are you an Aboriginal or Torres Strait Islander 
person? 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
Please specifically comment on whether you consider that Aboriginal /TSI origin may be 
considered a risk factor for depression due to the high burden of psychological stress found 
in these communities. 
 
 
 
 
 
Risk Factor: Responsibility for dependents 
(limited grade B evidence in ACS samples) 
Q12 Are you a carer for a child, parent or other who 
is dependent on you? 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
 
Risk Factor: Living alone 
(Oxford EBM level of evidence grade B) 
Q13 Do you live alone most of the time? 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
 
 
Appendix E 
 182 
 
Risk Factor: No close friend or confidant for 
support 
(Oxford EBM level of evidence grade B) 
Q14 Are you without a close friend or partner you 
can rely on for emotional support? 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
 
Risk Factor: Financial concerns 
(limited grade B evidence in ACS samples) 
Q15 Will your heart condition significantly worsen 
your financial situation? 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
 
Questions answered by staff members  
Risk Factor: Female gender 
(Oxford EBM level of evidence grade B) 
S1 Is the patient female? 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
 
Risk Factor: Younger age 
(Oxford EBM level of evidence grade B) 
S2 Is the patient aged 65 years or less? 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
 
Risk Factor: Impaired left ventricular function 
(Oxford EBM level of evidence grade B) 
S3 Does the patient have a LVEF < 40% or a 
recorded diagnosis of CHF? 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
 
Risk Factor: Prior cardiac history  
(Oxford EBM level of evidence grade B) 
S4 Does the patient have a prior history of MI or 
CABG? 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
 
Risk Factor: Smoking prior to admission  
(Oxford EBM level of evidence grade B) 
S5 Does the patient have a history of smoking on 
most days of the week? 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
 
Risk Factor: Past History of depressive disorder 
(Oxford EBM level of evidence grade B) 
S6 Does the patient have a past history of 
depression? 
 
   1 
 
    2 
 
   3 
 
    4 
Comment 
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Risk Factor: Current depressive symptoms 
(Oxford EBM level of evidence grade B) 
The depression scale that will be used in the project 
has yet to be determined 
S7 Has the patient scored above the cut-off score > 5 
on the depression scale PHQ-9 
 
   1 
 
   2 
 
   3 
 
   4 
Comment 
 
 
Additional questions: 
In an Australian context, there is insufficient evidence to assess Ethnicity as a risk factor for 
depression in cardiac patients. In your opinion, are there special groups of people or 
circumstances (eg recent migration) that may be seen to increase the risk of depression 
following ACS? 
 
 
 
 
 
 
 
Are there any redundant questions? 
 
 
 
 
 
 
 
Are there any significant risk factors that are not represented in the questionnaire? 
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Appendix F: DRAQ (Pre-Panel Review) 
 
Depression Risk Assessment Questionnaire (DRAQ) 
  
Please circle YES or NO in the column to show your answer. 
 
 
These questions are about your past mental health: 
 
Q1 Not including your current admission to hospital, have 
things happened to you or your family in the past 12 
months that have caused you to feel very stressed or 
depressed?  
 
Please specify: 
___________________________________________ 
 
YES NO 
Q2 In the past have you often felt stressed or anxious? 
 
If a doctor has said that you have a ‘stress-related’ 
problem please specify: 
___________________________________________ 
 
YES NO 
Q3 Have you been told by a doctor that you were 
depressed? 
 
Please specify details if known: 
___________________________________________ 
 
YES NO 
Q4 Have you been told by a doctor that you have any other 
mental health problems? 
 
Please specify if details known: 
___________________________________________ 
 
YES NO 
 
These questions are about when you first realised you had a serious 
heart problem: 
 
Q5 Were you very frightened when you had your heart 
attack or severe chest pain? 
 
YES NO 
Q6 Did you think that you might die when you had your 
heart attack or severe chest pain?  
 
YES NO 
 
These questions are about your current stay in hospital: 
 
Q7 Have you felt very stressed by your illness? 
 
YES NO 
Q8 Have you felt confused or found it difficult to make a 
decision? 
 
YES NO 
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These questions are about how you feel towards your heart problem 
and discharge home: 
 
Q9 Do you feel that your current heart problem will last a 
long time? 
 
YES NO 
Q10 Are you concerned that you will not get better? YES NO 
 
These questions are about your social background (optional): 
 
Q11 Are you an Aboriginal or Torres Strait Islander person? 
 
YES NO 
Q12 Are you a carer for a child, parent or other who is 
dependent on you? 
 
YES NO 
Q13 Do you live alone most of the time? 
 
YES NO 
Q14 Are you without a close friend or partner you can rely 
on for emotional support? 
 
YES NO 
Q15 Will your heart condition significantly worsen your 
financial situation? 
 
YES NO 
 
 
 
Please make comments or provide further information below: 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for completing the questionnaire 
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Appendix G: DRAQ (Staff) 
 
Depression Risk Assessment Questionnaire (DRAQ)  
  
STAFF ONLY 
 
 
 
Please circle YES or NO in the column to show your answer. 
 
Please total the number of YES answers given by the patient and staff 
as indicated 
 
 
S1 Is the patient female? 
 
YES NO 
S2 Is the patient aged 65 years or less? 
 
YES NO 
S3 Does the patient have a LVEF < 40% or a recorded 
diagnosis of CHF? 
 
YES NO 
S4 Does the patient have a prior history of MI or CABG? 
 
YES NO 
S5 Does the patient have a history of smoking on most 
days of the week? 
 
YES NO 
S6 Does the patient have a past history of depression? 
 
YES NO 
S7 Has the patient scored above the cut-off score 
(insert score) on the depression scale (insert name 
of depression scale to be used) 
YES NO 
 
 
 
SCORE: Patient (      ) 
               Staff     (      ) 
               TOTAL (      ) 
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Appendix H: HREC Approval Letter, Curtin University 
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Appendix I: HREC Approval Letter (Qualitative Study), SCGH 
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Appendix J: HREC Approval Letter (Instrument Development), SCGH 
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Appendix K: Participant Information Sheet and Consent (Qualitative Study) 
 
 
Sir Charles Gairdner Hospital 
 
CLINICAL STAFF PARTICIPANT INFORMATION SHEET 
 
Lay Title: A study exploring the views held by clinical staff regarding 
screening patients for depression in an acute care setting 
 
Study Title:  Facilitators and barriers to screening for depression in an 
acute care setting: A qualitative study exploring the perceptions of 
clinical staff 
 
Investigators:  Ms Jo Crittenden,  
Prof. Gavin Leslie, Prof. Patricia Davidson, Clinical Prof. 
Peter Thompson, A/Prof. Sean Hood 
 
Please take time to read the following information carefully and discuss it with 
your friends or family if you wish.  Ask us any question if some part of the 
information is not clear to you or if you would like more information. Please 
do this before you sign this consent form.   
 
Who is funding this study? 
This study is funded as a PhD research project by Curtin University of 
Technology.  
 
Contact persons: 
Should you have questions about the study you may contact: 
Ms Jo Crittenden:  Phone No. 9345 4301 
Phone No.  9358 5607(after hours) 
Prof Gavin Leslie  Phone No 9266 2070 
 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. 
 
You may decide to be in the study or not take part at all. If you do 
decide to take part in this study, you may stop at any time.  However, 
before you decide, it is important that you understand why this 
research is being done and what it will involve.  
 
Whatever your decision, this decision will not lead to any penalty or 
affect any benefit to which you are otherwise entitled.  
 
The following information sheet will explain the study and will include 
details such as: 
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o Why this study might be suitable for you; 
o The type, frequency and risks of any procedures required by the 
study; 
o The nature of your participation 
o Your rights and responsibilities 
 
What is the purpose of this study? 
Although there is strong evidence regarding the negative effects of depression 
in post acute coronary syndrome patients, depression remains under 
diagnosed with screening programmes yet to be fully integrated into routine 
clinical practice in Australia. This study is part of a programme of research to 
be undertaken within the Cardiovascular Medicine Department with the 
following objectives: 
• To establish current depression screening practice in the department 
• To determine what might facilitate the introduction of depression 
screening within the department 
 
Why is this study suitable to me? 
You have been invited to participate in this study because you are a member 
of staff within the Cardiovascular Medicine Department with expertise in the 
care of ACS patients. 
 
How long will I be in this study? 
Participants will be asked to help with the study on one occasion only. You 
will be asked to spend approximately one hour answering questions related 
to your daily practice.  
 
What will happen if I decide to be in this study? 
You will be one of 10 to 15 staff members who have volunteered to help with 
this research. You will be interviewed in private in the Heart Research 
Institute or at another mutually agreed private venue. You will be asked 
questions related to current practice and the possible introduction of 
depression screening in the department. 
Are there any reasons I should not be in this study? 
It is anticipated the interview will be concluded within one hour, however, due 
to the demanding nature of your clinical role, you may find it difficult to find 
time to assist in this research.  
What are the costs to me? 
There will be no direct costs to you whilst participating in this study, however, 
you will not be paid to take part in the study. 
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What are the possible benefits of taking part?  
You may not directly benefit from the study. However, you may find it 
professionally rewarding to actively participate in the research study. 
 
How will my safety be ensured? 
There are no obvious risks to your safety when participating in the study. 
 
What alternatives do I have to going on this study?: 
You may refuse to take part without affecting any aspect of your practice or 
rights as an employee. Whether you decide to participate or not will be kept 
confidential and known only to the Associate Investigator on site.  
What are the possible side effects, risks and discomforts of taking 
part?  
There are no physical risks associated with taking part in this study.  
 
What happens at the end of the study? 
Your participation in this study will be complete following your interview. Your 
interview will be analysed and the findings may be published at a future date. 
 
Will my taking part in this study be kept confidential? 
The researcher will need to collect personal data about you which may be 
sensitive e.g. date of birth and relevant employment information. Any personal 
information will be kept private and confidential. It will be stored securely and 
only authorised persons, who understand it must be kept confidential, will 
have access to it. Specifically, the data gained from the interviews will be kept 
confidential and you will not be identifiable to other members of staff as a 
result of discussions about the research programme within the department.  
 
Your study details will be given a number so that your identity will not be 
apparent. The study records will be kept in the Heart Research Institute 
during the study and in a locked archive for at least 5 years from the time the 
study is closed, and may be destroyed at any time thereafter. 
 
Authorised representatives of the hospital Human Research Ethics 
Committee, the Human Research Ethics Committee of Curtin University of 
Technology, the investigators or Research Governance and regulatory 
bodies, may require access to your study records to verify study procedures 
and/or data. In all cases when dealing with your information, these people 
are required to comply with privacy laws that protect you. 
 
The results of the research will be made available to other medical personnel 
through journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
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Will I find out the results of the study? 
The study is part of a PhD (Nursing) project and may be published in journals 
or discussed at professional meetings. The research results will be 
disseminated within the department on completion of the study. A summary 
of the overall research findings will be provided for interested participants. 
 
Who has reviewed the study? 
The Sir Charles Gairdner Group Human Research Ethics Committee has 
reviewed this study and has given its approval for the conduct of this 
research study. In doing so this study conforms to the principles set out by 
the National Statement on Ethical Conduct in Human Research and 
according to the Good Clinical Practice Guidelines. If you have any ethical 
concerns regarding the study you can contact the secretary of the Sir Charles 
Gairdner Group Human Research Ethics Committee on telephone No.  
(08) 9346.2999 
 
This study has also been approved by Curtin University of Technology Human 
Research Ethics Committee. If needed, verification of approval can be 
obtained either in writing to the Curtin University Human Research Ethics 
Committee, c/- Office of Research and Development, Curtin University of 
Technology, GPO Box U 1987, Perth, 6845 or by telephoning 9266 2784 or 
by emailing hrec@curtin.edu.au 
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                                  Consent Form 
 
Study Title:  Facilitators and barriers to screening for depression 
in an acute care setting: A qualitative study 
exploring the perceptions of clinical staff 
 
Investigators: Ms Jo Crittenden, Prof. Gavin Leslie, Prof. Patricia 
Davidson, Clinical Prof. Peter Thompson, A/Prof. Sean Hood 
 
Participant Name:_________________________________________ 
 
Date of Birth: _______________ 
 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
 
2. I have been told about the possible advantages and risks of taking part in 
the study and I understand what I am being asked to do. 
 
3. I have been able to have a member of my family or a friend with me while 
I was told about the study.  I have been able to ask questions and all 
questions have been answered satisfactorily. 
 
4. I know that I do not have to take part in the study and that I can withdraw 
at any time during the study without affecting my future practice or 
employment.  My participation in the study does not affect any right to 
compensation, which I may have under statute or common law. 
 
5. I agree to take part in this research study and for the data obtained to be 
published provided my name or other identifying information is not used. 
 
If you are unclear about anything you have read in the Participant 
Information Sheet or this Consent Form, please speak to the researcher 
before signing this Consent Form. 
 
 
Name of Participant                                                  Signature of Participant  
Date 
 
Name of Investigator                                                Signature of Investigator 
Date 
 
The Sir Charles Gairdner Group Human Research Ethics Committee has given ethics 
approval for the conduct of this project.  If you have any ethical concerns regarding the study 
you can contact the secretary of the Sir Charles Gairdner Group Human Research Ethics 
Committee on telephone No. (08) 9346.2999 
 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. 
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Appendix L: Interview Guide for Qualitative Study 
 
Aim: To establish current screening practice and future development plans. 
 
• From your own clinical experience, how do you determine whether a patient 
admitted to the department is depressed? 
 
• What procedure is followed if you suspect a patient may be depressed? 
 
• What problems, if any, exist with the current practice? 
 
• What would improve the identification of depressed patients? 
 
• What plans exist to change current practice? 
 
 
 
Aim: To determine barriers and facilitators to the introduction of a 
screening intervention as perceived by key members of the clinical team. 
 
• What barriers are there to establishing a depression screening intervention in 
the department? 
 
• What would assist the introduction of a depression screening system in the 
department?  
 
• In the past, how quickly has clinical practice in the department changed 
because of new clinical guidelines or relevant evidence? 
 
• What resources are you aware of within the hospital that might help facilitate 
change in clinical practice? 
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Appendix M: DRAQ (Post Panel Review) 
 
 
 
 
 
Depression Risk Assessment Questionnaire (DRAQ)   
Please put a circle around your answer.  
 
 
                                                                                                                       Please turn over.
These questions are about your mental health: 
Q1 Not including your current admission to hospital, have things happened to 
you or your family in the past 12 months that have caused you to feel 
depressed?  
                                                    NO          YES 
                                                                Please specify: 
                                                                   A little bit depressed 
 
                                                                   Moderately depressed 
 
 
                                                                          Very depressed 
Q2 Do you often feel anxious? 
                                                    NO          YES 
                                                                         Please specify: 
                                                                   A little bit anxious 
 
                                                                   Moderately anxious 
 
                                                                          Very anxious 
Q3 Have you ever been told by a doctor that you had depression? 
 
Please specify details if known: 
______________________________________ 
YES    NO 
Q4 Have you ever been prescribed antidepressant medication? YES    NO 
Q5 Have you ever been told by a doctor that you had any other  
mental health problems? 
 
Please specify details if known: 
________________________________________________ 
YES    NO 
These questions are about your social background (optional): 
Q6 Do you live alone most of the time? YES    NO 
Q7 Are you without a close friend, partner, or other family 
member you can rely on for emotional support? YES    NO 
Q8 Will your heart condition have a significant, negative affect on 
your financial situation? YES    NO 
Q9 Are you an Aboriginal or Torres Strait Islander person? YES    NO 
Patient ID label 
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Please make comments or provide further information below: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for completing the questionnaire 
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Appendix N: Participant Information Sheet and Consent (ACS Sample) 
 
 
Sir Charles Gairdner Hospital 
 
PARTICIPANT INFORMATION SHEET 
 
Lay Title:   Identifying people at risk of becoming depressed after a 
heart attack or severe chest pain and developing a 
practical method of screening patients for depression 
whilst in hospital. 
 
Study Title:  Identifying those at risk of depression following a 
diagnosis of acute coronary syndrome: Developing a 
screening intervention for use in the acute care hospital 
setting.  
 
Investigators:  Ms Jo Crittenden,  
Prof. Gavin Leslie, Prof. Patricia Davidson, 
Clinical Prof. Peter Thompson, Prof. Sean Hood 
 
Please take time to read the following information carefully and discuss 
it with your friends, family and general practitioner if you wish.  Ask us 
any question if some part of the information is not clear to you or if you 
would like more information. Please do this before you sign this 
consent form.   
 
Who is funding this study? 
This study is funded as a PhD research project by Curtin University of 
Technology and has received a grant from the Sir Charles Gairdner Hospital 
Research Advisory Committee. 
 
Contact persons: 
Should you have questions about the study you may contact: 
Ms Jo Crittenden:  Phone No. 9345 4301 
Phone No.  9358 5607(after hours) 
Prof Gavin Leslie  Phone No 9266 2070 
 
All study participants will be provided with a copy of the Information Sheet and 
Consent Form for their personal records. 
 
You may decide to be in the study or not take part at all. If you do decide to 
take part in this study, you may stop at any time.  However, before you 
decide, it is important that you understand why this research is being done 
and what it will involve.  
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Whatever your decision, this decision will not lead to any penalty or affect 
your regular medical care or any benefit to which you are otherwise entitled.  
 
The following information sheet will explain the study and will include details 
such as: 
o Why this study might be suitable for you 
 
o The type, frequency and risks of any procedures required by the study 
o The nature of your participation 
o Your rights and responsibilities 
 
What is the purpose of the study? 
Research has found that many people become depressed following a heart 
attack [myocardial infarction]. At the moment we do not know which patients 
may become depressed once they have left hospital. The aim of this 
research project is to develop a questionnaire that might be used to identify 
people who may become depressed so they can be given extra support or 
treatment. 
 
Why is this study suitable to me? 
You have been invited to participate in this study because you have recently 
had a heart attack or suffered severe chest pain. People with heart disease 
may also have depression or be at risk of becoming depressed. 
  
How long will I be in this study? 
You will be asked to help us with this study on two occasions only, just before 
you leave hospital and two weeks later.  
 
What will happen if I decide to be in this study? 
You will be one of 220 people who have volunteered to help with this 
research. You will be asked to complete two short questionnaires by 
answering a number of questions about your health and social matters. One 
questionnaire, the Depression Risk Assessment Questionnaire, is still being 
developed. The answers you give to that questionnaire will be kept 
confidential and the information will only be used to test the questionnaire 
itself.  
The other questionnaire, the Patient Health Questionnaire -9, will enable the 
researcher to assess if you are likely to have depression at the moment. The 
results of the questionnaire will enable the Cardiac Rehabilitation and Heart 
Failure Service staff to give you extra support and refer you for expert help if 
required.  You, your Cardiologist, and your GP will be informed of the results 
of the questionnaire. 
A few patients (10 to 15) will be asked more detailed questions about the 
new questionnaire, for example if it is easy to read. They will also be asked 
whether they think it is appropriate to ask about someone’s mental health 
and social situation whilst in hospital for heart problems. 
Once you return home, you will be asked to complete the questionnaires 
again for a second time and return them in the postage paid envelope 
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provided. The new questionnaire is in the early stages of development so we 
do not know how good it is at predicting whether someone might become 
depressed. It will require further advanced testing and therefore the 
researcher will be unable to tell you if you are at risk of depression in the 
future.  
If you do feel depressed at any time following discharge, the nurses of the 
Cardiac Rehabilitation and Heart Failure Service are able to offer support and 
arrange expert help. The service can be contacted on 08 9346 4302, Monday 
to Friday. Alternatively, you could contact your own GP for assistance. 
Additional information and help is provided by the national organization called 
beyondblue. The organization has an excellent website and confidential 24 
hour telephone information and referral service: 
 www.beyondblue.org.au      Tel: 1300 22 4636 
 
Are there any reasons I should not be in this study? 
There may be some reasons why the study may not be suitable for you, for 
instance if you have difficulties reading and writing English because it is not 
your main language. The researcher will discuss these with you in detail to 
ensure that this study is appropriate for you.  
 
What are the costs to me? 
There will be no direct costs to you whilst participating in this study, however, 
you will not be paid to take part in the study. 
 
What are the possible benefits of taking part?  
You may not directly benefit from the study. The aim of this study is to 
develop a questionnaire to help identify people who may become depressed 
following a heart attack. If you take part you will be helping the researcher 
improve the Depression Risk Assessment Questionnaire so that patients in 
the future will find it clear and easy to use. It is possible that you may be 
unaware that you have depression. Completing the Patient Health 
Questionnaire-9 may help identify this problem for you so you may be given 
extra support and treatment if required. 
 
How will my safety be ensured? 
Being involved in the study will not interfere with your usual medical 
treatment. You are being asked to complete the forms once your doctors feel 
you are well enough to go home and 2 weeks after you have been 
discharged from hospital. However, if you feel unwell whilst you are 
completing the questionnaires you may stop at any time without obligation to 
continue.   
 
What alternatives do I have to going on this study?: 
You will receive your normal treatment whether you take part in the study or 
not. You may refuse to take part without affecting your care.  
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What are the possible side effects, risks and discomforts of taking 
part?  
There are no physical risks in taking part in this study. However, you will be 
asked about your health and social situation. These questions may upset you 
or may bring back unpleasant memories. If you feel this may be the case, 
please tell the researcher so that you have the opportunity to discuss these 
matters in private with an independent member of the cardiac rehabilitation 
team. You have the right to withdraw from the study at any time after you 
have signed the consent form. 
 
What happens at the end of the study? 
Once you have completed the newly developed form and the questionnaire 
for detecting depression on two occasions, you will have finished 
participating in the study. Your treatment and outpatient care will be 
unaffected by your participation in the study. 
 
What if something goes wrong? 
Medical treatment will be provided at no cost to you for research –related 
harm. The term “research–related harm” means both physical and mental 
injury caused by the procedures required by the study. 
 
Your participation in this study does not prejudice any right to compensation that 
you may have under statute or common law 
 
Will my taking part in this study be kept confidential? 
The researchers will need to collect personal data about you, which may be 
sensitive e.g. date of birth and relevant health information. Any personal or 
health information will be kept private and confidential. It will be stored 
securely and only authorised persons, who understand it must be kept 
confidential, will have access to it. 
Your study details will be given a number so that your identity will not be 
apparent. The study records will be kept in the Heart Research Institute 
during the study and in a locked archive for at least 5 years from the time the 
study is closed, and may be destroyed at any time thereafter. 
 
Authorised representatives of the hospital Human Research Ethics 
Committee, the Human Research Ethics Committee of Curtin University of 
Technology, the investigators or Research Governance and regulatory 
bodies, may require access to your study records to verify study procedures 
and/or data. In all cases when dealing with your information, these people 
are required to comply with privacy laws that protect you. 
 
The results of the research will be made available to other medical personnel 
through journals or meetings, but you will not be identifiable in these 
communications. By taking part in this study you agree not to restrict the use 
of any data even if you withdraw. Your rights under any applicable data 
protection laws are not affected. 
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Will I find out the results of the study? 
The study will be completed as a PhD (Nursing) project and may be 
published in journals or discussed at professional meetings. Due to the 
nature of the study, no individual results will be available for the newly 
developed questionnaire; however, results from the depression assessment 
will be given to yourself, your Cardiologist, your GP and the staff of the 
Cardiac Rehabilitation and Heart Failure Service.  
A summary of the overall research findings will be provided for interested 
participants. 
 
Who has reviewed the study? 
The Sir Charles Gairdner Group Human Research Ethics Committee has 
reviewed this study and has given its approval for the conduct of this 
research study. In doing so this study conforms to the principles set out by 
the National Statement on Ethical Conduct in Research involving Humans 
and according to the Good Clinical Practice Guidelines. 
 
This study has also been approved by Curtin University of Technology 
Human Research Ethics Committee (Approval Number HR 151/2007). If 
needed, verification of approval can be obtained either in writing to the Curtin 
University Human Research Ethics Committee, c/- Office of Research and 
Development, Curtin University of Technology, GPO Box U 1987, Perth, 
6845 or by telephoning 9266 2784 or by emailing hrec@curtin.edu.au 
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                                  Consent Form 
 
Study Title:  Identifying those at risk of depression following a 
diagnosis of acute coronary syndrome: Developing a 
screening intervention for use in the acute care 
hospital setting. 
 
Investigators:  Ms Jo Crittenden, Prof. Gavin Leslie, Prof. Patricia 
Davidson, Clinical Prof. Peter Thompson, Prof. Sean 
Hood 
 
Participant Name:_________________________________________ 
 
Date of Birth: _______________ 
 
6. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
 
7. I have been told about the possible advantages and risks of taking part in 
the study and I understand what I am being asked to do. 
 
8. I have been able to have a member of my family or a friend with me while 
I was told about the study.  I have been able to ask questions and all 
questions have been answered satisfactorily. 
 
9. I know that I do not have to take part in the study and that I can withdraw 
at any time during the study without affecting my future medical care.  My 
participation in the study does not affect any right to compensation, which 
I may have under statute or common law. 
 
10. I agree to take part in this research study and for the data obtained to be 
published provided my name or other identifying information is not used. 
 
If you are unclear about anything you have read in the Participant 
Information Sheet or this Consent Form, please speak to your doctor 
before signing this Consent Form. 
 
 
Name of Participant    Signature    Date 
 
 
Name of Investigator   Signature    Date 
 
The Sir Charles Gairdner Group Human Research Ethics Committee has given ethics 
approval for the conduct of this project.  If you have any ethical concerns regarding the study 
you can contact the secretary of the Sir Charles Gairdner Group Human Research Ethics 
Committee on telephone No. (08) 9346 2999.  
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Appendix O: Patient Health Questionnaire - 9 
 
